Maryland (State or other jurisdiction of incorporation or organization) | 13-3974868 (I.R.S. Employer Identification No.) | |
350 Park Avenue, 20th Floor, New York, New York (Address of principal executive offices) | 10022 (Zip Code) |
Title of Each Class | Name of Each Exchange on Which Registered | |
Common Stock, par value $0.01 per share | New York Stock Exchange | |
7.50% Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share | New York Stock Exchange | |
8.00% Senior Notes due 2042 | New York Stock Exchange |
Large accelerated filer x | Accelerated filer o | |
Non-accelerated filer o | Smaller reporting company o |
• | Adverse developments involving major financial institutions or involving one of our lenders could result in a rapid reduction in our ability to borrow and materially adversely affect our business, profitability and liquidity. As of December 31, 2016, we had amounts outstanding under repurchase agreements with 31 separate lenders. A material adverse development involving one or more major financial institutions or the financial markets in general could result in our lenders reducing our access to funds available under our repurchase agreements or terminating such repurchase agreements altogether. Because all of our repurchase agreements are uncommitted and renewable at the discretion of our lenders, our lenders could determine to reduce or terminate our access to future borrowings at virtually any time, which could materially adversely affect our business and profitability. Furthermore, if a number of our lenders became unwilling or unable to continue to provide us with financing, we could be forced to sell assets, including MBS in an unrealized loss position, in order to maintain liquidity. Forced sales, particularly under adverse market conditions may result in lower sales prices than ordinary market sales made in the normal course of business. If our residential mortgage investments were liquidated at prices below our amortized cost (i.e., the cost basis) of such assets, we would incur losses, which could adversely affect our earnings. In addition, uncertainty in the global finance market and weak economic conditions in Europe, including as a result of the United Kingdom’s decision to exit from the European Union (commonly referred to as “Brexit”), could cause the conditions described above to have a more pronounced affect on our European counterparties. |
• | Our profitability may be materially adversely affected by a reduction in our leverage. As long as we earn a positive spread between interest and other income we earn on our leveraged assets and our borrowing costs, we believe that we can generally increase our profitability by using greater amounts of leverage. There can be no assurance, however, that repurchase financing will remain an efficient source of long-term financing for our assets. The amount of leverage that |
• | If we are unable to renew our borrowings at acceptable interest rates, it may force us to sell assets under adverse market conditions, which may materially adversely affect our liquidity and profitability. Since we rely primarily on borrowings under repurchase agreements to finance our residential mortgage investments, our ability to achieve our investment objectives depends on our ability to borrow funds in sufficient amounts and on acceptable terms, and on our ability to renew or replace maturing borrowings on a continuous basis. Our repurchase agreement credit lines are renewable at the discretion of our lenders and, as such, do not contain guaranteed roll-over terms. Our ability to enter into repurchase transactions in the future will depend on the market value of our residential mortgage investments pledged to secure the specific borrowings, the availability of acceptable financing and market liquidity and other conditions existing in the lending market at that time. If we are not able to renew or replace maturing borrowings, we could be forced to sell assets, including MBS in an unrealized loss position, in order to maintain liquidity. Forced sales, particularly under adverse market conditions could result in lower sales prices than ordinary market sales made in the normal course of business. If our residential mortgage investments were liquidated at prices below our amortized cost (i.e., the cost basis) of such assets, we would incur losses, which could materially adversely affect our earnings. |
• | A decline in the market value of our assets may result in margin calls that may force us to sell assets under adverse market conditions, which may materially adversely affect our liquidity and profitability. In general, the market value of our residential mortgage investments is impacted by changes in interest rates, prevailing market yields and other market conditions, including home prices A decline in the market value of our residential mortgage investments may limit our ability to borrow against such assets or result in lenders initiating margin calls, which require a pledge of additional collateral or cash to re-establish the required ratio of borrowing to collateral value, under our repurchase agreements. Posting additional collateral or cash to support our credit will reduce our liquidity and limit our ability to leverage our assets, which could materially adversely affect our business. As a result, we could be forced to sell a portion of our assets, including MBS in an unrealized loss position, in order to maintain liquidity. |
• | If a counterparty to our repurchase transactions defaults on its obligation to resell the underlying security back to us at the end of the transaction term or if we default on our obligations under the repurchase agreement, we could incur losses. When we engage in repurchase transactions, we generally transfer securities to lenders (i.e., repurchase agreement counterparties) and receive cash from such lenders. Because the cash we receive from the lender when we initially transfer the securities to the lender is less than the value of those securities (this difference is referred to as the “haircut”), if the lender defaults on its obligation to transfer the same securities back to us, we would incur a loss on the transaction equal to the amount of the haircut (assuming there was no change in the value of the securities). See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Annual Report on Form 10-K, for further discussion regarding risks related to exposure to financial institution counterparties in light of recent market conditions. Our exposure to defaults by counterparties may be more pronounced during periods of significant volatility in the market conditions for mortgages and mortgage-related assets as well as the broader financial markets. At December 31, 2016, we had greater than 5% stockholders’ equity at risk to the following repurchase agreement counterparties: Wells Fargo (approximately 12.8%), RBC (approximately 9.0%), Goldman Sachs (approximately 7.0%), Credit Suisse (approximately 6.3%) and UBS (approximately 5.5%). |
• | Our use of repurchase agreements to borrow money may give our lenders greater rights in the event of bankruptcy. Borrowings made under repurchase agreements may qualify for special treatment under the U.S. Bankruptcy Code. If a lender under one of our repurchase agreements defaults on its obligations, it may be difficult for us to recover our assets pledged as collateral to such lender. In the event of the insolvency or bankruptcy of a lender during the term of a repurchase |
• | Changes in interest rates, cyclical or otherwise, may materially adversely affect our profitability. Interest rates are highly sensitive to many factors, including fiscal and monetary policies and domestic and international economic and political conditions, as well as other factors beyond our control. In general, we finance the acquisition of our investments through borrowings in the form of repurchase transactions, which exposes us to interest rate risk on the financed assets. The cost of our borrowings is based on prevailing market interest rates. Because the terms of our repurchase transactions typically range from one to six months at inception, the interest rates on our borrowings generally adjust more frequently (as new repurchase transactions are entered into upon the maturity of existing repurchase transactions) than the interest rates on our investments. During a period of rising interest rates, our borrowing costs generally will increase at a faster pace than our interest earnings on the leveraged portion of our investment portfolio, which could result in a decline in our net interest spread and net interest margin. The severity of any such decline would depend on our asset/liability composition, including the impact of hedging transactions, at the time as well as the magnitude and period over which interest rates increase. Further, an increase in short-term interest rates could also have a negative impact on the market value of our residential mortgage investments. If any of these events happen, we could experience a decrease in net income or incur a net loss during these periods, which may negatively impact our distributions to stockholders. |
• | Interest rate caps on the mortgages collateralizing our MBS may materially adversely affect our profitability if short-term interest rates increase. The coupons earned on ARM-MBS adjust over time as interest rates change (typically after an initial fixed-rate period for Hybrids). The financial markets primarily determine the interest rates that we pay on the repurchase transactions used to finance the acquisition of our MBS; however, the level of adjustment to the interest rates earned on our ARM-MBS is typically limited by contract (or in certain cases by state or federal law). The interim and lifetime interest rate caps on the mortgages collateralizing our MBS limit the amount by which the interest rates on such assets can adjust. Interim interest rate caps limit the amount interest rates on a particular ARM can adjust during the next adjustment period. Lifetime interest rate caps limit the amount interest rates can adjust upward from inception through maturity of a particular ARM. Our repurchase transactions are not subject to similar restrictions. Accordingly, in a sustained period of rising interest rates or a period in which interest rates rise rapidly, we could experience a decrease in net income or a net loss because the interest rates paid by us on our borrowings (excluding the impact of hedging transactions) could increase without limitation (as new repurchase transactions are entered into upon the maturity of existing repurchase transactions) while increases in the interest rates earned on the mortgages collateralizing our MBS could be limited due to interim or lifetime interest rate caps. |
• | Adjustments of interest rates on our borrowings may not be matched to interest rate indexes on our MBS. In general, the interest rates on our repurchase transactions are based on LIBOR, while the interest rates on our ARM-MBS may be indexed to LIBOR or CMT rate. Accordingly, any increase in LIBOR relative to one-year CMT rates will generally result in an increase in our borrowing costs that is not matched by a corresponding increase in the interest earned on our ARM- |
• | A flat or inverted yield curve may adversely affect ARM-MBS prepayment rates and supply. Our net interest income varies primarily as a result of changes in interest rates as well as changes in interest rates across the yield curve. When the differential between short-term and long-term benchmark interest rates narrows, the yield curve is said to be “flattening.” In addition, a flatter yield curve generally leads to fixed-rate mortgage rates that are closer to the interest rates available on ARMs, potentially decreasing the supply of ARM-MBS. At times, short-term interest rates may increase and exceed long-term interest rates, causing an inverted yield curve. When the yield curve is inverted, fixed-rate mortgage rates may approach or be lower than mortgage rates on ARMs, further increasing ARM-MBS prepayments and further negatively impacting ARM-MBS supply. Increases in prepayments on our MBS portfolio cause our premium amortization to accelerate, lowering the yield on such assets. If this happens, we could experience a decrease in net income or incur a net loss during these periods, which may negatively impact our distributions to stockholders. |
• | interest rate hedging can be expensive, particularly during periods of rising and volatile interest rates; |
• | available interest rate hedges may not correspond directly with the interest rate risk for which protection is sought; |
• | the duration of the hedge may not match the duration of the related liability; |
• | the credit quality of the party owing money on the hedge may be downgraded to such an extent that it impairs our ability to sell or assign our side of the hedging transaction; and |
• | the party owing money in the hedging transaction may default on its obligation to pay. |
• | “business combination” provisions that, subject to limitations, prohibit certain business combinations between us and an “interested stockholder” (defined generally as any person who beneficially owns 10% or more of the voting power of our outstanding voting stock or an affiliate or associate of ours who, at any time within the two-year period immediately prior to the date in question, was the beneficial owner of 10% or more of the voting power of our then outstanding stock) or an affiliate of an interested stockholder for five years after the most recent date on which the stockholder becomes an interested stockholder, and thereafter impose two supermajority stockholder voting requirements to approve these combinations (unless our common stockholders receive a minimum price, as defined under Maryland law, for their shares in the form of cash or other consideration in the same form as previously paid by the interested stockholder for its shares); and |
• | “control share” provisions that provide that holders of “control shares” of our company (defined as voting shares of stock which, when aggregated with all other shares controlled by the acquiring stockholder, entitle the stockholder to exercise one of three increasing ranges of voting power in electing directors) acquired in a “control share acquisition” (defined as the direct or indirect acquisition of ownership or control of “control shares”) have no voting rights except to the extent approved by our stockholders by the affirmative vote of at least two-thirds of all the votes entitled to be cast on the matter, excluding all interested shares. |
2016 | 2015 | |||||||||||||||
Quarter Ended | High | Low | High | Low | ||||||||||||
March 31 | $ | 6.98 | $ | 5.61 | $ | 8.22 | $ | 7.68 | ||||||||
June 30 | 7.38 | 6.69 | 8.04 | 7.39 | ||||||||||||
September 30 | 7.86 | 7.21 | 7.80 | 5.78 | ||||||||||||
December 31 | 8.05 | 7.03 | 7.17 | 6.17 |
Year | Declaration Date | Record Date | Payment Date | Dividend per Share | |||||||
2016 | December 14, 2016 | December 28, 2016 | January 31, 2017 | $ | 0.20 | (1) | |||||
September 15, 2016 | September 28, 2016 | October 31, 2016 | 0.20 | ||||||||
June 14, 2016 | June 28, 2016 | July 29, 2016 | 0.20 | ||||||||
March 11, 2016 | March 28, 2016 | April 29, 2016 | 0.20 | ||||||||
2015 | December 9, 2015 | December 28, 2015 | January 29, 2016 | $ | 0.20 | ||||||
September 17, 2015 | September 29, 2015 | October 30, 2015 | 0.20 | ||||||||
June 15, 2015 | June 29, 2015 | July 31, 2015 | 0.20 | ||||||||
March 13, 2015 | March 27, 2015 | April 30, 2015 | 0.20 |
(1) | At December 31, 2016, the Company had accrued dividends and dividend equivalents payable of $74.7 million related to the common stock dividend declared on December 14, 2016. |
Month | Total Number of Shares Purchased | Weighted Average Price Paid Per Share (1) | Total Number of Shares Repurchased as Part of Publicly Announced Repurchase Program or Employee Plan | Maximum Number of Shares that May Yet be Purchased Under the Repurchase Program or Employee Plan | |||||||||
October 1-31, 2016: | |||||||||||||
Repurchase Program (2) | — | $ | — | — | 6,616,355 | ||||||||
Employee Transactions (3) | — | — | N/A | N/A | |||||||||
November 1-30, 2016: | |||||||||||||
Repurchase Program (2) | — | — | — | 6,616,355 | |||||||||
Employee Transactions (3) | — | — | N/A | N/A | |||||||||
December 1-31, 2016: | |||||||||||||
Repurchase Program (2) | — | — | — | 6,616,355 | |||||||||
Employee Transactions (3) | 270,095 | 7.67 | N/A | N/A | |||||||||
Total Repurchase Program (2) | — | $ | — | — | 6,616,355 | ||||||||
Total Employee Transactions (3) | 270,095 | $ | 7.67 | N/A | N/A |
(1) | Includes brokerage commissions. |
(2) | As of December 31, 2016, we had repurchased an aggregate of 3,383,645 shares under the Repurchase Program. |
(3) | Our Equity Plan provides that the value of the shares delivered or withheld be based on the price of our common stock on the date the relevant transaction occurs. |
Award (1) | Number of securities to be issued upon exercise of outstanding options, warrants and rights | Weighted-average exercise price of outstanding options, warrants and rights | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first column of this table) | ||||||
RSUs | 2,058,099 | ||||||||
Total | 2,058,099 | (2) | 8,162,746 | (3) |
At or/For the Year Ended December 31, | ||||||||||||||||||||
(Dollars in Thousands, Except per Share Amounts) | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
Operating Data: | ||||||||||||||||||||
Interest Income | $ | 457,169 | $ | 492,143 | $ | 463,817 | $ | 482,940 | $ | 499,157 | ||||||||||
Interest expense | (193,355 | ) | (176,948 | ) | (159,808 | ) | (164,013 | ) | (171,670 | ) | ||||||||||
Net impairment losses recognized in earnings (1) | (485 | ) | (705 | ) | — | — | (1,200 | ) | ||||||||||||
Net gain on residential whole loans held at fair value | 59,684 | 17,722 | 116 | — | — | |||||||||||||||
Gain on sales of MBS and U.S. Treasury securities, net (2) | 35,837 | 34,900 | 37,497 | 25,825 | 9,001 | |||||||||||||||
Unrealized net gains and net interest income from Linked Transactions | — | — | 17,092 | 3,225 | 12,610 | |||||||||||||||
Other income/(loss), net | 13,802 | (1,457 | ) | 80 | (7,298 | ) | 10 | |||||||||||||
Operating and other expense | (59,984 | ) | (52,429 | ) | (45,290 | ) | (37,970 | ) | (41,069 | ) | ||||||||||
Net income | $ | 312,668 | $ | 313,226 | $ | 313,504 | $ | 302,709 | $ | 306,839 | ||||||||||
Preferred stock dividends | 15,000 | 15,000 | 15,000 | 13,750 | 8,160 | |||||||||||||||
Issuance costs of redeemed preferred stock (3) | — | — | — | 3,947 | — | |||||||||||||||
Net income available to common stock and participating securities | $ | 297,668 | $ | 298,226 | $ | 298,504 | $ | 285,012 | $ | 298,679 | ||||||||||
Earnings per share — basic and diluted | $ | 0.80 | $ | 0.80 | $ | 0.81 | $ | 0.78 | $ | 0.83 | ||||||||||
Dividends declared per share of common stock (4) | $ | 0.80 | $ | 0.80 | $ | 0.80 | $ | 1.64 | $ | 0.88 | ||||||||||
Dividends declared per share of preferred stock (5) | $ | 1.875 | $ | 1.875 | $ | 1.875 | $ | 2.136 | $ | 2.125 | ||||||||||
Balance Sheet Data: | ||||||||||||||||||||
MBS and CRT securities | $ | 9,969,163 | $ | 11,356,643 | $ | 10,762,622 | $ | 11,371,358 | $ | 12,607,625 | ||||||||||
Residential whole loans, at carrying value | 590,540 | 271,845 | 207,923 | — | — | |||||||||||||||
Residential whole loans, at fair value | 814,682 | 623,276 | 143,472 | — | — | |||||||||||||||
Cash and cash equivalents | 260,112 | 165,007 | 182,437 | 565,370 | 401,293 | |||||||||||||||
Linked Transactions | — | — | 398,336 | 28,181 | 12,704 | |||||||||||||||
Total assets | 12,484,022 | 13,162,551 | 12,354,242 | 12,469,379 | 13,509,494 | |||||||||||||||
Repurchase agreements and other advances | 8,687,268 | 9,387,622 | 8,267,388 | 8,339,297 | 8,752,472 | |||||||||||||||
Securitized debt | — | 21,868 | 110,072 | 363,676 | 638,760 | |||||||||||||||
Swaps (in a liability position) | 46,954 | 70,526 | 62,198 | 28,217 | 63,034 | |||||||||||||||
Total liabilities | 9,450,120 | 10,195,290 | 9,150,970 | 9,327,128 | 10,198,488 | |||||||||||||||
Preferred stock, liquidation preference | 200,000 | 200,000 | 200,000 | 200,000 | 96,000 | |||||||||||||||
Total stockholders’ equity | 3,033,902 | 2,967,261 | 3,203,272 | 3,142,251 | 3,311,006 | |||||||||||||||
Other Data: | ||||||||||||||||||||
Average total assets | $ | 12,836,580 | $ | 13,669,055 | $ | 12,542,584 | $ | 13,192,285 | $ | 12,942,171 | ||||||||||
Average total stockholders’ equity | $ | 2,965,570 | $ | 3,129,461 | $ | 3,230,932 | $ | 3,262,458 | $ | 2,945,687 | ||||||||||
Return on average total assets (6) | 2.32 | % | 2.18 | % | 2.38 | % | 2.16 | % | 2.31 | % | ||||||||||
Return on average total stockholders’ equity (7) | 10.54 | % | 10.01 | % | 9.70 | % | 9.28 | % | 10.42 | % | ||||||||||
Total average stockholders’ equity to total average assets (8) | 23.10 | % | 22.89 | % | 25.75 | % | 24.73 | % | 22.76 | % | ||||||||||
Dividend payout ratio (9) | 1.00 | 1.00 | 0.99 | 1.10 | 1.06 | |||||||||||||||
Book value per share of common stock (10) | $ | 7.62 | $ | 7.47 | $ | 8.12 | $ | 8.06 | $ | 8.99 |
(1) | Reflects OTTI recognized through earnings related to Non-Agency MBS. |
(2) | 2016: We sold Non-Agency MBS for $85.6 million, realizing gross gains of $35.8 million. 2015: We sold Non-Agency MBS for $70.7 million, realizing gross gains of $34.9 million. 2014: We sold Non-Agency MBS for $123.9 million, realizing gross gains of $37.5 million. 2013: We sold Non-Agency MBS for $152.6 million, realizing gross gains of $25.8 million and sold U.S. Treasury securities for $422.2 million, realizing net losses of approximately $24,000. 2012: We sold Agency MBS for $168.9 million, realizing gross gains of $9.0 million. |
(3) | Issuance costs of redeemed preferred stock represent the original offering costs related to the 8.50% Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”), which was redeemed on May 16, 2013. |
(4) | 2013: Includes special cash dividends paid totaling $0.78 per share. |
(5) | 2013: Reflects dividends declared per share on Series A Preferred Stock and 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”) of $0.80 and $1.33, respectively. |
(6) | Reflects net income available to common stock and participating securities divided by average total assets. |
(7) | Reflects net income divided by average total stockholders’ equity. |
December 31, 2016 | |||||||||||||||
Underlying Mortgages | Agency MBS Fair Value (1) | Non-Agency MBS Fair Value (2) | Total MBS (1)(2) | Percent of Total | |||||||||||
(In Thousands) | |||||||||||||||
Hybrids in contractual fixed-rate period | $ | 918,371 | $ | 138,583 | $ | 1,056,954 | 15.3 | % | |||||||
Hybrids in adjustable period | 1,323,356 | 1,954,578 | 3,277,934 | 47.5 | |||||||||||
15-year fixed rate | 1,439,461 | 5,856 | 1,445,317 | 20.9 | |||||||||||
Greater than 15-year fixed rate | — | 1,032,276 | 1,032,276 | 14.9 | |||||||||||
Floaters | 54,705 | 39,832 | 94,537 | 1.4 | |||||||||||
Total | $ | 3,735,893 | $ | 3,171,125 | $ | 6,907,018 | 100.0 | % |
Agency MBS | Legacy Non-Agency MBS | 3 Year Step-up Securities (1) | MBS Portfolio | Residential Whole Loans, at Carrying Value (2) | Residential Whole Loans, at Fair Value | Other, net (3) | Total | |||||||||||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||||||||||||
Fair Value/Carrying Value | $ | 3,738,497 | $ | 3,171,125 | $ | 2,654,691 | $ | 9,564,313 | $ | 590,540 | $ | 814,682 | $ | 895,089 | $ | 11,864,624 | ||||||||||||||||
Less Repurchase Agreements | (3,095,020 | ) | (2,195,509 | ) | (2,078,684 | ) | (7,369,213 | ) | (343,063 | ) | (488,787 | ) | (271,205 | ) | (8,472,268 | ) | ||||||||||||||||
Less FHLB advances | (215,000 | ) | — | — | (215,000 | ) | — | — | — | (215,000 | ) | |||||||||||||||||||||
Less Senior Notes | — | — | — | — | — | — | (96,733 | ) | (96,733 | ) | ||||||||||||||||||||||
Equity Allocated | $ | 428,477 | $ | 975,616 | $ | 576,007 | $ | 1,980,100 | $ | 247,477 | $ | 325,895 | $ | 527,151 | $ | 3,080,623 | ||||||||||||||||
Less Swaps at Market Value | — | — | — | — | — | — | (46,721 | ) | (46,721 | ) | ||||||||||||||||||||||
Net Equity Allocated | $ | 428,477 | $ | 975,616 | $ | 576,007 | $ | 1,980,100 | $ | 247,477 | $ | 325,895 | $ | 480,430 | $ | 3,033,902 | ||||||||||||||||
Debt/Net Equity Ratio (4) | 7.7 | x | 2.3 | x | 3.6 | x | 1.4 | x | 1.5 | x | 3.1 | x |
(1) | 3 Year Step-up securities are MBS that are backed primarily by securitized re-performing and non-performing loans. The securities are structured such that the coupon increases up to 300 basis points at 36 months from issuance or sooner. Included with the balance of Non-Agency MBS reported on our consolidated balance sheets. |
(2) | The carrying value of such loans reflects the purchase price, accretion of income, cash received and provision for loan losses since acquisition. At December 31, 2016, the fair value of such loans is estimated to be approximately $621.5 million. |
(3) | Includes cash and cash equivalents and restricted cash, securities obtained and pledged as collateral, CRT securities, other assets, obligation to return securities obtained as collateral of $510.8 million and other liabilities. |
(4) | Represents the sum of borrowings under repurchase agreements and FHLB advances as a multiple of net equity allocated. The numerator of our Total Debt/Net Equity Ratio also includes the obligation to return securities obtained as collateral of $510.8 million and Senior Notes. |
(Dollars in Thousands) | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Loan Age (Months) (2) | Weighted Average Coupon (2) | 3 Month Average CPR | ||||||||||||||||
15-Year Fixed Rate: | |||||||||||||||||||||||
Low Loan Balance (3) | $ | 1,170,788 | 104.3 | % | 103.0 | % | $ | 1,206,174 | 55 | 2.97 | % | 11.2 | % | ||||||||||
HARP (4) | 116,790 | 104.7 | 103.0 | 120,290 | 54 | 2.96 | 12.1 | ||||||||||||||||
Other (Post June 2009) (5) | 106,343 | 104.0 | 105.7 | 112,400 | 75 | 4.14 | 14.3 | ||||||||||||||||
Other (Pre June 2009) (6) | 564 | 104.9 | 105.9 | 597 | 91 | 4.50 | 28.8 | ||||||||||||||||
Total 15-Year Fixed Rate | $ | 1,394,485 | 104.3 | % | 103.2 | % | $ | 1,439,461 | 57 | 3.06 | % | 11.5 | % | ||||||||||
Hybrid: | |||||||||||||||||||||||
Other (Post June 2009) (5) | $ | 1,370,019 | 104.4 | % | 104.8 | % | $ | 1,436,184 | 67 | 2.99 | % | 19.9 | % | ||||||||||
Other (Pre June 2009) (6) | 720,419 | 101.7 | 105.6 | 761,052 | 120 | 3.03 | 17.0 | ||||||||||||||||
Total Hybrid | $ | 2,090,438 | 103.5 | % | 105.1 | % | $ | 2,197,236 | 86 | 3.01 | % | 18.9 | % | ||||||||||
CMO/Other | $ | 96,379 | 102.5 | % | 102.9 | % | $ | 99,196 | 187 | 2.81 | % | 14.7 | % | ||||||||||
Total Portfolio | $ | 3,581,302 | 103.8 | % | 104.3 | % | $ | 3,735,893 | 77 | 3.02 | % | 15.9 | % |
(Dollars in Thousands) | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Loan Age (Months) (2) | Weighted Average Coupon (2) | 3 Month Average CPR | ||||||||||||||||
15-Year Fixed Rate: | |||||||||||||||||||||||
Low Loan Balance (3) | $ | 1,430,258 | 104.3 | % | 103.1 | % | $ | 1,475,086 | 44 | 2.99 | % | 8.4 | % | ||||||||||
HARP (4) | 146,821 | 104.7 | 103.1 | 151,387 | 43 | 2.98 | 7.9 | ||||||||||||||||
Other (Post June 2009) (5) | 144,596 | 103.9 | 106.1 | 153,477 | 63 | 4.14 | 16.1 | ||||||||||||||||
Other (Pre June 2009) (6) | 745 | 104.9 | 106.8 | 796 | 79 | 4.50 | 28.9 | ||||||||||||||||
Total 15-Year Fixed Rate | $ | 1,722,420 | 104.3 | % | 103.4 | % | $ | 1,780,746 | 45 | 3.09 | % | 9.1 | % | ||||||||||
Hybrid: | |||||||||||||||||||||||
Other (Post June 2009) (5) | $ | 1,811,007 | 104.4 | % | 104.8 | % | $ | 1,897,030 | 56 | 2.89 | % | 15.6 | % | ||||||||||
Other (Pre June 2009) (6) | 899,185 | 101.7 | 105.7 | 950,666 | 109 | 2.60 | 9.3 | ||||||||||||||||
Total Hybrid | $ | 2,710,192 | 103.5 | % | 105.1 | % | $ | 2,847,696 | 73 | 2.80 | % | 13.5 | % | ||||||||||
CMO/Other | $ | 117,791 | 102.5 | % | 104.2 | % | $ | 122,771 | 175 | 2.52 | % | 12.2 | % | ||||||||||
Total Portfolio | $ | 4,550,403 | 103.8 | % | 104.4 | % | $ | 4,751,213 | 65 | 2.90 | % | 11.8 | % |
Coupon | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Loan Age (Months) (2) | Weighted Average Loan Rate | Low Loan Balance and/or HARP (3) | 3 Month Average CPR | ||||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||||||
15-Year Fixed Rate: | ||||||||||||||||||||||||||
2.5% | $ | 700,388 | 104.0 | % | 101.6 | % | $ | 711,696 | 48 | 3.04 | % | 100 | % | 9.9 | % | |||||||||||
3.0% | 288,648 | 105.9 | 103.3 | 298,311 | 54 | 3.49 | 100 | 11.3 | ||||||||||||||||||
3.5% | 7,244 | 103.5 | 104.6 | 7,576 | 74 | 4.18 | 100 | 15.7 | ||||||||||||||||||
4.0% | 343,105 | 103.5 | 105.9 | 363,258 | 73 | 4.40 | 80 | 14.2 | ||||||||||||||||||
4.5% | 55,100 | 105.2 | 106.4 | 58,620 | 77 | 4.88 | 34 | 14.5 | ||||||||||||||||||
Total 15-Year Fixed Rate | $ | 1,394,485 | 104.3 | % | 103.2 | % | $ | 1,439,461 | 57 | 3.54 | % | 92 | % | 11.5 | % |
Coupon | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Loan Age (Months) (2) | Weighted Average Loan Rate | Low Loan Balance and/or HARP (3) | 3 Month Average CPR | ||||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||||||
15-Year Fixed Rate: | ||||||||||||||||||||||||||
2.5% | $ | 834,689 | 104.0 | % | 101.5 | % | $ | 846,925 | 36 | 3.04 | % | 100 | % | 6.9 | % | |||||||||||
3.0% | 355,439 | 105.9 | 103.4 | 367,471 | 42 | 3.49 | 100 | 8.0 | ||||||||||||||||||
3.5% | 9,238 | 103.5 | 104.9 | 9,691 | 62 | 4.18 | 100 | 12.6 | ||||||||||||||||||
4.0% | 448,064 | 103.5 | 106.4 | 476,793 | 61 | 4.40 | 79 | 13.1 | ||||||||||||||||||
4.5% | 74,990 | 105.2 | 106.5 | 79,866 | 65 | 4.88 | 33 | 13.3 | ||||||||||||||||||
Total 15-Year Fixed Rate | $ | 1,722,420 | 104.3 | % | 103.4 | % | $ | 1,780,746 | 45 | 3.57 | % | 92 | % | 9.1 | % |
(Dollars in Thousands) | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Coupon (2) | Weighted Average Loan Age (Months) (2) | Weighted Average Months to Reset (3) | Interest Only (4) | 3 Month Average CPR | ||||||||||||||||||||
Hybrid Post June 2009: | |||||||||||||||||||||||||||||
Agency 5/1 | $ | 551,736 | 104.3 | % | 105.7 | % | $ | 583,318 | 2.93 | % | 76 | 6 | 25 | % | 17.7 | % | |||||||||||||
Agency 7/1 | 618,414 | 104.5 | 104.3 | 645,200 | 3.00 | 62 | 21 | 24 | 22.8 | ||||||||||||||||||||
Agency 10/1 | 199,869 | 104.7 | 103.9 | 207,666 | 3.13 | 58 | 61 | 64 | 17.1 | ||||||||||||||||||||
Total Hybrids Post June 2009 | $ | 1,370,019 | 104.4 | % | 104.8 | % | $ | 1,436,184 | 2.99 | % | 67 | 21 | 30 | % | 19.9 | % | |||||||||||||
Hybrid Pre June 2009: | |||||||||||||||||||||||||||||
Coupon < 4.5% (5) | $ | 691,572 | 101.7 | % | 105.6 | % | $ | 730,626 | 2.92 | % | 121 | 6 | 33 | % | 16.9 | % | |||||||||||||
Coupon >= 4.5% (6) | 28,847 | 101.4 | 105.5 | 30,426 | 5.71 | 112 | 7 | 69 | 18.1 | ||||||||||||||||||||
Total Hybrids Pre June 2009 | $ | 720,419 | 101.7 | % | 105.6 | % | $ | 761,052 | 3.03 | % | 120 | 6 | 34 | % | 17.0 | % | |||||||||||||
Total Hybrids | $ | 2,090,438 | 103.5 | % | 105.1 | % | $ | 2,197,236 | 3.01 | % | 86 | 15 | 32 | % | 18.9 | % |
(Dollars in Thousands) | Current Face | Weighted Average Purchase Price | Weighted Average Market Price | Fair Value (1) | Weighted Average Coupon (2) | Weighted Average Loan Age (Months) (2) | Weighted Average Months to Reset (3) | Interest Only (4) | 3 Month Average CPR | ||||||||||||||||||||
Hybrid Post June 2009: | |||||||||||||||||||||||||||||
Agency 5/1 | $ | 723,853 | 104.2 | % | 105.7 | % | $ | 765,426 | 2.62 | % | 64 | 7 | 23 | % | 15.6 | % | |||||||||||||
Agency 7/1 | 838,505 | 104.5 | 104.2 | 873,765 | 3.04 | 51 | 32 | 22 | 16.7 | ||||||||||||||||||||
Agency 10/1 | 248,649 | 104.7 | 103.7 | 257,839 | 3.18 | 47 | 72 | 61 | 11.5 | ||||||||||||||||||||
Total Hybrids Post June 2009 | $ | 1,811,007 | 104.4 | % | 104.8 | % | $ | 1,897,030 | 2.89 | % | 56 | 27 | 28 | % | 15.6 | % | |||||||||||||
Hybrid Pre June 2009: | |||||||||||||||||||||||||||||
Coupon < 4.5% (5) | $ | 853,168 | 101.7 | % | 105.7 | % | $ | 901,870 | 2.43 | % | 109 | 6 | 59 | % | 8.9 | % | |||||||||||||
Coupon >= 4.5% (6) | 46,017 | 101.5 | 106.0 | 48,796 | 5.73 | 102 | 18 | 73 | 17.4 | ||||||||||||||||||||
Total Hybrids Pre June 2009 | $ | 899,185 | 101.7 | % | 105.7 | % | $ | 950,666 | 2.60 | % | 109 | 6 | 60 | % | 9.3 | % | |||||||||||||
Total Hybrids | $ | 2,710,192 | 103.5 | % | 105.1 | % | $ | 2,847,696 | 2.80 | % | 73 | 20 | 39 | % | 13.5 | % |
December 31, | |||||||||
(In Thousands) | 2016 | 2015 | |||||||
Non-Agency MBS | |||||||||
Face/Par | $ | 6,206,598 | $ | 6,961,493 | |||||
Fair Value | 5,825,816 | 6,420,817 | |||||||
Amortized Cost | 5,234,223 | 5,861,843 | |||||||
Purchase Discount Designated as Credit Reserve and OTTI | (694,241 | ) | (1) | (787,541 | ) | (2) | |||
Purchase Discount Designated as Accretable | (278,191 | ) | (312,182 | ) | |||||
Purchase Premiums | 57 | 73 |
For the Year Ended December 31, | ||||||||||||||||
2016 | 2015 | |||||||||||||||
Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | |||||||||||||
(In Thousands) | ||||||||||||||||
Balance at beginning of period | $ | (787,541 | ) | $ | (312,182 | ) | $ | (900,557 | ) | $ | (399,564 | ) | ||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | — | — | (15,543 | ) | 1,832 | |||||||||||
Impact of RMBS Issuer settlement (2) | — | (59,900 | ) | — | — | |||||||||||
Accretion of discount | — | 80,548 | — | 93,173 | ||||||||||||
Realized credit losses | 64,217 | — | 80,821 | — | ||||||||||||
Purchases | (25,999 | ) | 13,094 | (1,200 | ) | (4,925 | ) | |||||||||
Sales | 17,863 | 37,953 | 8,525 | 38,420 | ||||||||||||
Net impairment losses recognized in earnings | (485 | ) | — | (705 | ) | — | ||||||||||
Transfers/release of credit reserve | 37,704 | (37,704 | ) | 41,118 | (41,118 | ) | ||||||||||
Balance at end of period | $ | (694,241 | ) | $ | (278,191 | ) | $ | (787,541 | ) | $ | (312,182 | ) |
(2) | Includes the impact of approximately $61.8 million and $7.0 million of cash proceeds (a one-time payment) received by us during the year ended December 31, 2016 in connection with the settlements of litigation related to certain Countrywide and Citigroup sponsored residential mortgage backed securitization trusts, respectively. |
For the Year Ended December 31, | |||||||||||||||||
2016 | 2015 | 2014 | |||||||||||||||
Legacy Non-Agency MBS | 3 Year Step-up Securities | Legacy Non-Agency MBS | 3 Year Step-up Securities | Legacy Non-Agency MBS | 3 Year Step-up Securities | ||||||||||||
Non-Agency MBS | |||||||||||||||||
Coupon Yield (1) | 5.24 | % | 3.82 | % | 5.08 | % | 3.61 | % | 5.19 | % | 3.55 | % | |||||
Effective Yield Adjustment (2) | 2.66 | 0.08 | 2.54 | 0.07 | 2.55 | 0.14 | |||||||||||
Net Yield | 7.90 | % | 3.90 | % | 7.62 | % | 3.68 | % | 7.74 | % | 3.69 | % |
(1) | Reflects coupon interest income divided by the average amortized cost. The discounted purchase price on Legacy Non-Agency MBS causes the coupon yield to be higher than the pass-through coupon interest rate. |
(2) | The effective yield adjustment is the difference between the net yield, calculated utilizing management’s estimates of timing and amount of future cash flows for Legacy Non-Agency MBS and 3 Year Step-up Securities, less the current coupon yield. |
One to Five Years | Five to Ten Years | Over Ten Years | Total MBS | |||||||||||||||||||||||||||||
(Dollars in Thousands) | Amortized Cost | Weighted Average Yield | Amortized Cost | Weighted Average Yield | Amortized Cost | Weighted Average Yield | Total Amortized Cost | Total Fair Value | Weighted Average Yield | |||||||||||||||||||||||
Agency MBS: | ||||||||||||||||||||||||||||||||
Fannie Mae | $ | — | — | % | $ | 304,938 | 2.92 | % | $ | 2,683,127 | 1.89 | % | $ | 2,988,065 | $ | 3,014,464 | 1.99 | % | ||||||||||||||
Freddie Mac | — | — | 126,313 | 2.81 | 596,972 | 1.73 | 723,285 | 716,209 | 1.92 | |||||||||||||||||||||||
Ginnie Mae | — | — | — | — | 7,686 | 1.93 | 7,686 | 7,824 | 1.93 | |||||||||||||||||||||||
Total Agency MBS | $ | — | — | % | $ | 431,251 | 2.89 | % | $ | 3,287,785 | 1.86 | % | $ | 3,719,036 | $ | 3,738,497 | 1.98 | % | ||||||||||||||
Non-Agency MBS | $ | 265,625 | 4.93 | % | $ | 3,462 | 7.89 | % | $ | 4,965,136 | 6.32 | % | $ | 5,234,223 | $ | 5,825,816 | 6.25 | % | ||||||||||||||
Total MBS | $ | 265,625 | 4.93 | % | $ | 434,713 | 2.93 | % | $ | 8,252,921 | 4.54 | % | $ | 8,953,259 | $ | 9,564,313 | 4.47 | % |
(In Thousands) | Residential Whole Loans at Carrying Value | Residential Whole Loans at Fair Value | ||||||
Amount due: | ||||||||
Within one year | $ | 1,257 | $ | 6,302 | ||||
After one year: | ||||||||
Over one to five years | 3,176 | 5,833 | ||||||
Over five years | 586,107 | 802,547 | ||||||
Total due after one year | $ | 589,283 | $ | 808,380 | ||||
Total residential whole loans | $ | 590,540 | $ | 814,682 |
(In Thousands) | Residential Whole Loans at Fair Value (1) | |||
Interest rates: | ||||
Fixed | $ | 512,988 | ||
Adjustable | 295,392 | |||
Total | $ | 808,380 |
Residential Whole Loans at Fair Value | ||||||||
(Dollars in Thousands) | December 31, 2016 | December 31, 2015 | ||||||
Loans 90 days or more past due: | ||||||||
Number of Loans | 2,560 | 2,426 | ||||||
Aggregate Amount Outstanding | $ | 570,025 | $ | 493,640 |
Country | Number of Counterparties | Repurchase Agreement Financing and Other Advances | Swaps at Fair Value | Exposure (1) | Exposure as a Percentage of MFA Total Assets | ||||||||||||
(Dollars in Thousands) | |||||||||||||||||
European Countries: (2) | |||||||||||||||||
Switzerland (3) | 3 | $ | 1,184,333 | $ | — | $ | 387,945 | 3.11 | % | ||||||||
United Kingdom | 3 | 317,098 | — | 104,529 | 0.84 | ||||||||||||
France | 2 | 577,553 | — | 128,123 | 1.03 | ||||||||||||
Holland | 1 | 217,174 | 52 | 14,293 | 0.11 | ||||||||||||
Germany | 1 | — | 90 | (66 | ) | — | |||||||||||
Total | 10 | 2,296,158 | 142 | 634,824 | 5.09 | % | |||||||||||
Other Countries: | |||||||||||||||||
United States (4) | 16 | $ | 4,683,567 | $ | (46,863 | ) | $ | 1,110,546 | 8.90 | % | |||||||
Canada (5) | 4 | 1,298,419 | — | 289,422 | 2.32 | ||||||||||||
Japan (6) | 3 | 507,379 | — | 33,578 | 0.27 | ||||||||||||
China (6) | 1 | 401,955 | — | 15,446 | 0.12 | ||||||||||||
Total | 24 | 6,891,320 | (46,863 | ) | 1,448,992 | 11.61 | % | ||||||||||
Total Counterparty Exposure | 34 | $ | 9,187,478 | (7) | $ | (46,721 | ) | $ | 2,083,816 | 16.70 | % |
(1) | Represents for each counterparty the amount of cash and/or securities pledged as collateral less the aggregate of repurchase agreement financing and other advances, Swaps at fair value, and net interest receivable/payable on all such instruments. |
(2) | Includes European-based counterparties as well as U.S.-domiciled subsidiaries of the European parent entity. |
(3) | Includes London branch of one counterparty and Cayman Islands branch of the other counterparty. |
(4) | Includes one counterparty that is a central clearing house for our Swaps. |
(5) | Includes Canada-based counterparties as well as U.S.-domiciled subsidiaries of Canadian parent entities. In the case of one counterparty, also includes exposure of $241.6 million to Barbados-based affiliate of the Canadian parent entity. |
(6) | Exposure is to U.S.-domiciled subsidiary of the Japanese or Chinese parent entity, as the case may be. |
(7) | Includes $500.0 million of repurchase agreements entered into in connection with contemporaneous repurchase and reverse repurchase agreements with a single counterparty. |
For the Year Ended December 31, | |||||||||||||||||||||||||||||||||
2016 | 2015 | 2014 | |||||||||||||||||||||||||||||||
Average Balance | Interest | Average Yield/Cost | Average Balance | Interest | Average Yield/Cost | Average Balance | Interest | Average Yield/Cost | |||||||||||||||||||||||||
(Dollars in Thousands) | |||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||
Interest-earning assets: | |||||||||||||||||||||||||||||||||
Agency MBS (1) | $ | 4,258,744 | $ | 83,069 | 1.95 | % | $ | 5,282,198 | $ | 105,835 | 2.00 | % | $ | 6,388,112 | $ | 142,543 | 2.23 | % | |||||||||||||||
Legacy Non-Agency MBS (1) | 2,941,507 | 232,500 | 7.90 | 3,600,339 | 274,352 | 7.62 | 4,072,237 | 314,998 | 7.74 | ||||||||||||||||||||||||
3 Year Step-up securities (1) | 2,618,775 | 102,140 | 3.90 | 2,423,808 | 89,218 | 3.68 | 36,065 | 1,332 | 3.69 | ||||||||||||||||||||||||
Total MBS | 9,819,026 | 417,709 | 4.25 | 11,306,345 | 469,405 | 4.15 | 10,496,414 | 458,873 | 4.37 | ||||||||||||||||||||||||
CRT securities (1) | 271,566 | 14,770 | 5.44 | 133,458 | 6,572 | 4.92 | 16,972 | 772 | 4.55 | ||||||||||||||||||||||||
Residential whole loans, at carrying value (2) | 389,910 | 23,916 | 6.13 | 241,801 | 16,036 | 6.63 | 58,762 | 4,083 | 6.95 | ||||||||||||||||||||||||
Cash and cash equivalents (3) | 291,064 | 774 | 0.27 | 212,917 | 130 | 0.06 | 358,576 | 89 | 0.02 | ||||||||||||||||||||||||
Total interest-earning assets | 10,771,566 | 457,169 | 4.24 | 11,894,521 | 492,143 | 4.14 | 10,930,724 | 463,817 | 4.24 | ||||||||||||||||||||||||
Total non-interest-earning assets (2) | 2,065,014 | 1,774,534 | 1,611,860 | ||||||||||||||||||||||||||||||
Total assets | $ | 12,836,580 | $ | 13,669,055 | $ | 12,542,584 | |||||||||||||||||||||||||||
Liabilities and stockholders’ equity: | |||||||||||||||||||||||||||||||||
Interest-bearing liabilities: | |||||||||||||||||||||||||||||||||
Agency repurchase agreements and FHLB advances (4) | $ | 3,820,611 | $ | 50,420 | 1.32 | $ | 4,723,760 | $ | 52,888 | 1.12 | $ | 5,662,872 | $ | 65,128 | 1.15 | ||||||||||||||||||
Legacy Non-Agency repurchase agreements (4) | 2,322,688 | 68,771 | 2.96 | 2,629,059 | 74,062 | 2.82 | 2,625,403 | 79,302 | 3.01 | ||||||||||||||||||||||||
3 Year Step-up securities repurchase agreements | 2,040,257 | 42,785 | 2.10 | 1,928,392 | 32,246 | 1.67 | 17,200 | 273 | 1.59 | ||||||||||||||||||||||||
CRT securities repurchase agreements | 196,296 | 4,091 | 2.08 | 92,860 | 1,614 | 1.74 | 11,323 | 189 | 1.67 | ||||||||||||||||||||||||
Residential whole loan at carrying value repurchase agreements | 170,206 | 5,020 | 2.95 | 47,459 | 1,131 | 2.38 | 5,460 | 120 | 2.19 | ||||||||||||||||||||||||
Residential whole loan at fair value repurchase agreements | 422,417 | 13,899 | 3.29 | 174,877 | 4,977 | 2.85 | 10,600 | 232 | 2.19 | ||||||||||||||||||||||||
Total repurchase agreements and other advances | 8,972,475 | 184,986 | 2.06 | 9,596,407 | 166,918 | 1.74 | 8,332,858 | 145,244 | 1.74 | ||||||||||||||||||||||||
Securitized debt | 6,700 | 333 | 4.97 | 65,319 | 1,996 | 3.06 | 230,345 | 6,533 | 2.84 | ||||||||||||||||||||||||
Senior Notes | 96,714 | 8,036 | 8.31 | 96,680 | 8,034 | 8.31 | 96,649 | 8,031 | 8.31 | ||||||||||||||||||||||||
Total interest-bearing liabilities | 9,075,889 | 193,355 | 2.13 | 9,758,406 | 176,948 | 1.81 | 8,659,852 | 159,808 | 1.85 | ||||||||||||||||||||||||
Total non-interest-bearing liabilities | 795,121 | 781,188 | 651,800 | ||||||||||||||||||||||||||||||
Total liabilities | 9,871,010 | 10,539,594 | 9,311,652 | ||||||||||||||||||||||||||||||
Stockholders’ equity | 2,965,570 | 3,129,461 | 3,230,932 | ||||||||||||||||||||||||||||||
Total liabilities and stockholders’ equity | $ | 12,836,580 | $ | 13,669,055 | $ | 12,542,584 | |||||||||||||||||||||||||||
Net interest income/net interest rate spread (5) | $ | 263,814 | 2.11 | % | $ | 315,195 | 2.33 | % | $ | 304,009 | 2.39 | % | |||||||||||||||||||||
Net interest-earning assets/net interest margin (6) | $ | 1,695,677 | 2.45 | % | $ | 2,136,115 | 2.65 | % | $ | 2,270,872 | 2.78 | % | |||||||||||||||||||||
Ratio of interest-earning assets to interest-bearing liabilities | 1.19 | x | 1.22 | x | 1.26 | x |
(1) | Yields presented throughout this Annual Report on Form 10-K are calculated using average amortized cost data for securities which excludes unrealized gains and losses and includes principal payments receivable on securities. For GAAP reporting purposes, purchases and sales are reported on the trade date. Average amortized cost data used to determine yields is calculated based on the settlement date of the associated purchase or sale as interest income is not earned on purchased assets and continues to be earned on sold assets until settlement date. Includes Non-Agency MBS transferred to consolidated VIEs. |
(2) | Excludes residential whole loans held at fair value that are reported as a component of total non-interest-earning assets. |
(3) | Includes average interest-earning cash, cash equivalents and restricted cash. |
(4) | Average cost of repurchase agreements includes the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration. |
(5) | Net interest rate spread reflects the difference between the yield on average interest-earning assets and average cost of funds. |
(6) | Net interest margin reflects net interest income divided by average interest-earning assets. |
Year Ended December 31, 2016 | Year Ended December 31, 2015 | |||||||||||||||||||||||
Compared to | Compared to | |||||||||||||||||||||||
Year Ended December 31, 2015 | Year Ended December 31, 2014 | |||||||||||||||||||||||
Increase/(Decrease) due to | Total Net Change in Interest Income/Expense | Increase/(Decrease) due to | Total Net Change in Interest Income/Expense | |||||||||||||||||||||
(In Thousands) | Volume | Rate | Volume | Rate | ||||||||||||||||||||
Interest-earning assets: | ||||||||||||||||||||||||
Agency MBS | $ | (20,028 | ) | $ | (2,738 | ) | $ | (22,766 | ) | $ | (23,092 | ) | $ | (13,616 | ) | $ | (36,708 | ) | ||||||
Legacy Non-Agency MBS | (51,758 | ) | 9,906 | (41,852 | ) | (36,021 | ) | (4,625 | ) | (40,646 | ) | |||||||||||||
3 Year Step-up securities | 7,422 | 5,500 | 12,922 | 87,884 | 2 | 87,886 | ||||||||||||||||||
CRT securities | 7,446 | 752 | 8,198 | 5,731 | 69 | 5,800 | ||||||||||||||||||
Residential whole loans, at carrying value (1) | 9,166 | (1,286 | ) | 7,880 | 11,872 | 81 | 11,953 | |||||||||||||||||
Cash and cash equivalents | 64 | 580 | 644 | (5 | ) | 46 | 41 | |||||||||||||||||
Total net change in income from interest-earning assets | $ | (47,688 | ) | $ | 12,714 | $ | (34,974 | ) | $ | 46,369 | $ | (18,043 | ) | $ | 28,326 | |||||||||
Interest-bearing liabilities: | ||||||||||||||||||||||||
Agency repurchase agreements and FHLB advances | $ | (11,046 | ) | $ | 8,578 | $ | (2,468 | ) | $ | (12,903 | ) | $ | 663 | $ | (12,240 | ) | ||||||||
Legacy Non-Agency repurchase agreements | (8,937 | ) | 3,646 | (5,291 | ) | 110 | (5,350 | ) | (5,240 | ) | ||||||||||||||
3 Year Step-up securities repurchase agreements | 1,959 | 8,580 | 10,539 | 31,957 | 16 | 31,973 | ||||||||||||||||||
CRT securities repurchase agreements | 2,102 | 375 | 2,477 | 1,417 | 8 | 1,425 | ||||||||||||||||||
Residential whole loan at carrying value repurchase agreements | 3,562 | 327 | 3,889 | 999 | 12 | 1,011 | ||||||||||||||||||
Residential whole loan at fair value repurchase agreements | 8,036 | 886 | 8,922 | 4,654 | 91 | 4,745 | ||||||||||||||||||
Securitized debt | (2,452 | ) | 789 | (1,663 | ) | (5,013 | ) | 476 | (4,537 | ) | ||||||||||||||
Senior Notes | 2 | — | 2 | — | 3 | 3 | ||||||||||||||||||
Total net change in expense from interest-bearing liabilities | $ | (6,774 | ) | $ | 23,181 | $ | 16,407 | $ | 21,221 | $ | (4,081 | ) | $ | 17,140 | ||||||||||
Net change in net interest income | $ | (40,914 | ) | $ | (10,467 | ) | $ | (51,381 | ) | $ | 25,148 | $ | (13,962 | ) | $ | 11,186 |
(1) | Excludes residential whole loans held at fair value which are reported as a component of non-interest-earning assets. |
Total Interest-Earning Assets and Interest- Bearing Liabilities | ||||||
Quarter Ended | Net Interest Spread (1) | Net Interest Margin (2) | ||||
December 31, 2016 | 2.12 | % | 2.46 | % | ||
September 30, 2016 | 2.13 | 2.46 | ||||
June 30, 2016 | 2.14 | 2.46 | ||||
March 31, 2016 | 2.18 | 2.51 | ||||
December 31, 2015 | 2.22 | 2.54 | ||||
September 30, 2015 | 2.24 | 2.58 | ||||
June 30, 2015 | 2.33 | 2.66 | ||||
March 31, 2015 | 2.44 | 2.77 |
(1) | Reflects the difference between the yield on average interest-earning assets and average cost of funds. |
(2) | Reflects annualized net interest income divided by average interest-earning assets. |
Agency MBS | Legacy Non-Agency MBS | 3 Year Step-up Securities | Total MBS | |||||||||||||||||||||||||||||||||
Quarter Ended | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | ||||||||||||||||||||||||
December 31, 2016 | 1.92 | % | 1.41 | % | 0.51 | % | 8.24 | % | 3.01 | % | 5.23 | % | 3.94 | % | 2.16 | % | 1.78 | % | 4.35 | % | 2.07 | % | 2.28 | % | ||||||||||||
September 30, 2016 | 1.83 | 1.28 | 0.55 | 8.09 | 2.98 | 5.11 | 3.86 | 2.05 | 1.81 | 4.24 | 1.96 | 2.28 | ||||||||||||||||||||||||
June 30, 2016 | 1.96 | 1.26 | 0.70 | 7.72 | 2.88 | 4.84 | 3.83 | 2.01 | 1.82 | 4.19 | 1.91 | 2.28 | ||||||||||||||||||||||||
March 31, 2016 | 2.07 | 1.27 | 0.80 | 7.61 | 2.86 | 4.75 | 3.97 | 2.07 | 1.90 | 4.23 | 1.91 | 2.32 | ||||||||||||||||||||||||
December 31, 2015 | 2.04 | 1.17 | 0.87 | 7.64 | 2.90 | 4.74 | 3.70 | 1.81 | 1.89 | 4.17 | 1.81 | 2.36 | ||||||||||||||||||||||||
September 30, 2015 | 1.84 | 1.13 | 0.71 | 7.60 | 2.76 | 4.84 | 3.74 | 1.73 | 2.01 | 4.08 | 1.73 | 2.35 | ||||||||||||||||||||||||
June 30, 2015 | 1.89 | 1.06 | 0.83 | 7.59 | 2.77 | 4.82 | 3.66 | 1.60 | 2.06 | 4.09 | 1.65 | 2.44 | ||||||||||||||||||||||||
March 31, 2015 | 2.22 | 1.13 | 1.09 | 7.64 | 2.85 | 4.79 | 3.62 | 1.52 | 2.10 | 4.26 | 1.69 | 2.57 |
(1) | Reflects annualized interest income on MBS divided by average amortized cost of MBS. |
(2) | Reflects annualized interest expense divided by average balance of repurchase agreements and other advances, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration and securitized debt. Agency cost of funding includes 65, 62, 63, 65, 74, 74, 70 and 78 basis points and Legacy Non-Agency cost of funding includes 69, 74, 69, 65, 69, 66, 68 and 78 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended December 31, 2016, September 30, 2016, June 30, 2016, March 31, 2016, December 31, 2015, September 30, 2015, June 30, 2015 and March 31, 2015, respectively. |
(3) | Reflects the difference between the net yield on average MBS and average cost of funds on MBS. |
Agency MBS | Legacy Non-Agency MBS | 3 Year Step-up Securities | |||||||||||||||||||||||||
Quarter Ended | Coupon Yield (1) | Net Yield (2) | 3 Month Average CPR (3) | Coupon Yield (1) | Net Yield (2) | 3 Month Average CPR (3) | Coupon Yield (1) | Net Yield (2) | 3 Month Average Bond CPR (4) | ||||||||||||||||||
December 31, 2016 | 2.86 | % | 1.92 | % | 15.9 | % | 5.40 | % | 8.24 | % | 17.3 | % | 3.91 | % | 3.94 | % | 25.6 | % | |||||||||
September 30, 2016 | 2.83 | 1.83 | 16.7 | 5.28 | 8.09 | 15.9 | 3.83 | 3.86 | 32.2 | ||||||||||||||||||
June 30, 2016 | 2.80 | 1.96 | 13.9 | 5.19 | 7.72 | 16.1 | 3.81 | 3.83 | 25.4 | ||||||||||||||||||
March 31, 2016 | 2.78 | 2.07 | 11.7 | 5.09 | 7.61 | 13.3 | 3.73 | 3.97 | 23.0 | ||||||||||||||||||
December 31, 2015 | 2.76 | 2.04 | 11.8 | 5.09 | 7.64 | 14.6 | 3.68 | 3.70 | 21.5 | ||||||||||||||||||
September 30, 2015 | 2.74 | 1.84 | 15.4 | 5.10 | 7.60 | 16.3 | 3.62 | 3.74 | 29.5 | ||||||||||||||||||
June 30, 2015 | 2.77 | 1.89 | 14.8 | 5.06 | 7.59 | 14.8 | 3.57 | 3.66 | 28.6 | ||||||||||||||||||
March 31, 2015 | 2.99 | 2.22 | 10.9 | 5.11 | 7.64 | 11.1 | 3.56 | 3.62 | 19.6 |
At or for the Quarter Ended | Return on Average Total Assets (1) | Return on Average Total Stockholders’ Equity (2) | Total Average Stockholders’ Equity to Total Average Assets (3) | Dividend Payout Ratio (4) | Leverage Multiple (5) | Book Value per Share of Common Stock (6) | |||||||||||
December 31, 2016 | 2.18 | % | 9.52 | % | 24.19 | % | 1.11 | 3.1 | $ | 7.62 | |||||||
September 30, 2016 | 2.47 | 11.05 | 23.46 | 0.95 | 3.1 | 7.64 | |||||||||||
June 30, 2016 | 2.33 | 10.83 | 22.58 | 1.00 | 3.3 | 7.41 | |||||||||||
March 31, 2016 | 2.29 | 10.82 | 22.19 | 1.00 | 3.4 | 7.17 | |||||||||||
December 31, 2015 | 2.10 | 9.80 | 22.56 | 1.05 | 3.4 | 7.47 | |||||||||||
September 30, 2015 | 2.22 | 10.21 | 22.85 | 1.00 | 3.3 | 7.70 | |||||||||||
June 30, 2015 | 2.16 | 9.78 | 23.18 | 1.00 | 3.3 | 7.96 | |||||||||||
March 31, 2015 | 2.25 | 10.26 | 22.97 | 0.95 | 3.3 | 8.13 |
(1) | Reflects annualized net income available to common stock and participating securities divided by average total assets. |
(2) | Reflects annualized net income divided by average total stockholders’ equity. |
(3) | Reflects total average stockholders’ equity divided by total average assets. |
(4) | Reflects dividends declared per share of common stock divided by earnings per share. |
(5) | Represents the sum of borrowings under repurchase agreements, FHLB advances, securitized debt, payable for unsettled purchases, and obligations to return securities obtained as collateral and Senior Notes divided by stockholders’ equity. |
(6) | Reflects total stockholders’ equity less the preferred stock liquidation preference divided by total shares of common stock outstanding. |
Total Interest-Earning Assets and Interest- Bearing Liabilities | ||||||
Quarter Ended | Net Interest Spread (1) | Net Interest Margin (2) | ||||
December 31, 2015 | 2.22 | % | 2.54 | % | ||
September 30, 2015 | 2.24 | 2.58 | ||||
June 30, 2015 | 2.33 | 2.66 | ||||
March 31, 2015 | 2.44 | 2.77 | ||||
December 31, 2014 | 2.41 | 2.76 | ||||
September 30, 2014 | 2.32 | 2.70 | ||||
June 30, 2014 | 2.42 | 2.80 | ||||
March 31, 2014 | 2.44 | 2.84 |
(1) | Reflected the difference between the yield on average interest-earning assets and average cost of funds. |
(2) | Reflected annualized net interest income divided by average interest-earning assets. |
Agency MBS | Legacy Non-Agency MBS | 3 Year Step-up Securities | Total MBS | |||||||||||||||||||||||||||||||||
Quarter Ended | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | Net Yield (1) | Cost of Funding (2) | Net Interest Spread (3) | ||||||||||||||||||||||||
December 31, 2015 | 2.04 | % | 1.17 | % | 0.87 | % | 7.64 | % | 2.90 | % | 4.74 | % | 3.70 | % | 1.81 | % | 1.89 | % | 4.17 | % | 1.81 | % | 2.36 | % | ||||||||||||
September 30, 2015 | 1.84 | 1.13 | 0.71 | 7.60 | 2.76 | 4.84 | 3.74 | 1.73 | 2.01 | 4.08 | 1.73 | 2.35 | ||||||||||||||||||||||||
June 30, 2015 | 1.89 | 1.06 | 0.83 | 7.59 | 2.77 | 4.82 | 3.66 | 1.60 | 2.06 | 4.09 | 1.65 | 2.44 | ||||||||||||||||||||||||
March 31, 2015 | 2.22 | 1.13 | 1.09 | 7.64 | 2.85 | 4.79 | 3.62 | 1.52 | 2.10 | 4.26 | 1.69 | 2.57 | ||||||||||||||||||||||||
December 31, 2014 | 2.17 | 1.12 | 1.05 | 7.68 | 2.95 | 4.73 | 3.19 | 1.60 | 1.59 | 4.33 | 1.76 | 2.57 | ||||||||||||||||||||||||
September 30, 2014 | 2.09 | 1.14 | 0.95 | 7.70 | 2.97 | 4.73 | 3.53 | 1.49 | 2.04 | 4.28 | 1.75 | 2.53 | ||||||||||||||||||||||||
June 30, 2014 | 2.26 | 1.13 | 1.13 | 7.72 | 3.11 | 4.61 | 4.16 | — | 4.16 | 4.36 | 1.77 | 2.59 | ||||||||||||||||||||||||
March 31, 2014 | 2.39 | 1.21 | 1.18 | 7.80 | 3.04 | 4.76 | 4.30 | — | 4.30 | 4.50 | 1.80 | 2.70 |
(1) | Reflected annualized interest income on MBS divided by average amortized cost of MBS. |
(2) | Reflected annualized interest expense divided by average balance of repurchase agreements and other advances, including the cost of Swaps allocated based on the proportionate share of the overall estimated weighted average portfolio duration and securitized debt. Agency cost of funding includes 74, 74, 70, 78, 79, 82, 81 and 85 basis points and Legacy Non-Agency cost of funding includes 69, 66, 68,78, 84, 89, 88 and 74 basis points associated with Swaps to hedge interest rate sensitivity on these assets for the quarters ended December 31, 2015, September 30, 2015, June 30, 2015, March 31, 2015, December 31, 2014, September 30, 2014, June 30, 2014 and March 31, 2014, respectively. |
(3) | Reflected the difference between the net yield on average MBS and average cost of funds on MBS. |
Agency MBS | Legacy Non-Agency MBS | 3 Year Step-up Securities | |||||||||||||||||||||||||
Quarter Ended | Coupon Yield (1) | Net Yield (2) | 3 Month Average CPR (3) | Coupon Yield (1) | Net Yield (2) | 3 Month Average CPR (3) | Coupon Yield (1) | Net Yield (2) | 3 Month Average Bond CPR (4) | ||||||||||||||||||
December 31, 2015 | 2.76 | % | 2.04 | % | 11.8 | % | 5.09 | % | 7.64 | % | 14.6 | % | 3.68 | % | 3.70 | % | 21.5 | % | |||||||||
September 30, 2015 | 2.74 | 1.84 | 15.4 | 5.10 | 7.60 | 16.3 | 3.62 | 3.74 | 29.5 | ||||||||||||||||||
June 30, 2015 | 2.77 | 1.89 | 14.8 | 5.06 | 7.59 | 14.8 | 3.57 | 3.66 | 28.6 | ||||||||||||||||||
March 31, 2015 | 2.99 | 2.22 | 10.9 | 5.11 | 7.64 | 11.1 | 3.56 | 3.62 | 19.6 | ||||||||||||||||||
December 31, 2014 | 2.91 | 2.17 | 12.3 | 5.13 | 7.68 | 12.5 | 3.91 | 3.19 | 17.6 | ||||||||||||||||||
September 30, 2014 | 2.94 | 2.09 | 15.1 | 5.18 | 7.70 | 12.7 | 3.53 | 3.53 | 19.7 | ||||||||||||||||||
June 30, 2014 | 2.99 | 2.26 | 13.0 | 5.27 | 7.72 | 12.1 | 4.16 | 4.16 | 15.8 | ||||||||||||||||||
March 31, 2014 | 3.01 | 2.39 | 11.5 | 5.19 | 7.80 | 11.9 | 4.30 | 4.30 | 16.0 |
At or for the Quarter Ended | Return on Average Total Assets (1) | Return on Average Total Stockholders’ Equity (2) | Total Average Stockholders’ Equity to Total Average Assets (3) | Dividend Payout Ratio (4) | Leverage Multiple (5) | Book Value per Share of Common Stock (6) | |||||||||||
December 31, 2015 | 2.10 | % | 9.80 | % | 22.56 | % | 1.05 | 3.4 | $ | 7.47 | |||||||
September 30, 2015 | 2.22 | 10.21 | 22.85 | 1.00 | 3.3 | 7.70 | |||||||||||
June 30, 2015 | 2.16 | 9.78 | 23.18 | 1.00 | 3.3 | 7.96 | |||||||||||
March 31, 2015 | 2.25 | 10.26 | 22.97 | 0.95 | 3.3 | 8.13 | |||||||||||
December 31, 2014 | 2.44 | 9.91 | 25.78 | 1.00 | 2.8 | 8.12 | |||||||||||
September 30, 2014 | 2.41 | 9.62 | 26.27 | 1.00 | 2.7 | 8.28 | |||||||||||
June 30, 2014 | 2.38 | 9.25 | 25.69 | 1.00 | 2.8 | 8.37 | |||||||||||
March 31, 2014 | 2.30 | 9.10 | 25.27 | 1.00 | 2.9 | 8.20 |
At December 31, 2016 | Weighted Average Haircut | Low | High | ||||||
Repurchase agreement borrowings secured by: | |||||||||
Agency MBS | 4.67 | % | 3.00 | % | 6.00 | % | |||
Legacy Non-Agency MBS | 24.01 | 15.00 | 60.00 | ||||||
3 Year Step-up securities | 22.28 | 15.00 | 50.00 | ||||||
U.S. Treasury securities | 1.60 | 1.00 | 2.00 | ||||||
CRT securities | 23.22 | 20.00 | 25.00 | ||||||
Residential whole loans | 25.03 | 20.00 | 35.00 | ||||||
At December 31, 2015 | Weighted Average Haircut | Low | High | ||||||
Repurchase agreement borrowings secured by: | |||||||||
Agency MBS | 4.67 | % | 3.00 | % | 6.00 | % | |||
Legacy Non-Agency MBS | 25.84 | 10.00 | 63.50 | ||||||
3 Year Step-up securities | 21.05 | 20.00 | 30.00 | ||||||
U.S. Treasury securities | 1.60 | 1.00 | 2.00 | ||||||
CRT securities | 25.04 | 20.00 | 30.00 | ||||||
Residential whole loans | 27.69 | 25.00 | 36.00 |
Repurchase Agreements and Other Advances | Securitized Debt | ||||||||||||||||||||||||||
Quarter Ended (1) | Quarterly Average Balance | End of Period Balance | Maximum Balance at Any Month-End | Quarterly Average Balance | End of Period Balance | Maximum Balance at Any Month-End | |||||||||||||||||||||
(In Thousands) | |||||||||||||||||||||||||||
December 31, 2016 | $ | 8,684,803 | $ | 8,687,268 | $ | 8,815,846 | $ | — | $ | — | $ | — | |||||||||||||||
September 30, 2016 | 8,868,173 | 8,697,756 | 8,917,550 | — | — | — | |||||||||||||||||||||
June 30, 2016 | 9,102,457 | 9,038,087 | 9,114,859 | 8,520 | — | 8,568 | |||||||||||||||||||||
March 31, 2016 | 9,238,772 | 9,143,645 | 9,205,547 | 18,425 | 11,821 | 18,247 | |||||||||||||||||||||
December 31, 2015 | 9,428,211 | 9,387,622 | 9,413,189 | 28,009 | 21,868 | 27,686 | |||||||||||||||||||||
September 30, 2015 | 9,422,882 | 9,475,834 | 9,486,357 | 50,691 | 31,940 | 49,941 | |||||||||||||||||||||
June 30, 2015 | 9,720,193 | 9,635,035 | 9,746,825 | 80,343 | 61,965 | 80,331 | |||||||||||||||||||||
March 31, 2015 | 9,820,548 | (2 | ) | 9,809,587 | (2 | ) | 9,863,779 | (2 | ) | 103,218 | 90,842 | 103,827 | |||||||||||||||
December 31, 2014 | 8,190,491 | 8,267,388 | 8,271,123 | 137,503 | 110,574 | 138,026 | |||||||||||||||||||||
September 30, 2014 | 8,267,905 | 8,125,723 | 8,272,039 | 190,753 | 156,276 | 190,423 | |||||||||||||||||||||
June 30, 2014 | 8,464,135 | 8,384,101 | 8,501,978 | 264,806 | 214,048 | 267,740 | |||||||||||||||||||||
March 31, 2014 | 8,412,045 | 8,606,129 | 8,606,129 | 336,893 | 292,526 | 338,965 |
Collateral Pledged to Meet Margin Calls | Cash and Securities Received For Reverse Margin Calls | Net Assets Received/(Pledged) For Margin Activity | ||||||||||||||||||
For the Quarter Ended | Fair Value of Securities Pledged | Cash Pledged | Aggregate Assets Pledged For Margin Calls | |||||||||||||||||
(In Thousands) | ||||||||||||||||||||
December 31, 2016 | $ | 337,694 | $ | 8,000 | $ | 345,694 | $ | 357,163 | $ | 11,469 | ||||||||||
September 30, 2016 | 343,351 | 28,700 | 372,051 | 343,139 | (28,912 | ) | ||||||||||||||
June 30, 2016 | 326,555 | 63,600 | 390,155 | 281,912 | (108,243 | ) | ||||||||||||||
March 31, 2016 | 269,027 | 117,800 | 386,827 | 325,233 | (61,594 | ) |
Due During the Year Ending December 31, | ||||||||||||||||||||||||||||
(In Thousands) | 2017 | 2018 | 2019 | 2020 | 2021 | Thereafter | Total | |||||||||||||||||||||
Repurchase agreements | $ | 8,472,268 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 8,472,268 | ||||||||||||||
Interest expense on repurchase agreements (1) | 38,486 | — | — | — | — | — | 38,486 | |||||||||||||||||||||
FHLB advances (2) | 215,000 | — | — | — | — | — | 215,000 | |||||||||||||||||||||
Interest expense on FHLB advances (1)(2) | 144 | — | — | — | — | — | 144 | |||||||||||||||||||||
Senior Notes (3) | — | — | — | — | — | 100,000 | 100,000 | |||||||||||||||||||||
Interest expense on Senior Notes (1) | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 163,911 | 203,911 | |||||||||||||||||||||
Long-term lease obligations | 2,553 | 2,553 | 2,553 | 1,082 | 32 | — | 8,773 | |||||||||||||||||||||
Total | $ | 8,736,451 | $ | 10,553 | $ | 10,553 | $ | 9,082 | $ | 8,032 | $ | 263,911 | $ | 9,038,582 |
Agency MBS | Legacy Non-Agency MBS (1) | Total (1) | ||||||||||||||||||||||||||||
Fair Value (2) | Average Months to Reset (3) | 3 Month Average CPR (4) | Fair Value | Average Months to Reset (3) | 3 Month Average CPR (4) | Fair Value (2) | Average Months to Reset (3) | 3 Month Average CPR (4) | ||||||||||||||||||||||
Time to Reset | ||||||||||||||||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||||||||||
< 2 years (5) | $ | 1,789,859 | 7 | 18.8 | % | $ | 2,132,993 | 5 | 16.9 | % | $ | 3,922,852 | 6 | 17.7 | % | |||||||||||||||
2-5 years | 384,703 | 33 | 19.8 | — | — | — | 384,703 | 33 | 19.8 | |||||||||||||||||||||
> 5 years | 121,870 | 69 | 14.4 | — | — | — | 121,870 | 69 | 14.4 | |||||||||||||||||||||
ARM-MBS Total | $ | 2,296,432 | 15 | 18.7 | % | $ | 2,132,993 | 5 | 16.9 | % | $ | 4,429,425 | 10 | 17.8 | % | |||||||||||||||
15-year fixed (6) | $ | 1,439,461 | 11.5 | % | $ | 5,856 | 4.3 | % | $ | 1,445,317 | 11.5 | % | ||||||||||||||||||
30-year fixed (6) | — | — | 1,021,505 | 18.1 | 1,021,505 | 18.1 | ||||||||||||||||||||||||
40-year fixed (6) | — | — | 10,771 | 21.0 | 10,771 | 21.0 | ||||||||||||||||||||||||
Fixed-Rate Total | $ | 1,439,461 | 11.5 | % | $ | 1,038,132 | 18.0 | % | $ | 2,477,593 | 14.5 | % | ||||||||||||||||||
MBS Total | $ | 3,735,893 | 15.9 | % | $ | 3,171,125 | 17.3 | % | $ | 6,907,018 | 16.6 | % |
(1) | Excludes $2.7 billion of 3 Year Step-up securities. Refer to table below for further information. |
(2) | Does not include principal payments receivable of $2.6 million. |
(3) | Months to reset is the number of months remaining before the coupon interest rate resets. At reset, the MBS coupon will adjust based upon the underlying benchmark interest rate index, margin and periodic and/or lifetime caps. The months to reset do not reflect scheduled amortization or prepayments. |
(4) | 3 month average CPR weighted by positions as of the beginning of each month in the quarter. |
(5) | Includes floating-rate MBS that may be collateralized by fixed-rate mortgages. |
(6) | Information presented based on data available at time of loan origination. |
Fair Value | Net Coupon | Months to Step-Up (1) | Current Credit Support (2) | Original Credit Support | 3 Month Average Bond CPR (3) | ||||||||||||||
(Dollars in Thousands) | |||||||||||||||||||
Re-Performing loans | $ | 317,064 | 3.60 | % | 13 | 41 | % | 37 | % | 23.4 | % | ||||||||
Non-Performing loans and other | 2,337,627 | 3.97 | 20 | 47 | 45 | 25.9 | |||||||||||||
Total 3 Year Step-up securities | $ | 2,654,691 | 3.92 | % | 19 | 46 | % | 44 | % | 25.6 | % |
(1) | Months to step-up is the weighted average number of months remaining before the coupon interest rate increases pursuant to the first coupon reset. We anticipate that the securities will be redeemed prior to the step-up date. |
(2) | Credit Support for a particular security is expressed as a percentage of all outstanding mortgage loan collateral. A particular security will not be subject to principal loss as long as credit enhancement is greater than zero. |
(3) | All principal payments are considered to be prepayments for CPR purposes. |
Change in Interest Rates | Estimated Value of Assets (1) | Estimated Value of Swaps | Estimated Value of Financial Instruments | Change in Estimated Value | Percentage Change in Net Interest Income | Percentage Change in Portfolio Value | ||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||
+100 Basis Point Increase | $ | 11,724,000 | $ | 29,484 | $ | 11,753,484 | $ | (91,546 | ) | (8.94 | )% | (0.77 | )% | |||||||||
+ 50 Basis Point Increase | $ | 11,809,837 | $ | (8,618 | ) | $ | 11,801,219 | $ | (43,811 | ) | (4.48 | )% | (0.37 | )% | ||||||||
Actual at December 31, 2016 | $ | 11,891,751 | $ | (46,721 | ) | $ | 11,845,030 | $ | — | — | — | |||||||||||
- 50 Basis Point Decrease | $ | 11,969,743 | $ | (84,823 | ) | $ | 11,884,920 | $ | 39,890 | 1.24 | % | 0.34 | % | |||||||||
-100 Basis Point Decrease | $ | 12,043,812 | $ | (122,925 | ) | $ | 11,920,887 | $ | 75,857 | (1.27 | )% | 0.64 | % |
Change in Interest Rates | Estimated Value of Assets (1) | Estimated Value of Swaps | Estimated Value of Financial Instruments | Change in Estimated Value | Percentage Change in Net Interest Income | Percentage Change in Portfolio Value | ||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||
+100 Basis Point Increase | $ | 12,318,148 | $ | 33,313 | $ | 12,351,461 | $ | (85,300 | ) | (8.98 | )% | (0.69 | )% | |||||||||
+ 50 Basis Point Increase | $ | 12,415,124 | $ | (18,043 | ) | $ | 12,397,081 | $ | (39,680 | ) | (5.82 | )% | (0.32 | )% | ||||||||
Actual at December 31, 2015 | $ | 12,506,160 | $ | (69,399 | ) | $ | 12,436,761 | $ | — | — | — | |||||||||||
- 50 Basis Point Decrease | $ | 12,591,257 | $ | (120,756 | ) | $ | 12,470,501 | $ | 33,740 | (1.01 | )% | 0.27 | % | |||||||||
-100 Basis Point Decrease | $ | 12,670,416 | $ | (172,112 | ) | $ | 12,498,304 | $ | 61,543 | (8.20 | )% | 0.49 | % |
(1) | Such assets include MBS and CRT securities, residential whole loans, cash and cash equivalents and restricted cash. |
Securities with Average Loan FICO of 715 or Higher (1) | Securities with Average Loan FICO Below 715 (1) | |||||||||||||||||||||||||||
Year of Securitization (2) | 2007 | 2006 | 2005 and Prior | 2007 | 2006 | 2005 and Prior | Total | |||||||||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||||||||||
Number of securities | 92 | 71 | 95 | 27 | 60 | 66 | 411 | |||||||||||||||||||||
MBS current face (3) | $ | 978,484 | $ | 615,984 | $ | 717,330 | $ | 181,009 | $ | 541,624 | $ | 518,653 | $ | 3,553,084 | ||||||||||||||
Total purchase discounts, net (3) | $ | (269,039 | ) | $ | (167,317 | ) | $ | (126,649 | ) | $ | (60,400 | ) | $ | (195,871 | ) | $ | (151,500 | ) | $ | (970,776 | ) | |||||||
Purchase discount designated as Credit Reserve and OTTI (3)(4) | $ | (172,756 | ) | $ | (86,401 | ) | $ | (64,045 | ) | $ | (54,953 | ) | $ | (197,032 | ) | $ | (119,054 | ) | $ | (694,241 | ) | |||||||
Purchase discount designated as Credit Reserve and OTTI as percentage of current face | 17.7 | % | 14.0 | % | 8.9 | % | 30.4 | % | 36.4 | % | 23.0 | % | 19.5 | % | ||||||||||||||
MBS amortized cost (3) | $ | 709,445 | $ | 448,667 | $ | 590,681 | $ | 120,609 | $ | 345,753 | $ | 367,153 | $ | 2,582,308 | ||||||||||||||
MBS fair value (3) | $ | 874,166 | $ | 546,262 | $ | 670,586 | $ | 154,704 | $ | 458,380 | $ | 467,027 | $ | 3,171,125 | ||||||||||||||
Weighted average fair value to current face | 89.3 | % | 88.7 | % | 93.5 | % | 85.5 | % | 84.6 | % | 90.0 | % | 89.2 | % | ||||||||||||||
Weighted average coupon (5) | 4.03 | % | 3.27 | % | 3.46 | % | 5.01 | % | 4.97 | % | 4.55 | % | 4.05 | % | ||||||||||||||
Weighted average loan age (months) (5)(6) | 117 | 126 | 140 | 121 | 128 | 140 | 128 | |||||||||||||||||||||
Weighted average current loan size (5)(6) | $ | 507 | $ | 500 | $ | 306 | $ | 372 | $ | 259 | $ | 244 | $ | 382 | ||||||||||||||
Percentage amortizing (7) | 66 | % | 99 | % | 100 | % | 81 | % | 99 | % | 100 | % | 89 | % | ||||||||||||||
Weighted average FICO score at origination (5)(8) | 730 | 729 | 726 | 704 | 703 | 703 | 720 | |||||||||||||||||||||
Owner-occupied loans | 90.5 | % | 90.9 | % | 86.0 | % | 84.1 | % | 86.2 | % | 84.5 | % | 87.8 | % | ||||||||||||||
Rate-term refinancings | 29.1 | % | 21.6 | % | 14.8 | % | 21.7 | % | 15.7 | % | 14.4 | % | 20.4 | % | ||||||||||||||
Cash-out refinancings | 35.1 | % | 35.0 | % | 27.5 | % | 44.8 | % | 44.9 | % | 38.5 | % | 36.0 | % | ||||||||||||||
3 Month CPR (6) | 18.2 | % | 18.4 | % | 18.2 | % | 19.6 | % | 14.5 | % | 19.0 | % | 17.9 | % | ||||||||||||||
3 Month CRR (6)(9) | 16.0 | % | 16.9 | % | 15.5 | % | 16.4 | % | 11.7 | % | 14.8 | % | 15.2 | % | ||||||||||||||
3 Month CDR (6)(9) | 2.9 | % | 1.9 | % | 3.2 | % | 4.1 | % | 3.4 | % | 4.9 | % | 3.2 | % | ||||||||||||||
3 Month loss severity | 62.6 | % | 49.5 | % | 41.1 | % | 79.2 | % | 62.6 | % | 58.1 | % | 57.0 | % | ||||||||||||||
60+ days delinquent (8) | 11.6 | % | 12.0 | % | 9.5 | % | 16.9 | % | 16.0 | % | 13.8 | % | 12.5 | % | ||||||||||||||
Percentage of always current borrowers (Lifetime) (10) | 37.6 | % | 35.9 | % | 42.7 | % | 29.8 | % | 25.9 | % | 30.5 | % | 35.1 | % | ||||||||||||||
Percentage of always current borrowers (12M) (11) | 77.9 | % | 77.1 | % | 78.7 | % | 68.9 | % | 68.4 | % | 68.4 | % | 74.6 | % | ||||||||||||||
Weighted average credit enhancement (8)(12) | 0.2 | % | 0.5 | % | 4.8 | % | 0.0 | % | 1.2 | % | 3.4 | % | 1.8 | % |
(1) | FICO score is used by major credit bureaus to indicate a borrower’s creditworthiness at time of loan origination. |
(2) | Information presented based on the initial year of securitization of the underlying collateral. Certain of our Non-Agency MBS have been resecuritized. The historical information presented in the table is based on the initial securitization date and data available at the time of original securitization (and not the date of resecuritization). No information has been updated with respect to any MBS that have been resecuritized. |
(3) | Excludes Non-Agency MBS issued since 2012 in which the underlying collateral consists of 3 Year Step-up securities. These Non-Agency MBS have a current face of $2.7 billion, amortized cost of $2.7 billion, fair value of $2.7 billion and purchase discounts of $1.6 million at December 31, 2016. |
(4) | Purchase discounts designated as Credit Reserve and OTTI are not expected to be accreted into interest income. |
(5) | Weighted average is based on MBS current face at December 31, 2016. |
(6) | Information provided is based on loans for individual groups owned by us. |
(7) | Percentage of face amount for which the original mortgage note contractually calls for principal amortization in the current period. |
(8) | Information provided is based on loans for all groups that provide credit enhancement for MBS with credit enhancement. |
(9) | CRR represents voluntary prepayments and CDR represents involuntary prepayments. |
(10) | Percentage of face amount of loans for which the borrower has not been delinquent since origination. |
(11) | Percentage of face amount of loans for which the borrower has not been delinquent in the last twelve months. |
(12) | Credit enhancement for a particular security is expressed as a percentage of all outstanding mortgage loan collateral. A particular security will not be subject to principal loss as long as its credit enhancement is greater than zero. As of December 31, 2016, a total of 291 Non-Agency MBS in our portfolio representing approximately $2.6 billion or 75% of the current face amount of the portfolio had no credit enhancement. |
Property Location | Percent of Interest-Bearing Unpaid Principal Balance | |
California | 43.2 | % |
Florida | 7.6 | % |
New York | 6.2 | % |
Virginia | 3.9 | % |
New Jersey | 3.9 | % |
Property Location | Percent of Interest-Bearing Unpaid Principal Balance | |
California | 21.5 | % |
New York | 14.3 | % |
Florida | 8.0 | % |
New Jersey | 7.0 | % |
Maryland | 5.3 | % |
Page | |
Financial Statements: | |
(In Thousands, Except Per Share Amounts) | December 31, 2016 | December 31, 2015 | ||||||
Assets: | ||||||||
Mortgage-backed securities (“MBS”) and credit risk transfer (“CRT”) securities: | ||||||||
Agency MBS, at fair value ($3,540,401 and $4,532,094 pledged as collateral, respectively) | $ | 3,738,497 | $ | 4,752,244 | ||||
Non-Agency MBS, at fair value ($4,978,199 and $4,874,372 pledged as collateral, respectively) | 5,651,412 | 5,822,519 | ||||||
Non-Agency MBS transferred to consolidated variable interest entities (“VIEs”), at fair value (1) | 174,404 | 598,298 | ||||||
CRT securities, at fair value ($357,488 and $170,352 pledged as collateral, respectively) | 404,850 | 183,582 | ||||||
Securities obtained and pledged as collateral, at fair value | 510,767 | 507,443 | ||||||
Residential whole loans, at carrying value ($427,880 and $93,692 pledged as collateral, respectively) | 590,540 | 271,845 | ||||||
Residential whole loans, at fair value ($734,331, and $585,971 pledged as collateral, respectively) | 814,682 | 623,276 | ||||||
Cash and cash equivalents | 260,112 | 165,007 | ||||||
Restricted cash | 58,463 | 71,538 | ||||||
Other assets | 280,295 | 166,799 | ||||||
Total Assets | $ | 12,484,022 | $ | 13,162,551 | ||||
Liabilities: | ||||||||
Repurchase agreements and other advances | $ | 8,687,268 | $ | 9,387,622 | ||||
Obligation to return securities obtained as collateral, at fair value | 510,767 | 507,443 | ||||||
8% Senior Notes due 2042 (“Senior Notes”) | 96,733 | 96,697 | ||||||
Other liabilities (2) | 155,352 | 203,528 | ||||||
Total Liabilities | $ | 9,450,120 | $ | 10,195,290 | ||||
Commitments and contingencies (See Note 11) | ||||||||
Stockholders’ Equity: | ||||||||
Preferred stock, $.01 par value; 7.50% Series B cumulative redeemable; 8,050 shares authorized; 8,000 shares issued and outstanding ($200,000 aggregate liquidation preference) | $ | 80 | $ | 80 | ||||
Common stock, $.01 par value; 886,950 shares authorized; 371,854 and 370,584 shares issued and outstanding, respectively | 3,719 | 3,706 | ||||||
Additional paid-in capital, in excess of par | 3,029,062 | 3,019,956 | ||||||
Accumulated deficit | (572,641 | ) | (572,332 | ) | ||||
Accumulated other comprehensive income | 573,682 | 515,851 | ||||||
Total Stockholders’ Equity | $ | 3,033,902 | $ | 2,967,261 | ||||
Total Liabilities and Stockholders’ Equity | $ | 12,484,022 | $ | 13,162,551 |
For the Year Ended December 31, | ||||||||||||
(In Thousands, Except Per Share Amounts) | 2016 | 2015 | 2014 | |||||||||
Interest Income: | ||||||||||||
Agency MBS | $ | 83,069 | $ | 105,835 | $ | 142,543 | ||||||
Non-Agency MBS | 319,030 | 317,821 | 185,806 | |||||||||
Non-Agency MBS transferred to consolidated VIEs | 15,610 | 45,749 | 130,524 | |||||||||
CRT securities | 14,770 | 6,572 | 772 | |||||||||
Residential whole loans held at carrying value | 23,916 | 16,036 | 4,083 | |||||||||
Cash and cash equivalent investments | 774 | 130 | 89 | |||||||||
Interest Income | $ | 457,169 | $ | 492,143 | $ | 463,817 | ||||||
Interest Expense: | ||||||||||||
Repurchase agreements and other advances | $ | 184,986 | $ | 166,918 | $ | 145,244 | ||||||
Senior Notes and other interest expense | 8,369 | 10,030 | 14,564 | |||||||||
Interest Expense | $ | 193,355 | $ | 176,948 | $ | 159,808 | ||||||
Net Interest Income | $ | 263,814 | $ | 315,195 | $ | 304,009 | ||||||
Other-Than-Temporary Impairments: | ||||||||||||
Total other-than-temporary impairment losses | $ | (1,255 | ) | $ | (525 | ) | $ | — | ||||
Portion of loss recognized in/(reclassed from) other comprehensive income | 770 | (180 | ) | — | ||||||||
Net Impairment Losses Recognized in Earnings | $ | (485 | ) | $ | (705 | ) | $ | — | ||||
Other Income, net: | ||||||||||||
Net gain on residential whole loans held at fair value | $ | 59,684 | $ | 17,722 | $ | 116 | ||||||
Gain on sales of MBS | 35,837 | 34,900 | 37,497 | |||||||||
Unrealized net gains and net interest income from Linked Transactions | — | — | 17,092 | |||||||||
Other, net | 13,802 | (1,457 | ) | 80 | ||||||||
Other Income, net | $ | 109,323 | $ | 51,165 | $ | 54,785 | ||||||
Operating and Other Expense: | ||||||||||||
Compensation and benefits | $ | 29,281 | $ | 26,293 | $ | 25,581 | ||||||
Other general and administrative expense | 16,331 | 15,752 | 15,164 | |||||||||
Loan servicing and other related operating expenses | 14,372 | 10,384 | 3,383 | |||||||||
Excise tax and interest | — | — | 1,162 | |||||||||
Operating and Other Expense | $ | 59,984 | $ | 52,429 | $ | 45,290 | ||||||
Net Income | $ | 312,668 | $ | 313,226 | $ | 313,504 | ||||||
Less Preferred Stock Dividends | 15,000 | 15,000 | 15,000 | |||||||||
Net Income Available to Common Stock and Participating Securities | $ | 297,668 | $ | 298,226 | $ | 298,504 | ||||||
Earnings per Common Share - Basic and Diluted | $ | 0.80 | $ | 0.80 | $ | 0.81 |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
Net Income | $ | 312,668 | $ | 313,226 | $ | 313,504 | ||||||
Other Comprehensive Income/(Loss): | ||||||||||||
Unrealized (loss)/gain on Agency MBS, net | (9,322 | ) | (51,332 | ) | 65,739 | |||||||
Unrealized gain/(loss) on Non-Agency MBS, net | 81,882 | (143,558 | ) | 29,812 | ||||||||
Reclassification adjustment for MBS sales included in net income | (36,922 | ) | (37,207 | ) | (34,948 | ) | ||||||
Reclassification adjustment for other-than-temporary impairments included in net income | (485 | ) | (705 | ) | — | |||||||
Unrealized gain/(loss) on derivative hedging instruments, net | 22,678 | (10,337 | ) | (44,292 | ) | |||||||
Reclassification of unrealized loss on de-designated derivative hedging instruments | — | — | 447 | |||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | — | 4,537 | — | |||||||||
Other Comprehensive Income/(Loss) | 57,831 | (238,602 | ) | 16,758 | ||||||||
Comprehensive Income before preferred stock dividends | $ | 370,499 | $ | 74,624 | $ | 330,262 | ||||||
Dividends declared on preferred stock | (15,000 | ) | (15,000 | ) | (15,000 | ) | ||||||
Comprehensive Income Available to Common Stock and Participating Securities | $ | 355,499 | $ | 59,624 | $ | 315,262 |
MFA FINANCIAL, INC. CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY | ||||||||||||||||||||||||||||||
For the Year Ended December 31, 2016 | ||||||||||||||||||||||||||||||
(In Thousands, Except Per Share Amounts) | Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income | Total | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||
Balance at December 31, 2015 | 8,000 | $ | 80 | 370,584 | $ | 3,706 | $ | 3,019,956 | $ | (572,332 | ) | $ | 515,851 | $ | 2,967,261 | |||||||||||||||
Net income | — | — | — | — | — | 312,668 | — | 312,668 | ||||||||||||||||||||||
Issuance of common stock, net of expenses | — | — | 1,758 | 13 | 4,647 | — | — | 4,660 | ||||||||||||||||||||||
Repurchase of shares of common stock (1) | — | — | (488 | ) | — | (3,551 | ) | — | — | (3,551 | ) | |||||||||||||||||||
Equity based compensation expense | — | — | — | — | 8,695 | — | — | 8,695 | ||||||||||||||||||||||
Accrued dividends attributable to stock-based awards | — | — | — | — | (685 | ) | — | — | (685 | ) | ||||||||||||||||||||
Dividends declared on common stock | — | — | — | — | — | (297,046 | ) | — | (297,046 | ) | ||||||||||||||||||||
Dividends declared on preferred stock | — | — | — | — | — | (15,000 | ) | — | (15,000 | ) | ||||||||||||||||||||
Dividends attributable to dividend equivalents | — | — | — | — | — | (931 | ) | — | (931 | ) | ||||||||||||||||||||
Change in unrealized gains on MBS, net | — | — | — | — | — | — | 35,153 | 35,153 | ||||||||||||||||||||||
Change in unrealized gains on derivative hedging instruments, net | — | — | — | — | — | — | 22,678 | 22,678 | ||||||||||||||||||||||
Balance at December 31, 2016 | 8,000 | $ | 80 | 371,854 | $ | 3,719 | $ | 3,029,062 | $ | (572,641 | ) | $ | 573,682 | $ | 3,033,902 |
For the Year Ended December 31, 2015 | ||||||||||||||||||||||||||||||
(In Thousands, Except Per Share Amounts) | Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income | Total | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||
Balance at December 31, 2014 | 8,000 | $ | 80 | 370,084 | $ | 3,701 | $ | 3,013,634 | $ | (568,596 | ) | $ | 754,453 | $ | 3,203,272 | |||||||||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | — | — | — | — | — | (4,537 | ) | 4,537 | — | |||||||||||||||||||||
Net income | — | — | — | — | — | 313,226 | — | 313,226 | ||||||||||||||||||||||
Issuance of common stock, net of expenses | — | — | 809 | 5 | 1,216 | — | — | 1,221 | ||||||||||||||||||||||
Repurchase of shares of common stock (1) | — | — | (309 | ) | — | (2,273 | ) | — | — | (2,273 | ) | |||||||||||||||||||
Equity based compensation expense | — | — | — | — | 7,829 | — | — | 7,829 | ||||||||||||||||||||||
Accrued dividends attributable to stock-based awards | — | — | — | — | (450 | ) | — | — | (450 | ) | ||||||||||||||||||||
Dividends declared on common stock | — | — | — | — | — | (296,384 | ) | — | (296,384 | ) | ||||||||||||||||||||
Dividends declared on preferred stock | — | — | — | — | — | (15,000 | ) | — | (15,000 | ) | ||||||||||||||||||||
Dividends attributable to dividend equivalents | — | — | — | — | — | (1,041 | ) | — | (1,041 | ) | ||||||||||||||||||||
Change in unrealized losses on MBS, net | — | — | — | — | — | — | (232,802 | ) | (232,802 | ) | ||||||||||||||||||||
Change in unrealized losses on derivative hedging instruments, net | — | — | — | — | — | — | (10,337 | ) | (10,337 | ) | ||||||||||||||||||||
Balance at December 31, 2015 | 8,000 | $ | 80 | 370,584 | $ | 3,706 | $ | 3,019,956 | $ | (572,332 | ) | $ | 515,851 | $ | 2,967,261 |
For the Year Ended December 31, 2014 | ||||||||||||||||||||||||||||||
(In Thousands, Except Per Share Amounts) | Preferred Stock 7.50% Series B Cumulative Redeemable - Liquidation Preference $25.00 per Share | Common Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Income | Total | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||
Balance at December 31, 2013 | 8,000 | $ | 80 | 365,125 | $ | 3,651 | $ | 2,972,369 | $ | (571,544 | ) | $ | 737,695 | $ | 3,142,251 | |||||||||||||||
Net income | — | — | — | — | — | 313,504 | — | 313,504 | ||||||||||||||||||||||
Issuance of common stock, net of expenses | — | — | 5,305 | 50 | 35,590 | — | — | 35,640 | ||||||||||||||||||||||
Repurchase of shares of common stock (1) | — | — | (346 | ) | — | (2,688 | ) | — | — | (2,688 | ) | |||||||||||||||||||
Equity based compensation expense | — | — | — | — | 8,581 | — | — | 8,581 | ||||||||||||||||||||||
Accrued dividends attributable to stock-based awards | — | — | — | — | (218 | ) | — | — | (218 | ) | ||||||||||||||||||||
Dividends declared on common stock | — | — | — | — | — | (294,792 | ) | — | (294,792 | ) | ||||||||||||||||||||
Dividends declared on preferred stock | — | — | — | — | — | (15,000 | ) | — | (15,000 | ) | ||||||||||||||||||||
Dividends attributable to dividend equivalents | — | — | — | — | — | (764 | ) | — | (764 | ) | ||||||||||||||||||||
Change in unrealized gains on MBS, net | — | — | — | — | — | — | 60,603 | 60,603 | ||||||||||||||||||||||
Change in unrealized losses on derivative hedging instruments, net | — | — | — | — | — | — | (43,845 | ) | (43,845 | ) | ||||||||||||||||||||
Balance at December 31, 2014 | 8,000 | $ | 80 | 370,084 | $ | 3,701 | $ | 3,013,634 | $ | (568,596 | ) | $ | 754,453 | $ | 3,203,272 |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
Cash Flows From Operating Activities: | ||||||||||||
Net income | $ | 312,668 | $ | 313,226 | $ | 313,504 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
Gain on sales of MBS | (35,837 | ) | (34,900 | ) | (37,497 | ) | ||||||
Gain on sales of real estate owned | (3,229 | ) | (76 | ) | — | |||||||
Other-than-temporary impairment charges | 485 | 705 | — | |||||||||
Accretion of purchase discounts on MBS and CRT securities and residential whole loans | (84,615 | ) | (95,377 | ) | (89,182 | ) | ||||||
Amortization of purchase premiums on MBS and CRT securities | 36,725 | 41,624 | 32,052 | |||||||||
Depreciation and amortization on real estate, fixed assets and other assets | 964 | 860 | 1,191 | |||||||||
Equity-based compensation expense | 9,162 | 7,832 | 8,581 | |||||||||
Unrealized (gain)/loss on residential whole loans at fair value | (31,254 | ) | (6,532 | ) | 96 | |||||||
Increase in other assets | (112,614 | ) | (5,407 | ) | (9,796 | ) | ||||||
(Decrease)/increase in other liabilities | (6,943 | ) | 56,170 | 36,864 | ||||||||
Net cash provided by operating activities | $ | 85,512 | $ | 278,125 | $ | 255,813 | ||||||
Cash Flows From Investing Activities: | ||||||||||||
Principal payments on MBS and CRT securities | $ | 3,339,597 | $ | 2,916,807 | $ | 1,939,948 | ||||||
Proceeds from sale of MBS | 85,594 | 70,747 | 123,910 | |||||||||
Purchases of MBS and CRT securities | (1,908,346 | ) | (1,810,303 | ) | (1,261,646 | ) | ||||||
Purchases of residential whole loans and capitalized advances | (677,003 | ) | (617,017 | ) | (356,440 | ) | ||||||
Principal payments on residential whole loans | 103,997 | 51,427 | 6,017 | |||||||||
Proceeds from sales of real estate owned | 34,200 | 4,049 | — | |||||||||
Redemption of Federal Home Loan Bank stock | 51,400 | — | — | |||||||||
Purchases of Federal Home Loan Bank stock | (1,805 | ) | (60,017 | ) | — | |||||||
Additions to leasehold improvements, furniture and fixtures | (708 | ) | (1,560 | ) | (786 | ) | ||||||
Net cash provided by investing activities | $ | 1,026,926 | $ | 554,133 | $ | 451,003 | ||||||
Cash Flows From Financing Activities: | ||||||||||||
Principal payments on repurchase agreements and other advances | $ | (82,408,484 | ) | $ | (92,012,931 | ) | $ | (75,939,948 | ) | |||
Proceeds from borrowings under repurchase agreements and other advances | 81,706,806 | 91,614,851 | 75,868,039 | |||||||||
Principal payments on securitized debt | (22,057 | ) | (88,347 | ) | (254,078 | ) | ||||||
Cash disbursements on financial instruments underlying Linked Transactions | — | — | (6,750,803 | ) | ||||||||
Cash received from financial instruments underlying Linked Transactions | — | — | 6,336,872 | |||||||||
Payments made for margin calls on repurchase agreements and interest rate swap agreements (“Swaps”) | (177,363 | ) | (267,200 | ) | (208,600 | ) | ||||||
Proceeds from reverse margin calls on repurchase agreements and Swaps | 192,000 | 215,100 | 132,800 | |||||||||
Proceeds from issuances of common stock | 4,660 | 1,218 | 35,639 | |||||||||
Dividends paid on preferred stock | (15,000 | ) | (15,000 | ) | (15,000 | ) | ||||||
Dividends paid on common stock and dividend equivalents | (297,895 | ) | (297,379 | ) | (294,670 | ) | ||||||
Net cash used in financing activities | $ | (1,017,333 | ) | $ | (849,688 | ) | $ | (1,089,749 | ) | |||
Net increase/(decrease) in cash and cash equivalents | $ | 95,105 | $ | (17,430 | ) | $ | (382,933 | ) | ||||
Cash and cash equivalents at beginning of period | $ | 165,007 | $ | 182,437 | $ | 565,370 | ||||||
Cash and cash equivalents at end of period | $ | 260,112 | $ | 165,007 | $ | 182,437 | ||||||
Supplemental Disclosure of Cash Flow Information: | ||||||||||||
Interest paid | $ | 194,626 | $ | 172,919 | $ | 160,935 | ||||||
Non-cash Investing and Financing Activities: | ||||||||||||
MBS and CRT securities recorded upon adoption of revised accounting standard for repurchase agreement financing | $ | — | $ | 1,917,813 | $ | — | ||||||
Repurchase agreements recorded upon adoption of revised accounting standard for repurchase agreement financing | $ | — | $ | 1,519,593 | $ | — | ||||||
MBS recorded upon de-linking of Linked Transactions | $ | — | $ | — | $ | 86,449 | ||||||
Repurchase agreements recorded upon de-linking of Linked Transactions | $ | — | $ | — | $ | 49,095 | ||||||
Net increase in securities obtained as collateral/obligation to return securities obtained as collateral | $ | 5,385 | $ | 32,670 | $ | 135,165 | ||||||
Transfer from residential whole loans to real estate owned | $ | 91,896 | $ | 30,104 | $ | 2,904 | ||||||
Dividends and dividend equivalents declared and unpaid | $ | 74,657 | $ | 74,575 | $ | 74,529 |
(In Thousands) | Principal/ Current Face | Purchase Premiums | Accretable Purchase Discounts | Discount Designated as Credit Reserve and OTTI (1) | Amortized Cost (2) | Fair Value | Gross Unrealized Gains | Gross Unrealized Losses | Net Unrealized Gain/(Loss) | |||||||||||||||||||||||||||
Agency MBS: | ||||||||||||||||||||||||||||||||||||
Fannie Mae | $ | 2,879,807 | $ | 108,310 | $ | (51 | ) | $ | — | $ | 2,988,066 | $ | 3,014,464 | $ | 45,706 | $ | (19,308 | ) | $ | 26,398 | ||||||||||||||||
Freddie Mac | 693,945 | 26,736 | — | — | 723,285 | 716,209 | 4,809 | (11,885 | ) | (7,076 | ) | |||||||||||||||||||||||||
Ginnie Mae | 7,550 | 136 | — | — | 7,686 | 7,824 | 138 | — | 138 | |||||||||||||||||||||||||||
Total Agency MBS | 3,581,302 | 135,182 | (51 | ) | — | 3,719,037 | 3,738,497 | 50,653 | (31,193 | ) | 19,460 | |||||||||||||||||||||||||
Non-Agency MBS: | ||||||||||||||||||||||||||||||||||||
Expected to Recover Par (3)(4) | 2,847,398 | 57 | (24,273 | ) | — | 2,823,182 | 2,847,291 | 26,477 | (2,368 | ) | 24,109 | |||||||||||||||||||||||||
Expected to Recover Less than Par (3) | 3,359,200 | — | (253,918 | ) | (694,241 | ) | 2,411,041 | 2,978,525 | 570,318 | (2,834 | ) | 567,484 | ||||||||||||||||||||||||
Total Non-Agency MBS (5) | 6,206,598 | 57 | (278,191 | ) | (694,241 | ) | 5,234,223 | 5,825,816 | 596,795 | (5,202 | ) | 591,593 | ||||||||||||||||||||||||
Total MBS | 9,787,900 | 135,239 | (278,242 | ) | (694,241 | ) | 8,953,260 | 9,564,313 | 647,448 | (36,395 | ) | 611,053 | ||||||||||||||||||||||||
CRT securities (6) | 384,993 | 3,312 | (5,557 | ) | — | 382,748 | 404,850 | 22,105 | (3 | ) | 22,102 | |||||||||||||||||||||||||
Total MBS and CRT securities | $ | 10,172,893 | $ | 138,551 | $ | (283,799 | ) | $ | (694,241 | ) | $ | 9,336,008 | $ | 9,969,163 | $ | 669,553 | $ | (36,398 | ) | $ | 633,155 |
(In Thousands) | Principal/ Current Face | Purchase Premiums | Accretable Purchase Discounts | Discount Designated as Credit Reserve and OTTI (1) | Amortized Cost (2) | Fair Value | Gross Unrealized Gains | Gross Unrealized Losses | Net Unrealized Gain/(Loss) | |||||||||||||||||||||||||||
Agency MBS: | ||||||||||||||||||||||||||||||||||||
Fannie Mae | $ | 3,690,020 | $ | 139,243 | $ | (59 | ) | $ | — | $ | 3,829,204 | $ | 3,865,485 | $ | 62,111 | $ | (25,830 | ) | $ | 36,281 | ||||||||||||||||
Freddie Mac | 851,087 | 32,680 | — | — | 884,798 | 877,109 | 6,906 | (14,595 | ) | (7,689 | ) | |||||||||||||||||||||||||
Ginnie Mae | 9,296 | 164 | — | — | 9,460 | 9,650 | 190 | — | 190 | |||||||||||||||||||||||||||
Total Agency MBS | 4,550,403 | 172,087 | (59 | ) | — | 4,723,462 | 4,752,244 | 69,207 | (40,425 | ) | 28,782 | |||||||||||||||||||||||||
Non-Agency MBS: | ||||||||||||||||||||||||||||||||||||
Expected to Recover Par (3)(4) | 2,906,878 | 73 | (31,576 | ) | — | 2,875,375 | 2,878,532 | 23,300 | (20,143 | ) | 3,157 | |||||||||||||||||||||||||
Expected to Recover Less than Par (3) | 4,054,615 | — | (280,606 | ) | (787,541 | ) | 2,986,468 | 3,542,285 | 564,031 | (8,214 | ) | 555,817 | ||||||||||||||||||||||||
Total Non-Agency MBS (5) | 6,961,493 | 73 | (312,182 | ) | (787,541 | ) | 5,861,843 | 6,420,817 | 587,331 | (28,357 | ) | 558,974 | ||||||||||||||||||||||||
Total MBS | 11,511,896 | 172,160 | (312,241 | ) | (787,541 | ) | 10,585,305 | 11,173,061 | 656,538 | (68,782 | ) | 587,756 | ||||||||||||||||||||||||
CRT securities | 192,000 | — | (5,689 | ) | — | 186,311 | 183,582 | 418 | (3,147 | ) | (2,729 | ) | ||||||||||||||||||||||||
Total MBS and CRT securities | $ | 11,703,896 | $ | 172,160 | $ | (317,930 | ) | $ | (787,541 | ) | $ | 10,771,616 | $ | 11,356,643 | $ | 656,956 | $ | (71,929 | ) | $ | 585,027 |
Unrealized Loss Position For: | ||||||||||||||||||||||||||||||
Less than 12 Months | 12 Months or more | Total | ||||||||||||||||||||||||||||
(Dollars in Thousands) | Fair Value | Unrealized Losses | Number of Securities | Fair Value | Unrealized Losses | Number of Securities | Fair Value | Unrealized Losses | ||||||||||||||||||||||
Agency MBS: | ||||||||||||||||||||||||||||||
Fannie Mae | $ | 380,834 | $ | 3,207 | 76 | $ | 933,019 | $ | 16,101 | 156 | $ | 1,313,853 | $ | 19,308 | ||||||||||||||||
Freddie Mac | 276,595 | 4,838 | 47 | 248,498 | 7,047 | 65 | 525,093 | 11,885 | ||||||||||||||||||||||
Total Agency MBS | 657,429 | 8,045 | 123 | 1,181,517 | 23,148 | 221 | 1,838,946 | 31,193 | ||||||||||||||||||||||
Non-Agency MBS: | ||||||||||||||||||||||||||||||
Expected to Recover Par (1) | 691,114 | 1,426 | 19 | 196,431 | 942 | 14 | 887,545 | 2,368 | ||||||||||||||||||||||
Expected to Recover Less than Par (1) | 37,344 | 310 | 8 | 94,320 | 2,524 | 14 | 131,664 | 2,834 | ||||||||||||||||||||||
Total Non-Agency MBS | 728,458 | 1,736 | 27 | 290,751 | 3,466 | 28 | 1,019,209 | 5,202 | ||||||||||||||||||||||
Total MBS | 1,385,887 | 9,781 | 150 | 1,472,268 | 26,614 | 249 | 2,858,155 | 36,395 | ||||||||||||||||||||||
CRT securities (2) | 2,503 | 3 | 1 | — | — | — | 2,503 | 3 | ||||||||||||||||||||||
Total MBS and CRT securities | $ | 1,388,390 | $ | 9,784 | 151 | $ | 1,472,268 | $ | 26,614 | 249 | $ | 2,860,658 | $ | 36,398 |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
Total OTTI losses | $ | (1,255 | ) | $ | (525 | ) | $ | — | ||||
OTTI recognized in/(reclassified from) OCI | 770 | (180 | ) | — | ||||||||
OTTI recognized in earnings | $ | (485 | ) | $ | (705 | ) | $ | — |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
Credit loss component of OTTI at beginning of period | $ | 36,820 | $ | 36,115 | $ | 36,115 | ||||||
Additions for credit related OTTI not previously recognized | 314 | 461 | — | |||||||||
Subsequent additional credit related OTTI recorded | 171 | 244 | — | |||||||||
Credit loss component of OTTI at end of period | $ | 37,305 | $ | 36,820 | $ | 36,115 |
For the Year Ended December 31, | ||||||||||||||||
2016 | 2015 | |||||||||||||||
(In Thousands) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | Discount Designated as Credit Reserve and OTTI | Accretable Discount (1) | ||||||||||||
Balance at beginning of period | $ | (787,541 | ) | $ | (312,182 | ) | $ | (900,557 | ) | $ | (399,564 | ) | ||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | — | — | (15,543 | ) | 1,832 | |||||||||||
Impact of RMBS Issuer settlement (2) | — | (59,900 | ) | — | — | |||||||||||
Accretion of discount | — | 80,548 | — | 93,173 | ||||||||||||
Realized credit losses | 64,217 | — | 80,821 | — | ||||||||||||
Purchases | (25,999 | ) | 13,094 | (1,200 | ) | (4,925 | ) | |||||||||
Sales | 17,863 | 37,953 | 8,525 | 38,420 | ||||||||||||
Net impairment losses recognized in earnings | (485 | ) | — | (705 | ) | — | ||||||||||
Transfers/release of credit reserve | 37,704 | (37,704 | ) | 41,118 | (41,118 | ) | ||||||||||
Balance at end of period | $ | (694,241 | ) | $ | (278,191 | ) | $ | (787,541 | ) | $ | (312,182 | ) |
(2) | Includes the impact of approximately $61.8 million and $7.0 million of cash proceeds (a one-time payment) received by the Company during the year ended December 31, 2016 in connection with the settlements of litigation related to certain Countrywide and Citigroup sponsored residential mortgage backed securitization trusts, respectively. |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
AOCI from AFS securities: | ||||||||||||
Unrealized gain on AFS securities at beginning of period | $ | 585,250 | $ | 813,515 | $ | 752,912 | ||||||
Unrealized (loss)/gain on Agency MBS, net | (9,322 | ) | (51,332 | ) | 65,739 | |||||||
Unrealized gain/(loss) on Non-Agency MBS, net | 81,882 | (143,558 | ) | 29,812 | ||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | — | 4,537 | — | |||||||||
Reclassification adjustment for MBS sales included in net income | (36,922 | ) | (37,207 | ) | (34,948 | ) | ||||||
Reclassification adjustment for OTTI included in net income | (485 | ) | (705 | ) | — | |||||||
Change in AOCI from AFS securities | 35,153 | (228,265 | ) | 60,603 | ||||||||
Balance at end of period | $ | 620,403 | $ | 585,250 | $ | 813,515 |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
Agency MBS | ||||||||||||
Coupon interest | $ | 119,966 | $ | 147,066 | $ | 189,355 | ||||||
Effective yield adjustment (1) | (36,897 | ) | (41,231 | ) | (46,812 | ) | ||||||
Interest income | $ | 83,069 | $ | 105,835 | $ | 142,543 | ||||||
Legacy Non-Agency MBS | ||||||||||||
Coupon interest | $ | 154,057 | $ | 183,349 | $ | 212,073 | ||||||
Effective yield adjustment (2) | 78,443 | 91,003 | 103,491 | |||||||||
Interest income | $ | 232,500 | $ | 274,352 | $ | 315,564 | ||||||
3 Year Step-up securities | ||||||||||||
Coupon interest | $ | 100,032 | $ | 87,429 | $ | 898 | ||||||
Effective yield adjustment (1) | 2,108 | 1,789 | (132 | ) | ||||||||
Interest income | $ | 102,140 | $ | 89,218 | $ | 766 | ||||||
CRT securities | ||||||||||||
Coupon interest | $ | 13,023 | $ | 5,844 | $ | 665 | ||||||
Effective yield adjustment (2) | 1,747 | 728 | 107 | |||||||||
Interest income | $ | 14,770 | $ | 6,572 | $ | 772 |
(In Thousands) | For the Year Ended December 31, | |||||||||||
2016 | 2015 | 2014 | ||||||||||
Balance at the beginning of period | $ | 1,165 | $ | 137 | $ | — | ||||||
(Reversal of provisions)/provisions for loan losses | (175 | ) | 1,028 | 137 | ||||||||
Balance at the end of period | $ | 990 | $ | 1,165 | $ | 137 |
(In Thousands) | For the Year Ended December 31, | |||||||
2016 | 2015 | |||||||
Contractually required principal and interest | $ | 662,747 | $ | 160,806 | ||||
Contractual cash flows not expected to be collected (non-accretable yield) | (117,694 | ) | (27,040 | ) | ||||
Expected cash flows to be collected | 545,053 | 133,766 | ||||||
Interest component of expected cash flows (accretable yield) | (181,534 | ) | (51,413 | ) | ||||
Fair value at the date of acquisition | $ | 363,519 | $ | 82,353 |
(In Thousands) | For the Year Ended December 31, | |||||||
2016 | 2015 | |||||||
Balance at beginning of period | $ | 175,271 | $ | 133,012 | ||||
Additions | 181,534 | 51,413 | ||||||
Accretion | (23,916 | ) | (15,511 | ) | ||||
Reclassifications from non-accretable difference, net | 1,490 | 6,357 | ||||||
Balance at end of period | $ | 334,379 | $ | 175,271 |
(Dollars in Thousands) | December 31, 2016 | December 31, 2015 | ||||||
Outstanding principal balance | $ | 966,276 | $ | 786,330 | ||||
Aggregate fair value | $ | 814,682 | $ | 623,276 | ||||
Number of loans | 3,812 | 3,143 |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
Coupon payments and other income received | $ | 23,017 | $ | 9,304 | $ | 504 | ||||||
Net unrealized gains/(losses) | 31,254 | 6,539 | (427 | ) | ||||||||
Net gain on payoff/liquidation of loans | 5,413 | 1,879 | 39 | |||||||||
Total | $ | 59,684 | $ | 17,722 | $ | 116 |
(In Thousands) | December 31, 2016 | December 31, 2015 | ||||||
REO | $ | 80,503 | $ | 28,026 | ||||
Interest receivable | 27,795 | 29,002 | ||||||
Swaps, at fair value | 233 | 1,127 | ||||||
Goodwill | 7,189 | 7,189 | ||||||
Prepaid and other assets | 164,575 | 101,455 | ||||||
Total Other Assets | $ | 280,295 | $ | 166,799 |
For the Year Ended December 31, | ||||||||
(In Thousands) | 2016 | 2015 | ||||||
Balance at beginning of period | $ | 28,026 | $ | 5,492 | ||||
Adjustments to record at lower of cost or fair value | (7,527 | ) | (3,475 | ) | ||||
Transfer from residential whole loans (1) | 91,896 | 30,104 | ||||||
Purchases and capital improvements | 2,825 | 2,461 | ||||||
Disposals | (34,717 | ) | (6,556 | ) | ||||
Balance at end of period | $ | 80,503 | $ | 28,026 |
December 31, | ||||||||||||||||||||
2016 | 2015 | |||||||||||||||||||
Derivative Instrument | Designation | Balance Sheet Location | Notional Amount | Fair Value | Notional Amount | Fair Value | ||||||||||||||
(In Thousands) | ||||||||||||||||||||
Non-cleared legacy Swaps (1) | Hedging | Assets | $ | 350,000 | $ | 233 | $ | 450,000 | $ | 1,127 | ||||||||||
Non-cleared legacy Swaps (1) | Hedging | Liabilities | $ | — | $ | — | $ | 50,000 | $ | (59 | ) | |||||||||
Cleared Swaps (2) | Hedging | Liabilities | $ | 2,550,000 | $ | (46,954 | ) | $ | 2,550,000 | $ | (70,467 | ) |
December 31, | ||||||||
(In Thousands) | 2016 | 2015 | ||||||
Agency MBS, at fair value | $ | 32,468 | $ | 38,569 | ||||
Restricted cash | 53,849 | 70,573 | ||||||
Total assets pledged against Swaps | $ | 86,317 | $ | 109,142 |
(Dollars in Thousands) | December 31, 2016 | |||
New Swaps: | ||||
Aggregate notional amount | $ | — | ||
Weighted average fixed-pay rate | — | % | ||
Initial maturity date | N/A | |||
Number of new Swaps | — | |||
Swaps amortized/expired: | ||||
Aggregate notional amount | $ | 150,000 | ||
Weighted average fixed-pay rate | 1.03 | % |
December 31, 2016 | December 31, 2015 | |||||||||||||||||||
Maturity (1) | Notional Amount | Weighted Average Fixed-Pay Interest Rate | Weighted Average Variable Interest Rate (2) | Notional Amount | Weighted Average Fixed-Pay Interest Rate | Weighted Average Variable Interest Rate (2) | ||||||||||||||
(Dollars in Thousands) | ||||||||||||||||||||
Within 30 days | $ | — | — | % | — | % | $ | 50,000 | 2.13 | % | 0.42 | % | ||||||||
Over 30 days to 3 months | 50,000 | 0.67 | 0.64 | — | — | — | ||||||||||||||
Over 3 months to 6 months | 300,000 | 0.57 | 0.66 | — | — | — | ||||||||||||||
Over 6 months to 12 months | — | — | — | 100,000 | 0.48 | 0.32 | ||||||||||||||
Over 12 months to 24 months | 550,000 | 1.49 | 0.71 | 350,000 | 0.58 | 0.27 | ||||||||||||||
Over 24 months to 36 months | 200,000 | 1.71 | 0.76 | 550,000 | 1.49 | 0.32 | ||||||||||||||
Over 36 months to 48 months | 1,500,000 | 2.22 | 0.74 | 200,000 | 1.71 | 0.42 | ||||||||||||||
Over 48 months to 60 months | 200,000 | 2.20 | 0.75 | 1,500,000 | 2.22 | 0.36 | ||||||||||||||
Over 60 months to 72 months | — | — | — | 200,000 | 2.20 | 0.30 | ||||||||||||||
Over 72 months to 84 months (3) | 100,000 | 2.75 | 0.74 | — | — | — | ||||||||||||||
Over 84 months | — | — | — | 100,000 | 2.75 | 0.40 | ||||||||||||||
Total Swaps | $ | 2,900,000 | 1.87 | % | 0.72 | % | $ | 3,050,000 | 1.82 | % | 0.34 | % |
For the Year Ended December 31, | ||||||||||||
(Dollars in Thousands) | 2016 | 2015 | 2014 | |||||||||
Interest expense attributable to Swaps | $ | 40,898 | $ | 53,759 | $ | 69,842 | ||||||
Weighted average Swap rate paid | 1.82 | % | 1.86 | % | 1.93 | % | ||||||
Weighted average Swap rate received | 0.48 | % | 0.19 | % | 0.16 | % |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
AOCI from derivative hedging instruments: | ||||||||||||
Balance at beginning of period | $ | (69,399 | ) | $ | (59,062 | ) | $ | (15,217 | ) | |||
Unrealized gain/(loss) on Swaps, net | 22,678 | (10,337 | ) | (44,292 | ) | |||||||
Reclassification of unrealized loss on de-designated Swaps | — | — | 447 | |||||||||
Balance at end of period | $ | (46,721 | ) | $ | (69,399 | ) | $ | (59,062 | ) |
(In Thousands) | For the Year Ended December 31, 2014 | |||
Interest income attributable to MBS underlying Linked Transactions | $ | 24,443 | ||
Interest expense attributable to linked repurchase agreement borrowings underlying Linked Transactions | (8,028 | ) | ||
Change in fair value of Linked Transactions included in earnings | 677 | |||
Unrealized net gains and net interest income from Linked Transactions | $ | 17,092 |
December 31, | ||||||||
(In Thousands) | 2016 | 2015 | ||||||
MBS interest receivable: | ||||||||
Fannie Mae | $ | 7,402 | $ | 8,999 | ||||
Freddie Mac | 1,802 | 2,177 | ||||||
Ginnie Mae | 14 | 15 | ||||||
Non-Agency MBS | 13,435 | 15,438 | ||||||
Total MBS interest receivable | 22,653 | 26,629 | ||||||
Residential whole loans | 4,415 | 2,259 | ||||||
CRT securities | 254 | 92 | ||||||
Money market and other investments | 473 | 22 | ||||||
Total interest receivable | $ | 27,795 | $ | 29,002 |
(Dollars in Thousands) | December 31, 2016 | December 31, 2015 | ||||||
Repurchase agreement borrowings secured by Agency MBS | $ | 3,095,020 | $ | 2,727,542 | ||||
Fair value of Agency MBS pledged as collateral under repurchase agreements | $ | 3,280,689 | $ | 2,881,049 | ||||
Weighted average haircut on Agency MBS (1) | 4.67 | % | 4.67 | % | ||||
Repurchase agreement borrowings secured by Legacy Non-Agency MBS | $ | 1,690,937 | $ | 1,960,222 | ||||
Fair value of Legacy Non-Agency MBS pledged as collateral under repurchase agreements (2) | $ | 2,317,708 | $ | 2,818,968 | ||||
Weighted average haircut on Legacy Non-Agency MBS (1) | 24.01 | % | 25.84 | % | ||||
Repurchase agreement borrowings secured by 3 Year Step-up securities | $ | 2,078,684 | $ | 2,080,163 | ||||
Fair value of 3 Year Step-up securities pledged as collateral under repurchase agreements | $ | 2,660,491 | $ | 2,625,866 | ||||
Weighted average haircut on 3 Year Step-up securities (1) | 22.28 | % | 21.05 | % | ||||
Repurchase agreements secured by U.S. Treasuries | $ | 504,572 | $ | 504,760 | ||||
Fair value of U.S. Treasuries pledged as collateral under repurchase agreements | $ | 510,767 | $ | 507,443 | ||||
Weighted average haircut on U.S. Treasuries (1) | 1.60 | % | 1.60 | % | ||||
Repurchase agreements secured by CRT securities | $ | 271,205 | $ | 128,465 | ||||
Fair value of CRT securities pledged as collateral under repurchase agreements | $ | 357,488 | $ | 170,352 | ||||
Weighted average haircut on CRT securities (1) | 23.22 | % | 25.04 | % | ||||
Repurchase agreements secured by residential whole loans (3) | $ | 832,060 | $ | 487,750 | ||||
Fair value of residential whole loans pledged as collateral under repurchase agreements | $ | 1,175,088 | $ | 684,136 | ||||
Weighted average haircut on residential whole loans (1) | 25.03 | % | 27.69 | % |
December 31, 2016 | December 31, 2015 | |||||||||||||
Time Until Interest Rate Reset | Balance | Weighted Average Interest Rate | Balance | Weighted Average Interest Rate | ||||||||||
(Dollars in Thousands) | ||||||||||||||
Within 30 days | $ | 7,284,062 | 1.77 | % | $ | 7,054,483 | 1.44 | % | ||||||
Over 30 days to 3 months | 1,188,416 | 1.91 | 734,955 | 1.79 | ||||||||||
Over 3 months to 12 months | — | — | 99,464 | 2.36 | ||||||||||
Total repurchase agreements | $ | 8,472,478 | 1.79 | % | $ | 7,888,902 | 1.48 | % | ||||||
Less debt issuance costs | $ | 210 | $ | 1,280 | ||||||||||
Total repurchase agreements less debt issuance costs | $ | 8,472,268 | $ | 7,887,622 |
December 31, 2016 | |||||||||||||||||||||||||||||||
Contractual Maturity | Agency MBS | Legacy Non-Agency MBS | 3 Year Step-up Securities | U.S. Treasuries | CRT Securities | Residential Whole Loans | Total (1) | Weighted Average Interest Rate | |||||||||||||||||||||||
(Dollars in Thousands) | |||||||||||||||||||||||||||||||
Overnight | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | — | % | |||||||||||||||
Within 30 days | 2,768,277 | 1,006,956 | 1,379,254 | 504,572 | 267,316 | — | 5,926,375 | 1.67 | |||||||||||||||||||||||
Over 30 days to 3 months | 326,743 | 433,244 | 467,873 | — | 3,889 | 117,839 | 1,349,588 | 1.76 | |||||||||||||||||||||||
Over 3 months to 12 months | — | 250,737 | 231,557 | — | — | 714,221 | 1,196,515 | 2.72 | |||||||||||||||||||||||
Over 12 months | — | — | — | — | — | — | — | — | |||||||||||||||||||||||
Total | $ | 3,095,020 | $ | 1,690,937 | $ | 2,078,684 | $ | 504,572 | $ | 271,205 | $ | 832,060 | $ | 8,472,478 | 1.79 | % | |||||||||||||||
Gross amount of recognized liabilities for repurchase agreements in Note 8 | $ | 8,472,268 | |||||||||||||||||||||||||||||
Amounts related to repurchase agreements not included in offsetting disclosure in Note 8 | $ | — |
(1) | Excludes $210,000 of unamortized debt issuance costs at December 31, 2016. |
December 31, 2016 | |||||||||||
Counterparty | Counterparty Rating (1) | Amount at Risk (2) | Weighted Average Months to Maturity for Repurchase Agreements | Percent of Stockholders’ Equity | |||||||
(Dollars in Thousands) | |||||||||||
Wells Fargo (3) | AA-/Aa2/AA | $ | 388,455 | 4 | 12.8 | % | |||||
RBC (4) | AA-/Aa3/AA | 274,261 | 1 | 9.0 | |||||||
Goldman Sachs | BBB+/A3/A | 211,377 | 2 | 7.0 | |||||||
Credit Suisse (5) | BBB+/Aa2/A- | 191,594 | 3 | 6.3 | |||||||
UBS (6) | A+/A1/A+ | 167,127 | 6 | 5.5 |
December 31, 2016 | December 31, 2015 | |||||||||||||||
(In Thousands) | Assets Pledged | Collateral Held | Assets Pledged | Collateral Held | ||||||||||||
Derivative Hedging Instruments: | ||||||||||||||||
Agency MBS | $ | 32,468 | $ | — | $ | 38,569 | $ | — | ||||||||
Cash (1) | 53,849 | — | 70,573 | — | ||||||||||||
86,317 | — | 109,142 | — | |||||||||||||
Repurchase Agreement Borrowings: | ||||||||||||||||
Agency MBS | 3,280,689 | — | 2,881,049 | — | ||||||||||||
Legacy Non-Agency MBS (2)(3) | 2,317,708 | — | 2,818,968 | — | ||||||||||||
3 Year Step-up securities | 2,660,491 | — | 2,625,866 | — | ||||||||||||
U.S. Treasury securities | 510,767 | — | 507,443 | — | ||||||||||||
CRT securities | 357,488 | — | 170,352 | — | ||||||||||||
Residential whole loans | 1,175,088 | — | 684,136 | — | ||||||||||||
Cash (1) | 4,614 | — | 965 | — | ||||||||||||
10,306,845 | — | 9,688,779 | — | |||||||||||||
FHLB Advances: | ||||||||||||||||
Agency MBS | 227,244 | — | 1,612,476 | — | ||||||||||||
227,244 | — | 1,612,476 | — | |||||||||||||
Reverse Repurchase Agreements: | ||||||||||||||||
U.S. Treasury securities | — | 510,767 | — | 507,443 | ||||||||||||
— | 510,767 | — | 507,443 | |||||||||||||
Total | $ | 10,620,406 | $ | 510,767 | $ | 11,410,397 | $ | 507,443 |
December 31, 2016 | ||||||||||||||||||||||||||||
Assets Pledged Under Repurchase Agreements and Other Advances | Assets Pledged Against Derivative Hedging Instruments | Total Fair Value of Assets Pledged and Accrued Interest | ||||||||||||||||||||||||||
(In Thousands) | Fair Value | Amortized Cost | Accrued Interest on Pledged Assets | Fair Value/ Carrying Value | Amortized Cost | Accrued Interest on Pledged Assets | ||||||||||||||||||||||
Agency MBS (1) | $ | 3,507,933 | $ | 3,488,904 | $ | 8,654 | $ | 32,468 | $ | 33,216 | $ | 67 | $ | 3,549,122 | ||||||||||||||
Legacy Non-Agency MBS(2)(3) | 2,317,708 | 1,841,401 | 8,613 | — | — | — | 2,326,321 | |||||||||||||||||||||
3 Year Step-up securities | 2,660,491 | 2,657,726 | 1,848 | — | — | — | 2,662,339 | |||||||||||||||||||||
U.S. Treasuries | 510,767 | 510,767 | — | — | — | — | 510,767 | |||||||||||||||||||||
CRT securities | 357,488 | 336,706 | 222 | — | — | — | 357,710 | |||||||||||||||||||||
Residential whole loans (4) | 1,175,088 | 1,162,212 | 3,248 | — | — | — | 1,178,336 | |||||||||||||||||||||
Cash (5) | 4,614 | 4,614 | — | 53,849 | 53,849 | — | 58,463 | |||||||||||||||||||||
Total | $ | 10,534,089 | $ | 10,002,330 | $ | 22,585 | $ | 86,317 | $ | 87,065 | $ | 67 | $ | 10,643,058 |
Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Net Amounts of Assets Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset in the Consolidated Balance Sheets | Net Amount | ||||||||||||||||||||
(In Thousands) | Financial Instruments | Cash Collateral Received | ||||||||||||||||||||||
December 31, 2016 | ||||||||||||||||||||||||
Swaps, at fair value | $ | 233 | $ | — | $ | 233 | $ | (233 | ) | $ | — | $ | — | |||||||||||
Total | $ | 233 | $ | — | $ | 233 | $ | (233 | ) | $ | — | $ | — | |||||||||||
December 31, 2015 | ||||||||||||||||||||||||
Swaps, at fair value | $ | 1,127 | $ | — | $ | 1,127 | $ | (1,127 | ) | $ | — | $ | — | |||||||||||
Total | $ | 1,127 | $ | — | $ | 1,127 | $ | (1,127 | ) | $ | — | $ | — |
Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Net Amounts of Liabilities Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset in the Consolidated Balance Sheets | Net Amount | ||||||||||||||||||||
(In Thousands) | Financial Instruments (1) | Cash Collateral Pledged (1) | ||||||||||||||||||||||
December 31, 2016 | ||||||||||||||||||||||||
Swaps, at fair value (2) | $ | 46,954 | $ | — | $ | 46,954 | $ | — | $ | (46,954 | ) | $ | — | |||||||||||
Repurchase agreements and other advances (3)(4) | 8,687,478 | — | 8,687,478 | (8,682,864 | ) | (4,614 | ) | — | ||||||||||||||||
Total | $ | 8,734,432 | $ | — | $ | 8,734,432 | $ | (8,682,864 | ) | $ | (51,568 | ) | $ | — | ||||||||||
December 31, 2015 | ||||||||||||||||||||||||
Swaps, at fair value (2) | $ | 70,526 | $ | — | $ | 70,526 | $ | — | $ | (70,526 | ) | $ | — | |||||||||||
Repurchase agreements and other advances (3)(4) | 9,388,902 | — | 9,388,902 | (9,387,937 | ) | (965 | ) | — | ||||||||||||||||
Total | $ | 9,459,428 | $ | — | $ | 9,459,428 | $ | (9,387,937 | ) | $ | (71,491 | ) | $ | — |
(In Thousands) | December 31, 2016 | December 31, 2015 | ||||||
Accrued interest payable | $ | 14,129 | $ | 16,949 | ||||
Swaps, at fair value | 46,954 | 70,526 | ||||||
Dividends and dividend equivalents payable | 74,657 | 74,575 | ||||||
Securitized debt | — | 21,868 | ||||||
Accrued expenses and other liabilities | 19,612 | 19,610 | ||||||
Total Other Liabilities | $ | 155,352 | $ | 203,528 |
Year Ended December 31, | Minimum Rental Payments | |||
(In Thousands) | ||||
2017 | $ | 2,553 | ||
2018 | 2,553 | |||
2019 | 2,553 | |||
2020 | 1,082 | |||
2021 | 32 | |||
Total | $ | 8,773 |
Year | Declaration Date | Record Date | Payment Date | Dividend Per Share | ||||
2016 | November 22, 2016 | December 6, 2016 | December 30, 2016 | $0.46875 | ||||
August 12, 2016 | September 2, 2016 | September 30, 2016 | 0.46875 | |||||
May 18, 2016 | June 3, 2016 | June 30, 2016 | 0.46875 | |||||
February 12, 2016 | February 29, 2016 | March 31, 2016 | 0.46875 | |||||
2015 | November 19, 2015 | December 3, 2015 | December 31, 2015 | $0.46875 | ||||
August 24, 2015 | September 9, 2015 | September 30, 2015 | 0.46875 | |||||
May 18, 2015 | June 2, 2015 | June 30, 2015 | 0.46875 | |||||
February 13, 2015 | February 27, 2015 | March 31, 2015 | 0.46875 | |||||
2014 | November 21, 2014 | December 5, 2014 | December 31, 2014 | $0.46875 | ||||
August 25, 2014 | September 8, 2014 | September 30, 2014 | 0.46875 | |||||
May 19, 2014 | June 10, 2014 | June 30, 2014 | 0.46875 | |||||
February 14, 2014 | February 28, 2014 | March 31, 2014 | 0.46875 |
Year | Declaration Date | Record Date | Payment Date | Dividend Per Share | |||||
2016 | December 14, 2016 | December 28, 2016 | January 31, 2017 | $0.20 | (1) | ||||
September 15, 2016 | September 28, 2016 | October 31, 2016 | 0.20 | ||||||
June 14, 2016 | June 28, 2016 | July 29, 2016 | 0.20 | ||||||
March 11, 2016 | March 28, 2016 | April 29, 2016 | 0.20 | ||||||
2015 | December 9, 2015 | December 28, 2015 | January 29, 2016 | $0.20 | |||||
September 17, 2015 | September 29, 2015 | October 30, 2015 | 0.20 | ||||||
June 15, 2015 | June 29, 2015 | July 31, 2015 | 0.20 | ||||||
March 13, 2015 | March 27, 2015 | April 30, 2015 | 0.20 | ||||||
2014 | December 9, 2014 | December 26, 2014 | January 30, 2015 | $0.20 | |||||
September 17, 2014 | September 29, 2014 | October 31, 2014 | 0.20 | ||||||
June 13, 2014 | June 27, 2014 | July 31, 2014 | 0.20 | ||||||
March 10, 2014 | March 28, 2014 | April 30, 2014 | 0.20 |
For the Year Ended December 31, | ||||||||||||||||||||||||||||||||||||
2016 | 2015 | 2014 | ||||||||||||||||||||||||||||||||||
(In Thousands) | Net Unrealized Gain/(Loss) on AFS Securities | Net Unrealized Gain/(Loss) on Swaps | Total AOCI | Net Unrealized Gain/(Loss) on AFS Securities | Net Unrealized Gain/(Loss) on Swaps | Total AOCI | Net Unrealized Gain/(Loss) on AFS Securities | Net Unrealized Gain/(Loss) on Swaps | Total AOCI | |||||||||||||||||||||||||||
Balance at beginning of period | $ | 585,250 | $ | (69,399 | ) | $ | 515,851 | $ | 813,515 | $ | (59,062 | ) | $ | 754,453 | $ | 752,912 | $ | (15,217 | ) | $ | 737,695 | |||||||||||||||
OCI before reclassifications | 72,560 | 22,678 | 95,238 | (194,890 | ) | (10,337 | ) | (205,227 | ) | 95,551 | (44,292 | ) | 51,259 | |||||||||||||||||||||||
Amounts reclassified from AOCI (1) | (37,407 | ) | — | (37,407 | ) | (37,912 | ) | — | (37,912 | ) | (34,948 | ) | 447 | (34,501 | ) | |||||||||||||||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | — | — | — | 4,537 | — | 4,537 | — | — | — | |||||||||||||||||||||||||||
Net OCI during period (2) | 35,153 | 22,678 | 57,831 | (228,265 | ) | (10,337 | ) | (238,602 | ) | 60,603 | (43,845 | ) | 16,758 | |||||||||||||||||||||||
Balance at end of period | $ | 620,403 | $ | (46,721 | ) | $ | 573,682 | $ | 585,250 | $ | (69,399 | ) | $ | 515,851 | $ | 813,515 | $ | (59,062 | ) | $ | 754,453 |
For the Year Ended December 31, | ||||||||||||||
2016 | 2015 | 2014 | ||||||||||||
Details about AOCI Components | Amounts Reclassified from AOCI | Affected Line Item in the Statement Where Net Income is Presented | ||||||||||||
(In Thousands) | ||||||||||||||
AFS Securities: | ||||||||||||||
Realized gain on sale of securities | $ | (36,922 | ) | $ | (37,207 | ) | $ | (34,948 | ) | Gain on sales of MBS | ||||
OTTI recognized in earnings | (485 | ) | (705 | ) | — | Net impairment losses recognized in earnings | ||||||||
Total AFS Securities | (37,407 | ) | (37,912 | ) | (34,948 | ) | ||||||||
Swaps designated as cash flow hedges: | ||||||||||||||
De-designated Swaps | — | — | 447 | Other, net | ||||||||||
Total Swaps designated as cash flow hedges | — | — | 447 | |||||||||||
Total reclassifications for period | $ | (37,407 | ) | $ | (37,912 | ) | $ | (34,501 | ) |
For the Year Ended December 31, | ||||||||||||
(In Thousands, Except Per Share Amounts) | 2016 | 2015 | 2014 | |||||||||
Numerator: | ||||||||||||
Net income | $ | 312,668 | $ | 313,226 | $ | 313,504 | ||||||
Dividends declared on preferred stock | (15,000 | ) | (15,000 | ) | (15,000 | ) | ||||||
Dividends, dividend equivalents and undistributed earnings allocated to participating securities | (1,628 | ) | (1,539 | ) | (1,106 | ) | ||||||
Net income available to common stockholders - basic and diluted | $ | 296,040 | $ | 296,687 | $ | 297,398 | ||||||
Denominator: | ||||||||||||
Weighted average common shares for basic and diluted earnings per share (1) | 371,122 | 372,114 | 369,048 | |||||||||
Basic and diluted earnings per share | $ | 0.80 | $ | 0.80 | $ | 0.81 |
For the Year Ended December 31, | |||||||||
2016 | 2015 | 2014 | |||||||
Number of Dividend Equivalent Rights | |||||||||
Outstanding at beginning of year: | 8,215 | 24,402 | 218,225 | ||||||
Granted | — | — | — | ||||||
Cancelled, forfeited or expired | (8,215 | ) | (16,187 | ) | (193,823 | ) | |||
Outstanding at end of year | — | 8,215 | 24,402 |
For the Year Ended December 31, | |||||||
2014 | |||||||
Number of Options | Weighted Average Exercise Price | ||||||
Outstanding at beginning of year: | 5,000 | $ | 8.40 | ||||
Granted | — | — | |||||
Cancelled, forfeited or expired | (5,000 | ) | 8.40 | ||||
Exercised | — | — | |||||
Outstanding at end of year | — | $ | — | ||||
Options exercisable at end of year | — | $ | — |
For the Year Ended December 31, | ||||||||||||||||||||
2016 | 2015 | 2014 | ||||||||||||||||||
Shares of Restricted Stock | Weighted Average Grant Date Fair Value (1) | Shares of Restricted Stock | Weighted Average Grant Date Fair Value (1) | Shares of Restricted Stock | Weighted Average Grant Date Fair Value (1) | |||||||||||||||
Outstanding at beginning of year: | 110,920 | $ | 7.41 | 243,948 | $ | 7.48 | 443,967 | $ | 7.50 | |||||||||||
Granted | 487,216 | 7.66 | 497,007 | 6.83 | 491,797 | 8.29 | ||||||||||||||
Vested (2) | (567,851 | ) | 7.64 | (629,212 | ) | 6.98 | (690,397 | ) | 8.07 | |||||||||||
Cancelled/forfeited | (1,317 | ) | 7.12 | (823 | ) | 7.74 | (1,419 | ) | 7.58 | |||||||||||
Outstanding at end of year | 28,968 | $ | 7.12 | 110,920 | $ | 7.41 | 243,948 | $ | 7.48 |
For the Year Ended December 31, 2016 | ||||||||||||||||||||
RSUs With Service Condition | Weighted Average Grant Date Fair Value | RSUs With Market and Service Conditions | Weighted Average Grant Date Fair Value | Total RSUs | Total Weighted Average Grant Date Fair Value | |||||||||||||||
Outstanding at beginning of year: | 1,138,930 | $ | 7.71 | 736,800 | $ | 5.66 | 1,875,730 | $ | 6.90 | |||||||||||
Granted (1) | 420,695 | 6.81 | 307,500 | 4.81 | 728,195 | 5.96 | ||||||||||||||
Settled | (360,326 | ) | 7.75 | (175,500 | ) | 5.21 | (535,826 | ) | 6.92 | |||||||||||
Cancelled/forfeited | (5,000 | ) | 7.32 | (5,000 | ) | 5.27 | (10,000 | ) | 6.29 | |||||||||||
Outstanding at end of year | 1,194,299 | $ | 7.38 | 863,800 | $ | 5.45 | 2,058,099 | $ | 6.57 | |||||||||||
RSUs vested but not settled at end of year | 617,518 | $ | 7.45 | 293,800 | $ | 5.83 | 911,318 | $ | 6.93 | |||||||||||
RSUs unvested at end of year | 576,781 | $ | 7.30 | 570,000 | $ | 5.25 | 1,146,781 | $ | 6.28 |
For the Year Ended December 31, 2015 | ||||||||||||||||||||
RSUs With Service Condition | Weighted Average Grant Date Fair Value | RSUs With Market and Service Conditions | Weighted Average Grant Date Fair Value | Total RSUs | Total Weighted Average Grant Date Fair Value | |||||||||||||||
Outstanding at beginning of year: | 769,174 | $ | 7.55 | 449,300 | $ | 5.61 | 1,218,474 | $ | 6.84 | |||||||||||
Granted (2) | 390,804 | 7.96 | 291,250 | 5.73 | 682,054 | 7.01 | ||||||||||||||
Settled | (17,298 | ) | 6.60 | — | — | (17,298 | ) | 6.60 | ||||||||||||
Cancelled/forfeited | (3,750 | ) | 7.97 | (3,750 | ) | 5.73 | (7,500 | ) | 6.85 | |||||||||||
Outstanding at end of year | 1,138,930 | $ | 7.71 | 736,800 | $ | 5.66 | 1,875,730 | $ | 6.90 | |||||||||||
RSUs vested but not settled at end of year | 554,023 | $ | 7.83 | 175,500 | $ | 5.21 | 729,523 | $ | 7.20 | |||||||||||
RSUs unvested at end of year | 584,907 | $ | 7.59 | 561,300 | $ | 5.80 | 1,146,207 | $ | 6.71 |
For the Year Ended December 31, 2014 | ||||||||||||||||||||
RSUs With Service Condition | Weighted Average Grant Date Fair Value | RSUs With Market and Service Conditions | Weighted Average Grant Date Fair Value | Total RSUs | Total Weighted Average Grant Date Fair Value | |||||||||||||||
Outstanding at beginning of year: | 490,099 | $ | 7.75 | 287,719 | $ | 4.32 | 777,818 | $ | 6.48 | |||||||||||
Granted (3) | 357,015 | 7.22 | 273,800 | 5.87 | 630,815 | 6.64 | ||||||||||||||
Settled | (72,873 | ) | 7.28 | (14,465 | ) | 4.71 | (87,338 | ) | 6.86 | |||||||||||
Cancelled/forfeited | (5,067 | ) | 7.36 | (97,754 | ) | 2.67 | (102,821 | ) | 2.90 | |||||||||||
Outstanding at end of year | 769,174 | $ | 7.55 | 449,300 | $ | 5.61 | 1,218,474 | $ | 6.84 | |||||||||||
RSUs vested but not settled at end of year | 467,638 | $ | 7.81 | 175,500 | $ | 5.21 | 643,138 | $ | 7.10 | |||||||||||
RSUs unvested at end of year | 301,536 | $ | 7.15 | 273,800 | $ | 5.87 | 575,336 | $ | 6.54 |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
Restricted shares of common stock | $ | 4,326 | $ | 4,373 | $ | 5,553 | ||||||
RSUs (1) | 4,792 | 3,377 | 2,886 | |||||||||
Dividend equivalent rights | 44 | 82 | 146 | |||||||||
Total | $ | 9,162 | $ | 7,832 | $ | 8,585 |
For the Year Ended December 31, | ||||||||||||
(In Thousands) | 2016 | 2015 | 2014 | |||||||||
Non-employee directors | $ | 231 | $ | (59 | ) | $ | 69 | |||||
Total | $ | 231 | $ | (59 | ) | $ | 69 |
December 31, 2016 | December 31, 2015 | |||||||||||||||
(In Thousands) | Undistributed Income Deferred (1) | Liability Under Deferred Plans | Undistributed Income Deferred (1) | Liability Under Deferred Plans | ||||||||||||
Non-employee directors | $ | 1,066 | $ | 1,263 | $ | 601 | $ | 614 | ||||||||
Total | $ | 1,066 | $ | 1,263 | $ | 601 | $ | 614 |
(In Thousands) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Assets: | ||||||||||||||||
Agency MBS | $ | — | $ | 3,738,497 | $ | — | $ | 3,738,497 | ||||||||
Non-Agency MBS, including MBS transferred to consolidated VIEs | — | 5,825,816 | — | 5,825,816 | ||||||||||||
CRT securities | — | 404,850 | — | 404,850 | ||||||||||||
Securities obtained and pledged as collateral | 510,767 | — | — | 510,767 | ||||||||||||
Residential whole loans, at fair value | — | — | 814,682 | 814,682 | ||||||||||||
Swaps | — | 233 | — | 233 | ||||||||||||
Total assets carried at fair value | $ | 510,767 | $ | 9,969,396 | $ | 814,682 | $ | 11,294,845 | ||||||||
Liabilities: | ||||||||||||||||
Swaps | $ | — | $ | 46,954 | $ | — | $ | 46,954 | ||||||||
Obligation to return securities obtained as collateral | 510,767 | — | — | 510,767 | ||||||||||||
Total liabilities carried at fair value | $ | 510,767 | $ | 46,954 | $ | — | $ | 557,721 |
(In Thousands) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Assets: | ||||||||||||||||
Agency MBS | $ | — | $ | 4,752,244 | $ | — | $ | 4,752,244 | ||||||||
Non-Agency MBS, including MBS transferred to consolidated VIEs | — | 6,420,817 | — | 6,420,817 | ||||||||||||
CRT securities | — | 183,582 | — | 183,582 | ||||||||||||
Securities obtained and pledged as collateral | 507,443 | — | — | 507,443 | ||||||||||||
Residential whole loans, at fair value | — | — | 623,276 | 623,276 | ||||||||||||
Swaps | — | 1,127 | — | 1,127 | ||||||||||||
Total assets carried at fair value | $ | 507,443 | $ | 11,357,770 | $ | 623,276 | $ | 12,488,489 | ||||||||
Liabilities: | ||||||||||||||||
Swaps | $ | — | $ | 70,526 | $ | — | $ | 70,526 | ||||||||
Obligation to return securities obtained as collateral | 507,443 | — | — | 507,443 | ||||||||||||
Total liabilities carried at fair value | $ | 507,443 | $ | 70,526 | $ | — | $ | 577,969 |
Residential Whole Loans, at Fair Value | ||||||||
For the Year Ended December 31, | ||||||||
(In Thousands) | 2016 | 2015 | ||||||
Balance at beginning of period | $ | 623,276 | $ | 143,472 | ||||
Purchases and capitalized advances | 316,407 | 534,574 | ||||||
Changes in fair value recorded in Net gain on residential whole loans held at fair value | 31,254 | 6,539 | ||||||
Collection of principal, net of liquidation gains/losses | (66,694 | ) | (34,767 | ) | ||||
Repurchases | (2,909 | ) | — | |||||
Transfer to REO | (86,652 | ) | (26,542 | ) | ||||
Balance at end of period | $ | 814,682 | $ | 623,276 |
December 31, 2016 | ||||||||||||||
(Dollars in Thousands) | Fair Value (1) | Valuation Technique | Unobservable Input | Weighted Average (2) | Range | |||||||||
Residential whole loans, at fair value | $ | 253,287 | Discounted cash flow | Discount rate | 6.6 | % | 5.0-7.7% | |||||||
Prepayment rate | 7.6 | % | 0.0-12.0% | |||||||||||
Default rate | 2.9 | % | 0.0-9.7% | |||||||||||
Loss severity | 13.0 | % | 0.0-77.5% | |||||||||||
$ | 516,014 | Liquidation model | Discount rate | 7.7 | % | 6.8-26.9% | ||||||||
Annual change in home prices | 1.7 | % | (9.2)-7.7% | |||||||||||
Liquidation timeline (in years) | 1.6 | 0.1-4.4 | ||||||||||||
Current value of underlying properties (3) | $ | 634 | $5-$4,900 | |||||||||||
Total | $ | 769,301 |
December 31, 2015 | ||||||||||||||
(Dollars in Thousands) | Fair Value (1) | Valuation Technique | Unobservable Input | Weighted Average (2) | Range | |||||||||
Residential whole loans, at fair value | $ | 113,166 | Discounted cash flow | Discount rate | 7.0 | % | 6.0-8.7% | |||||||
Prepayment rate | 6.6 | % | 0.3-11.1% | |||||||||||
Default rate | 3.1 | % | 0.0-9.1% | |||||||||||
Loss severity | 17.03 | % | 10.0-79.4% | |||||||||||
$ | 392,557 | Liquidation model | Discount rate | 6.9 | % | 6.8-10.0% | ||||||||
Annual change in home prices | 1.3 | % | (5.5)-6.1% | |||||||||||
Liquidation timeline (in years) | 1.6 | 0.7-4.4 | ||||||||||||
Current value of underlying properties (3) | $ | 626 | $14-$3,500 | |||||||||||
Total | $ | 505,723 |
December 31, 2016 | December 31, 2015 | |||||||||||||||||||||||
(In Thousands) | Fair Value | Unpaid Principal Balance | Difference | Fair Value | Unpaid Principal Balance | Difference | ||||||||||||||||||
Residential whole loans, at fair value | ||||||||||||||||||||||||
Total loans | $ | 814,682 | $ | 966,174 | $ | (151,492 | ) | $ | 623,276 | $ | 786,330 | $ | (163,054 | ) | ||||||||||
Loans 90 days or more past due | $ | 570,025 | $ | 695,282 | $ | (125,257 | ) | $ | 493,640 | $ | 637,459 | $ | (143,819 | ) |
December 31, 2016 | December 31, 2015 | |||||||||||||||
(In Thousands) | Carrying Value | Estimated Fair Value | Carrying Value | Estimated Fair Value | ||||||||||||
Financial Assets: | ||||||||||||||||
Agency MBS | $ | 3,738,497 | $ | 3,738,497 | $ | 4,752,244 | $ | 4,752,244 | ||||||||
Non-Agency MBS, including MBS transferred to consolidated VIEs | 5,825,816 | 5,825,816 | 6,420,817 | 6,420,817 | ||||||||||||
CRT securities | 404,850 | 404,850 | 183,582 | 183,582 | ||||||||||||
Securities obtained and pledged as collateral | 510,767 | 510,767 | 507,443 | 507,443 | ||||||||||||
Residential whole loans, at carrying value | 590,540 | 621,548 | 271,845 | 289,696 | ||||||||||||
Residential whole loans, at fair value | 814,682 | 814,682 | 623,276 | 623,276 | ||||||||||||
Cash and cash equivalents | 260,112 | 260,112 | 165,007 | 165,007 | ||||||||||||
Restricted cash | 58,463 | 58,463 | 71,538 | 71,538 | ||||||||||||
Swaps | 233 | 233 | 1,127 | 1,127 | ||||||||||||
Financial Liabilities (1): | ||||||||||||||||
Repurchase agreements | 8,472,268 | 8,472,078 | 7,887,622 | 7,828,115 | ||||||||||||
FHLB advances | 215,000 | 215,000 | 1,500,000 | 1,500,000 | ||||||||||||
Securitized debt | — | — | 21,868 | 22,057 | ||||||||||||
Obligation to return securities obtained as collateral | 510,767 | 510,767 | 507,443 | 507,443 | ||||||||||||
Senior Notes | 96,733 | 101,111 | 96,697 | 101,391 | ||||||||||||
Swaps | 46,954 | 46,954 | 70,526 | 70,526 |
• | Whether the Company has both the power to direct the activities that most significantly impact the economic performance of the VIE; and |
• | Whether the Company has a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE. |
2016 Quarter Ended | ||||||||||||||||
(In Thousands, Except per Share Amounts) | March 31 | June 30 | September 30 | December 31 | ||||||||||||
Interest income | $ | 117,418 | $ | 114,507 | $ | 112,716 | $ | 112,528 | ||||||||
Interest expense | (47,600 | ) | (47,720 | ) | (48,167 | ) | (49,868 | ) | ||||||||
Net interest income | 69,818 | 66,787 | 64,549 | 62,660 | ||||||||||||
Net impairment losses recognized in earnings | — | — | (485 | ) | — | |||||||||||
Net gain on residential whole loans held at fair value | 11,881 | 14,470 | 18,701 | 14,632 | ||||||||||||
Gain on sales of MBS | 9,745 | 9,241 | 7,083 | 9,768 | ||||||||||||
Other income | 1,085 | 3,319 | 8,117 | 1,281 | ||||||||||||
Operating and other expense | (14,459 | ) | (14,867 | ) | (14,954 | ) | (15,704 | ) | ||||||||
Net income | 78,070 | 78,950 | 83,011 | 72,637 | ||||||||||||
Preferred stock dividends | (3,750 | ) | (3,750 | ) | (3,750 | ) | (3,750 | ) | ||||||||
Net income available to common stock and participating securities | $ | 74,320 | $ | 75,200 | $ | 79,261 | $ | 68,887 | ||||||||
Earnings per Common Share - Basic and Diluted | $ | 0.20 | $ | 0.20 | $ | 0.21 | $ | 0.18 |
2015 Quarter Ended | ||||||||||||||||
(In Thousands, Except per Share Amounts) | March 31 | June 30 | September 30 | December 31 | ||||||||||||
Interest income | $ | 129,943 | $ | 123,995 | $ | 119,706 | $ | 118,499 | ||||||||
Interest expense | (43,940 | ) | (42,849 | ) | (43,703 | ) | (46,456 | ) | ||||||||
Net interest income | 86,003 | 81,146 | 76,003 | 72,043 | ||||||||||||
Net impairment losses recognized in earnings | (407 | ) | (298 | ) | — | — | ||||||||||
Net gain on residential whole loans held at fair value | 2,034 | 3,224 | 5,565 | 6,899 | ||||||||||||
Gain on sales of MBS | 6,435 | 7,617 | 11,196 | 9,652 | ||||||||||||
Other income/(loss) | 311 | (678 | ) | (259 | ) | (831 | ) | |||||||||
Operating and other expense | (12,202 | ) | (12,940 | ) | (12,995 | ) | (14,292 | ) | ||||||||
Net income | 82,174 | 78,071 | 79,510 | 73,471 | ||||||||||||
Preferred stock dividends | (3,750 | ) | (3,750 | ) | (3,750 | ) | (3,750 | ) | ||||||||
Net income available to common stock and participating securities | $ | 78,424 | $ | 74,321 | $ | 75,760 | $ | 69,721 | ||||||||
Earnings per Common Share - Basic and Diluted | $ | 0.21 | $ | 0.20 | $ | 0.20 | $ | 0.19 |
Asset Type | Number | Interest Rate | Maturity Date Range | Balance Sheet Reported Amount | Principal Amount of Loans Subject to Delinquent Principal or Interest | ||||||||||
(Dollars in Thousands) | |||||||||||||||
Residential Whole Loans at Carrying Value | |||||||||||||||
Original loan balance $0 - $149,999 | 1,189 | 0.00% - 13.08% | 3/1/2011-9/1/2057 | $ | 82,718 | $ | 16,826 | ||||||||
Original loan balance $150,000 - $299,999 | 1,107 | 1.00% - 11.00% | 2/1/2016-11/1/2064 | 168,636 | 19,800 | ||||||||||
Original loan balance $300,000 - $449,999 | 469 | 1.31% - 9.75% | 3/1/2018-5/1/2062 | 126,681 | 15,258 | ||||||||||
Original loan balance greater than $449,999 | 461 | 1.25% - 8.50% | 9/1/2018-12/1/2057 | 212,505 | 24,258 | ||||||||||
3,226 | $ | 590,540 | $ | 76,142 | |||||||||||
Residential Whole Loans at Fair Value | |||||||||||||||
Original loan balance $0 - $149,999 | 1,268 | 1.00% - 14.99% | 2/1/2004-10/1/2056 | $ | 101,448 | $ | 71,868 | ||||||||
Original loan balance $150,000 - $299,999 | 1,324 | 1.80% - 12.38% | 6/1/2012-2/1/2057 | 217,555 | 176,177 | ||||||||||
Original loan balance $300,000 - $449,999 | 621 | 1.87% - 11.00% | 7/1/2013-7/1/2056 | 176,389 | 155,087 | ||||||||||
Original loan balance greater than $449,999 | 599 | 0.00% - 10.88% | 9/1/2013-12/1/2056 | 319,290 | 292,150 | ||||||||||
3,812 | $ | 814,682 | $ | 695,282 | |||||||||||
7,038 | $ | 1,405,222 | $ | 771,424 |
For the Year Ended December 31, 2016 | ||||||||
(In Thousands) | Residential Whole Loans at Carrying Value | Residential Whole Loans at Fair Value | ||||||
Beginning Balance | $ | 271,845 | $ | 623,276 | ||||
Additions during period: | ||||||||
Purchases and capitalized advances | 363,089 | 316,407 | ||||||
Yield accreted | 23,916 | N/A | ||||||
Deductions during period: | ||||||||
Collection of principal | (44,692 | ) | (66,694 | ) | ||||
Collection of interest | (21,428 | ) | N/A | |||||
Changes in fair value recorded in Gain on loans recorded at fair value | N/A | 31,254 | ||||||
Provision for loan loss | 175 | N/A | ||||||
Repurchases | — | (2,909 | ) | |||||
Transfer to REO | (2,365 | ) | (86,652 | ) | ||||
Ending Balance | $ | 590,540 | $ | 814,682 |
MFA Financial, Inc. | |||
Date: February 16, 2017 | By | /s/ | Stephen D. Yarad |
Stephen D. Yarad | |||
Chief Financial Officer |
Date: February 16, 2017 | By | /s/ | William S. Gorin |
William S. Gorin | |||
Chief Executive Officer and Director | |||
(Principal Executive Officer) | |||
Date: February 16, 2017 | By | /s/ | Stephen D. Yarad |
Stephen D. Yarad | |||
Chief Financial Officer | |||
(Principal Financial Officer) | |||
Date: February 16, 2017 | By | /s/ | Kathleen A. Hanrahan |
Kathleen A. Hanrahan | |||
Senior Vice President and | |||
Chief Accounting Officer | |||
(Principal Accounting Officer) | |||
Date: February 16, 2017 | By | /s/ | George H. Krauss |
George H. Krauss | |||
Chairman and Director | |||
Date: February 16, 2017 | By | /s/ | Stephen R. Blank |
Stephen R. Blank | |||
Director | |||
Date: February 16, 2017 | By | /s/ | James A. Brodsky |
James A. Brodsky | |||
Director | |||
Date: February 16, 2017 | By | /s/ | Richard J. Byrne |
Richard J. Byrne | |||
Director | |||
Date: February 16, 2017 | By | /s/ | Laurie Goodman |
Laurie Goodman | |||
Director | |||
Date: | By | ||
Alan L. Gosule | |||
Director | |||
Date: February 16, 2017 | By | /s/ | Robin Josephs |
Robin Josephs | |||
Director | |||
(Dollars in Thousands) | At December 31, 2016 | |||
Repurchase agreements and other advances | $ | 8,687,268 | ||
Obligation to return securities obtained as collateral, at fair value | 510,767 | |||
Senior Notes | 96,733 | |||
Total Debt | $ | 9,294,768 | ||
Stockholders' Equity | $ | 3,033,902 | ||
Ratio of Debt-to-Equity | 3.1 | :1 | ||
Debt-to-Equity Multiple | 3.1 | x |
Subsidiaries of Registrant | Jurisdiction | |
MFA Securities Holdings LLC | Delaware | |
MFA Securitization Holdings LLC | Delaware | |
MFResidential Assets I, LLC | Delaware | |
MFResidential Assets Holding Corp. | Delaware | |
MFA Kittiwake Investments Ltd. | Cayman Islands |
Date: February 16, 2017 | |
By: | /s/ William S. Gorin |
Name: William S. Gorin | |
Title: Chief Executive Officer |
Date: February 16, 2017 | |
By: | /s/ Stephen D. Yarad |
Name: Stephen D. Yarad | |
Title: Chief Financial Officer |
By: | /s/ William S. Gorin | Date: February 16, 2017 | |
Name: William S. Gorin | |||
Title: Chief Executive Officer |
By: | /s/ Stephen D. Yarad | Date: February 16, 2017 | |
Name: Stephen D. Yarad | |||
Title: Chief Financial Officer |
Document and Entity Information - USD ($) $ in Billions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016 |
Feb. 10, 2017 |
Jun. 30, 2016 |
|
Document and Entity Information | |||
Entity Registrant Name | MFA FINANCIAL, INC. | ||
Entity Central Index Key | 0001055160 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2016 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Public Float | $ 2.7 | ||
Entity Common Stock, Shares Outstanding (in shares) | 372,841,520 | ||
Document Fiscal Year Focus | 2016 | ||
Document Fiscal Period Focus | FY |
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - USD ($) $ in Millions |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Adjustments related to tax withholding for share-based compensation | $ 3.6 | $ 2.3 | $ 2.7 |
Shares paid for tax withholding for share based compensation | 487,559 | 309,206 | 345,559 |
Preferred Stock, Cumulative Redeemable - dividend rate (as a percent) | 7.50% | 7.50% | |
Preferred Stock | Series B Preferred Stock | |||
Preferred Stock, Cumulative Redeemable - dividend rate (as a percent) | 7.50% | ||
Preferred Stock, Cumulative Redeemable - Liquidation Preference per Share (in dollars per share) | $ 25.00 |
Organization |
12 Months Ended |
---|---|
Dec. 31, 2016 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | Organization MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998. The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes. In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders. The Company has elected to treat certain of its subsidiaries as a taxable REIT subsidiary (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business. (See Notes 2(o) and 12) |
Summary of Significant Accounting Policies |
12 Months Ended |
---|---|
Dec. 31, 2016 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies (a) Basis of Presentation and Consolidation The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition. Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3), valuation of MBS and CRT securities (See Notes 3 and 15), income recognition and valuation of residential whole loans (See Notes 4 and 15), valuation of derivative instruments (See Notes 5(b) and 15) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount. (See Note 3) In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest. (See Note 2(o)) Actual results could differ from those estimates. The Company has one reportable segment as it manages its business and analyzes and reports its results of operations on the basis of one operating segment; investing, on a leveraged basis, in residential mortgage assets. The consolidated financial statements of the Company include the accounts of all subsidiaries; all intercompany accounts and transactions have been eliminated. In addition, the Company consolidates the remaining special purpose entities created to facilitate resecuritization transactions completed in prior years and the acquisition of residential whole loans. Certain prior period amounts have been reclassified to conform to the current period presentation. (b) MBS (including Non-Agency MBS transferred to consolidated VIEs) and CRT Securities The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of previously securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including, for certain CRT securities, if the loans in the reference pool experience delinquencies exceeding specified thresholds. Designation The Company generally intends to hold its MBS until maturity; however, from time to time, it may sell any of its securities as part of the overall management of its business. As a result, all of the Company’s MBS are designated as “available-for-sale” (“AFS”) and, accordingly, are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method. The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting to more appropriately reflect the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statement of operations. Revenue Recognition, Premium Amortization and Discount Accretion Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity. Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs. (See Note 3) Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income. The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors. If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time. Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result. Determination of Fair Value for MBS and CRT Securities In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. (See Note 15) Impairments/OTTI When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired. The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.” If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date. If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the OTTI related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets. Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings. Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings. However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income. The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections. As a result, the timing and amount of OTTIs constitute material estimates that are susceptible to significant change. (See Note 3) Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes. The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS. The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, Fair Isaac Corporation (“FICO”) scores at loan origination, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations, as well as reports by credit rating agencies, such as Moody’s Investors Services, Inc. (“Moody’s”), Standard & Poor’s Corporation (“S&P”) or Fitch, Inc. (collectively with Moody’s and S&P, “Rating Agencies”), general market assessments, and dialogue with market participants. As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS. In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date. The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes. Impairment assessment for Non-Agency MBS and CRT securities that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date. The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR. Balance Sheet Presentation The Company’s MBS and CRT securities pledged as collateral against repurchase agreements, Federal Home Loan Bank advances and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically. Purchases and sales of securities are recorded on the trade date. (c) Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral The Company has obtained securities as collateral under collateralized financing arrangements in connection with its financing strategy for Non-Agency MBS. Securities obtained as collateral in connection with these transactions are recorded on the Company’s consolidated balance sheets as an asset along with a liability representing the obligation to return the collateral obtained, at fair value. While beneficial ownership of securities obtained remains with the counterparty, the Company has the right to transfer the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction. (See Note 2(k) for Repurchase Agreements and Reverse Repurchase Agreements) (d) Residential Whole Loans Residential whole loans included in the Company’s consolidated balance sheets are comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions generally at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below under “Residential Whole Loans at Carrying Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The accounting model described below under “Residential Whole Loans at Fair Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed. The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically. Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any repurchase agreement financing until the closing of the purchase transaction. Residential Whole Loans at Carrying Value Notwithstanding that the majority of these loans are considered to be performing substantially in accordance with their current contractual terms and conditions, the Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of the borrowers have previously experienced payment delinquencies and the amount owed on the mortgage loan may exceed the value of the property pledged as collateral. Consequently, the Company has assessed that these loans have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Such loans are initially recorded at fair value with no allowance for loan losses. Subsequent to acquisition, the recorded amount reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition. Under the application of this accounting model, the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, the Company estimates at acquisition and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans. A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level, thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. A significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield. (See Notes 4 and 16) Residential Whole Loans at Fair Value Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Given the significant uncertainty associated with estimating the timing of and amount of cash flows associated with these loans that will be collected, and that the cash flows ultimately collected may be dependent on the value of the property securing the loan, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns from these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the marketplace. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash outflows associated with loan related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in Net gain on residential whole loans held at fair value. (See Notes 4 and 15) (e) Cash and Cash Equivalents Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less. Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement and/or Swap counterparties as a result of reverse margin calls (i.e., margin calls made by the Company). The Company did not hold any cash pledged by its counterparties at December 31, 2016 or 2015. The Company’s investments in overnight money market funds, which are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency were $208.9 million and $120.4 million at December 31, 2016 and 2015, respectively. (See Notes 7 and 15) (f) Restricted Cash Restricted cash represents the Company’s cash held by its counterparties as collateral or otherwise in connection with the Company’s Swaps and/or repurchase agreements. Restricted cash is not available to the Company for general corporate purposes, but may be applied against amounts due to counterparties to the Company’s repurchase agreements and/or Swaps, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap or repurchase agreement. The Company had aggregate restricted cash held as collateral or otherwise in connection with its Swaps and repurchase agreements of $58.5 million and $71.5 million at December 31, 2016 and 2015, respectively. (See Notes 5(b), 6, 7 and 15) (g) Goodwill At December 31, 2016 and 2015, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998. Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level. Through December 31, 2016, the Company had not recognized any impairment against its goodwill. Goodwill is included in Other assets on the Company’s consolidated balance sheets. (h) Real Estate Owned (“REO”) REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 5(a)) (i) Depreciation Leasehold Improvements and Other Depreciable Assets Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term. Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase. (j) Resecuritization and Other Debt Issuance Costs Resecuritization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various resecuritization transactions completed by the Company. Other debt issuance and related costs include costs incurred by the Company in connection with issuing Senior Notes and certain other repurchase agreement financings. These costs may include underwriting, rating agency, legal, accounting and other fees. Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For resecuritization financings, amortization is based upon the actual repayments of the associated beneficial interests issued to third parties. For Senior Notes and other repurchase agreement financings, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations. (k) Repurchase Agreements and Other Advances Repurchase Agreements The Company finances the holdings of a significant portion of its residential mortgage assets with repurchase agreements. Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price. The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender. Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan, including any accrued interest and concurrently receives back its pledged collateral from the lender. With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms. Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions. The Company also may make margin calls on counterparties when collateral values increase. The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms. Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation. If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable or such collateral. (See Notes 6, 7 and 15) In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company has entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty. Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price. The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower. In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement. No net cash was exchanged between the Company and counterparty at the inception of the transactions. Securities obtained and pledged as collateral are recorded as an asset on the Company’s consolidated balance sheets. Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis. Both the Company and the counterparty have the right to make daily margin calls based on changes in the value of the collateral obtained and/or pledged. The Company’s liability to the counterparty in connection with this financing arrangement is recorded on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.” (See Note 2(c)) Federal Home Loan Bank (“FHLB”) Advances FHLB advances are secured financing transactions and are carried at their contractual amounts. The ability to borrow from the FHLB is subject to the Company’s continued creditworthiness, pledging of sufficient eligible collateral to secure advances, and compliance with certain agreements with the FHLB. The amount of collateral pledged to the FHLB to secure advances is subject to periodic adjustment based on changes in the fair value of the collateral. Accrued interest payable on FHLB advances is included in Other liabilities on the Company’s consolidated balance sheets. (See Notes 6, 7 and 15) In addition, as a condition to membership in the FHLB, the Company’s wholly-owned subsidiary, MFA Insurance, Inc. (“MFA Insurance”) is required to purchase and hold a certain amount of FHLB stock, which is based, in part, upon the outstanding principal balance of advances from the FHLB. FHLB stock is considered a non-marketable investment, is carried at cost and is subject to recoverability testing under applicable accounting standards. This stock can only be redeemed or sold at its par value, and only to the FHLB. Accordingly, when evaluating FHLB stock for impairment, the Company considers the ultimate recoverability of the par value rather than recognizing temporary declines in value. FHLB stock is included in Other assets on the Company’s consolidated balance sheets. (l) Equity-Based Compensation Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date. With respect to awards granted in 2009 and prior years, the Company applied a zero forfeiture rate for these awards, as they were granted to a limited number of employees, and historical forfeitures have been minimal. Forfeitures, or an indication that forfeitures are expected to occur, may result in a revised forfeiture rate and would be accounted for prospectively as a change in estimate. From 2011 through 2013, the Company granted certain restricted stock units (“RSUs”) that vested annually over a one or three-year period, provided that certain criteria were met, which were based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. Starting in January 2014, the Company has made annual grants of RSUs certain of which cliff vest after a three-year period and others of which cliff vest after a three-year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards. Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which in addition to estimates regarding the amount of RSUs expected to be forfeited during the associated service period, determined the amount of compensation expense recognized. The amount of compensation expense recognized was not dependent on whether the market condition was or will be achieved, while differences in actual forfeiture experience relative to estimated forfeitures results in adjustments to the timing and amount of compensation expense recognized. The Company has awarded dividend equivalents that may be granted as a separate instrument or may be a right associated with the grant of another equity-based award. Compensation expense for separately awarded dividend equivalents is based on the grant date fair value of such awards and is recognized over the vesting period. Payments pursuant to these dividend equivalents are charged to Stockholders’ Equity. Payments pursuant to dividend equivalents that are attached to equity-based awards are charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest. Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards do not or are not expected to vest and grantees are not required to return payments of dividends or dividend equivalents to the Company. (See Notes 2(m) and 14) (m) Earnings per Common Share (“EPS”) Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares. In applying the two-class method, earnings are allocated to both shares of common stock and securities that participate in dividends based on their respective weighted-average shares outstanding for the period. For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method. Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period. (See Note 13) (n) Comprehensive Income/(Loss) The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and de-designated derivative hedging instruments and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock. (o) U.S. Federal Income Taxes The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law. The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code. As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe. Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year. As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements. Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% of its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations. In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 25% (or, for 2018 and subsequent taxable years, 20%) of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U. S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company in 2016 or 2015, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not. Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of December 31, 2016, 2015 or 2014. The Company filed its 2015 tax return prior to September 15, 2016. The Company’s tax returns for tax years 2011 and 2013 through 2015 are open to examination. (p) Derivative Financial Instruments The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with its borrowings. Prior to 2015, the Company’s derivative financial instruments also included Linked Transactions, which were not designated as hedging instruments. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 5(b)) Swaps The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions. The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.” Swaps are carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value is positive, or in Other liabilities, if their fair value is negative. Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective. Changes in fair value for any ineffective amount of a Swap are recognized in earnings. The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness. The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate. Although permitted under certain circumstances, the Company does not offset cash collateral receivables or payables against its net derivative positions. (See Notes 5(b), 7 and 15) Linked Transactions Prior to 2015, it was presumed that the initial transfer of a financial asset (i.e., the purchase of an MBS by the Company) and contemporaneous repurchase financing of such security with the same counterparty were considered part of the same arrangement, or a “linked transaction,” unless certain criteria were met. The two components of a linked transaction (security purchase and repurchase financing) were not reported separately but were evaluated on a combined basis and reported as a forward (derivative) contract and were presented as “Linked Transactions” on the Company’s consolidated balance sheets. Changes in the fair value of the assets and liabilities underlying Linked Transactions and associated interest income and expense were reported as “Unrealized net gains/(losses) and net interest income from Linked Transactions” on the Company’s consolidated statements of operations and were not included in OCI. However, if certain criteria were met, the initial transfer (i.e., the purchase of a security by the Company) and repurchase financing were not treated as a Linked Transaction and would have been evaluated and reported separately as an MBS purchase and MBS repurchase financing. When or if a transaction was no longer considered to be linked, the security and repurchase financing were reported on a gross basis. In this case, the fair value of the MBS at the time the transactions were no longer considered linked became the cost basis of the MBS, and the income recognition yield for such MBS was calculated prospectively using this new cost basis. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting as described above. This resulted in changes subsequent to January 1, 2015 to the presentation of assets and liabilities, and revenues and expenses of Non-Agency MBS and associated repurchase agreements that had been accounted for as Linked Transactions prior to that date. The changes include the presentation of Non-Agency MBS and associated repurchase agreements as separate assets and liabilities, rather than on a combined basis on the Company’s consolidated balance sheets. In addition, starting in 2015, interest income related to the securities and interest expense related to the associated repurchase agreements are separately presented and included in the determination of the Company’s net interest income on its consolidated statement of operations. Further, the previous treatment of Linked Transactions as forward (derivative) instruments recorded at fair value at the end of each period, with changes in fair value included in net income, was discontinued and effective January 1, 2015, MBS that were previously accounted for as components of Linked Transactions are accounted for on a consistent basis with other MBS held by the Company as AFS securities. (See Note 5(b)) (q) Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability. The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability. This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value. In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans and CRT securities at time of acquisition. Subsequent changes in the fair value of these loans and CRT securities are reported in Net gain on residential whole loans held at fair value and Other income, net respectively on the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2(d), 4 and 15) (r) Variable Interest Entities An entity is referred to as a VIE if it meets at least one of the following criteria: (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights. The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE. The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE. The Company has in prior years entered into several resecuritization transactions which resulted in the Company consolidating the VIEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred. In determining the accounting treatment to be applied to these resecuritization transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated. If the Company had determined that consolidation was not required, it would have then assessed whether the transfer of the underlying assets would qualify as a sale or should be accounted for as secured financings under GAAP. Prior to the completion of its initial resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or Qualifying Special Purpose Entities (“QSPEs”) and other than acquiring MBS issued by such entities, had no other involvement with VIEs or QSPEs. (See Note 16) The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and /or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance. (s) Offering Costs Related to Issuance and Redemption of Preferred Stock Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS. (t) New Accounting Standards and Interpretations Accounting Standards Adopted in 2016 Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-03, Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with the presentation of debt issued at a discount. The recognition and measurement guidance of debt issuance costs are not affected by the amendments in this ASU. ASU 2015-03 requires retrospective application and was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. While the Company’s adoption of ASU 2015-03 beginning on January 1, 2016, did not have a material impact on the Company’s financial position, it did result in changes, subsequent to adoption, to the presentation of assets and liabilities prior to that date. On adoption of the new standard on January 1, 2016, the Company reclassified debt issuance costs of $3.3 million related to Senior Notes, $1.3 million related to repurchase agreements and $189,000 related to its Securitized debt from Other assets and presented them as a reduction in the corresponding liability on its consolidated balance sheet. Consolidation - Amendments to the Consolidation Analysis In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis (“ASU 2015-02”). The amendments in this ASU change the way reporting enterprises evaluate whether (a) they should consolidate limited partnerships and similar entities, (b) fees paid to a decision maker or service provider are variable interests in a VIE, and (c) variable interests in a VIE held by related parties of the reporting enterprise require the reporting enterprise to consolidate the VIE. It also eliminates the VIE consolidation model based on majority exposure to variability that applied to certain investment companies and similar entities. At the effective date, all previous consolidation analyses that the guidance affects must be reconsidered. ASU 2015-02 was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The Company’s adoption of ASU 2015-02 on January 1, 2016 did not have an impact on the Company’s consolidated financial statements. Presentation of Financial Statements - Going Concern In August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). The amendments in this ASU provide guidance in GAAP about management’s responsibility to evaluate whether there is a substantial doubt about an entity’s going concern and to provide related footnote disclosures. In connection with preparing financial statements for each annual and interim reporting period, an entity’s management should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). ASU 2014-15 was effective for the Company for the annual period ending after December 15, 2016, and for annual and interim periods thereafter. The adoption of ASU 2014-15 did not have any impact on the Company’s financial position or financial statement disclosures. |
MBS and CRT Securities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MBS and CRT Securities | MBS and CRT Securities Agency and Non-Agency MBS The Company’s MBS are comprised of Agency MBS and Non-Agency MBS which include MBS issued prior to 2008 (“Legacy Non-Agency MBS”). These MBS are secured by: (i) hybrid mortgages (“Hybrids”), which have interest rates that are fixed for a specified period of time and, thereafter, generally adjust annually to an increment over a specified interest rate index; (ii) adjustable-rate mortgages (“ARMs”); (iii) mortgages that have interest rates that reset more frequently (collectively, “ARM-MBS”); and (iv) 15 year and longer-term fixed rate mortgages. In addition, the Company also holds MBS that are structured with a contractual coupon step-up feature where the coupon increases up to 300 basis points at 36 months from issuance or sooner (“3 Year Step-up securities”). The majority of the Company’s 3 Year Step-up securities are backed by securitized re-performing and non-performing loans and the cash flows of the bond may not reflect the contractual cash flows of the underlying collateral. The Company pledges a significant portion of its MBS as collateral against its borrowings under repurchase agreements, FHLB advances and Swaps. Non-Agency MBS that were accounted for as components of Linked Transactions prior to 2015 are not reflected in the tables for prior periods set forth in this note, as they were accounted for as derivatives. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 5(b)) Agency MBS: Agency MBS are guaranteed as to principal and/or interest by a federally chartered corporation, such as Fannie Mae or Freddie Mac, or an agency of the U.S. Government, such as Ginnie Mae. The payment of principal and/or interest on Ginnie Mae MBS is explicitly backed by the full faith and credit of the U.S. Government. Since the third quarter of 2008, Fannie Mae and Freddie Mac have been under the conservatorship of the Federal Housing Finance Agency, which significantly strengthened the backing for these government-sponsored entities. Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs): The Company’s Non-Agency MBS are primarily secured by pools of residential mortgages, which are not guaranteed by an agency of the U.S. Government or any federally chartered corporation. Credit risk associated with Non-Agency MBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral. CRT Securities CRT securities are debt obligations issued by Fannie Mae and Freddie Mac. While the coupon payments are paid by Fannie Mae or Freddie Mac on a monthly basis, the payment of principal is dependent on the performance of loans in a reference pool of MBS securitized by Fannie Mae or Freddie Mac. As principal on loans in the reference pool are paid, principal payments on the securities are made and the principal balances of the securities are reduced. Consequently, CRT securities mirror the payment and prepayment behavior of the mortgage loans in the reference pool. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including, for certain CRT securities, if the loans in the reference pool experience delinquencies exceeding specified thresholds. The Company assesses the credit risk associated with CRT securities by assessing the current and expected future performance of the associated reference pool. The Company pledges a significant portion of its CRT securities as collateral against its borrowings under repurchase agreements. CRT securities that were accounted for as components of Linked Transactions prior to 2015 are not reflected in the tables for prior periods set forth in this note, as they were accounted for as derivatives. (See Note 5(b)) The following tables present certain information about the Company’s MBS and CRT securities at December 31, 2016 and 2015: December 31, 2016
December 31, 2015
(1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income. Amounts disclosed at December 31, 2016 reflect Credit Reserve of $675.6 million and OTTI of $18.6 million. Amounts disclosed at December 31, 2015 reflect Credit Reserve of $766.0 million and OTTI of $21.5 million. (2) Includes principal payments receivable of $2.6 million and $1.0 million at December 31, 2016 and 2015, respectively, which are not included in the Principal/Current Face. (3) Based on management’s current estimates of future principal cash flows expected to be received. (4) At December 31, 2016, 3 Year Step-up securities had a $2.7 billion Principal/Current face, $2.7 billion amortized cost and $2.7 billion fair value. At December 31, 2015, 3 Year Step-up securities had a $2.6 billion Principal/Current face, $2.6 billion amortized cost and $2.6 billion fair value. (5) At December 31, 2016 and 2015, the Company expected to recover approximately 89% and 89%, respectively, of the then-current face amount of Non-Agency MBS. (6) Amounts disclosed at December 31, 2016 includes CRT securities with a fair value of $271.2 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $12.7 million and net unrealized losses of approximately $3,000 at December 31, 2016. Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $332,000, gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015. Unrealized Losses on MBS and CRT Securities The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at December 31, 2016:
(1) Based on management’s current estimates of future principal cash flows expected to be received. (2) Amounts disclosed at December 31, 2016 includes CRT securities with a fair value of $2.5 million for which the fair value option has been elected. Such securities have unrealized losses of $3,000 at December 31, 2016. At December 31, 2016, the Company did not intend to sell any of its investments that were in an unrealized loss position, and it is “more likely than not” that the Company will not be required to sell these securities before recovery of their amortized cost basis, which may be at their maturity. Gross unrealized losses on the Company’s Agency MBS were $31.2 million at December 31, 2016. Agency MBS are issued by Government Sponsored Entities (“GSEs”) and enjoy either the implicit or explicit backing of the full faith and credit of the U.S. Government. While the Company’s Agency MBS are not rated by any rating agency, they are currently perceived by market participants to be of high credit quality, with risk of default limited to the unlikely event that the U.S. Government would not continue to support the GSEs. Given the credit quality inherent in Agency MBS, the Company does not consider any of the current impairments on its Agency MBS to be credit related. In assessing whether it is more likely than not that it will be required to sell any impaired security before its anticipated recovery, which may be at its maturity, the Company considers for each impaired security, the significance of each investment, the amount of impairment, the projected future performance of such impaired securities, as well as the Company’s current and anticipated leverage capacity and liquidity position. Based on these analyses, the Company determined that at December 31, 2016 any unrealized losses on its Agency MBS were temporary. Gross unrealized losses on the Company’s Non-Agency MBS (including Non-Agency MBS transferred to consolidated VIEs) were $5.2 million at December 31, 2016. Based upon the most recent evaluation, the Company does not consider these unrealized losses to be indicative of OTTI and does not believe that these unrealized losses are credit related, but are rather a reflection of current market yields and/or marketplace bid-ask spreads. The Company has reviewed its Non-Agency MBS that are in an unrealized loss position to identify those securities with losses that are other-than-temporary based on an assessment of changes in expected cash flows for such securities, which considers recent bond performance and, where possible, expected future performance of the underlying collateral. The Company recognized credit-related OTTI losses through earnings related to its Non-Agency MBS of $485,000 and $705,000 during the years ended December 31, 2016 and 2015. The Company did not recognize any credit-related OTTI losses through earnings related to its investments during the year ended 2014. Non-Agency MBS on which OTTI is recognized have experienced, or are expected to experience, credit-related adverse cash flow changes. The Company’s estimate of cash flows for these Non-Agency MBS is based on its review of the underlying mortgage loans securing these MBS. The Company considers information available about the structure of the securitization, including structural credit enhancement, if any, and the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, FICO scores at loan origination, year of origination, LTVs, geographic concentrations, as well as Rating Agency reports, general market assessments, and dialogue with market participants. Changes in the Company’s evaluation of each of these factors impacts the cash flows expected to be collected at the OTTI assessment date. For Non-Agency MBS purchased at a discount to par that were assessed for and had no OTTI recorded this period, such cash flow estimates indicated that the amount of expected losses decreased compared to the previous OTTI assessment date. These positive cash flow changes are primarily driven by recent improvements in LTVs due to loan amortization and home price appreciation, which, in turn, positively impacts the Company’s estimates of default rates and loss severities for the underlying collateral. In addition, voluntary prepayments (i.e. loans that prepay in full with no loss) have generally trended higher for these MBS which also positively impacts the Company’s estimate of expected loss. Overall, the combination of higher voluntary prepayments and lower LTVs supports the Company’s assessment that such MBS are not other-than-temporarily impaired. The following table presents the composition of OTTI charges recorded by the Company for the years ended December 31, 2016, 2015 and 2014:
The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI. Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.
Purchase Discounts on Non-Agency MBS The following table presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the years ended December 31, 2016 and 2015:
(1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.
Impact of AFS Securities on AOCI The following table presents the impact of the Company’s AFS securities on its AOCI for the years ended December 31, 2016, 2015, and 2014:
Sales of MBS During 2016, the Company sold certain Non-Agency MBS for $85.6 million, realizing gross gains of $35.8 million. During 2015, the Company sold certain Non-Agency MBS for $70.7 million, realizing gross gains of $34.9 million. During 2014, the Company sold certain Non-Agency MBS for $123.9 million realizing gross gains of $37.5 million. The Company has no continuing involvement with any of the sold MBS. Interest Income on MBS and CRT Securities The following table presents components of interest income on the Company’s MBS and CRT securities for the years ended December 31, 2016, 2015 and 2014:
(1) Includes amortization of premium paid net of accretion of purchase discount. For Agency MBS and 3 Year Step-up securities, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity. (2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield. |
Residential Whole Loans |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Residential Whole Loans [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Residential Whole Loans | Residential Whole Loans Included on the Company’s consolidated balance sheets as of December 31, 2016 and 2015 are approximately $1.4 billion and $895.1 million, respectively, of residential whole loans arising from the Company’s 100% equity interest in certificates issued by certain trusts established to acquire the loans. Based on its evaluation of these interests and other factors, the Company has determined that the trusts are required to be consolidated for financial reporting purposes. Residential Whole Loans at Carrying Value Residential whole loans at carrying value totaled approximately $590.5 million and $271.8 million at December 31, 2016 and 2015, respectively. The carrying value reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. The carrying value is reduced by any allowance for loan losses established subsequent to acquisition. As of December 31, 2016 the Company had established an allowance for loan losses of approximately $1.0 million on its residential whole loan pools held at carrying value. For the year ended December 31, 2016, a net reversal of provision for loan losses of approximately $175,000 was recorded, which is included in Operating and Other expense on the Company’s consolidated statements of operations. For the years ended December 31, 2015 and 2014, a net provision for loan losses of approximately $1.0 million and $137,000 was recorded, respectively. The following table presents the activity in the Company’s allowance for loan losses on its residential whole loan pools at carrying value for the years ended December 31, 2016, 2015 and 2014:
The following table presents information regarding estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the residential whole loans held at carrying value acquired by the Company for the years ended December 31, 2016, 2015 and 2014:
The following table presents accretable yield activity for the Company’s residential whole loans held at carrying value for the years ended December 31, 2016 and 2015:
Accretable yield for residential whole loans is the excess of loan cash flows expected to be collected over the purchase price. The cash flows expected to be collected represent the Company’s estimate of the amount and timing of undiscounted principal and interest cash flows. Additions include accretable yield estimates for purchases made during the period and reclassification to accretable yield from non-accretable yield. Accretable yield is reduced by accretion during the period. The reclassifications between accretable and non-accretable yield and the accretion of interest income are based on changes in estimates regarding loan performance and the value of the underlying real estate securing the loans. In future periods, as the Company updates estimates of cash flows expected to be collected from the loans and the underlying collateral, the accretable yield may change. Therefore, the amount of accretable income recorded during the year ended December 31, 2016 is not necessarily indicative of future results. Residential Whole Loans at Fair Value Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. The following table presents information regarding the Company’s residential whole loans held at fair value at December 31, 2016 and 2015:
During the years ended December 31, 2016, 2015 and 2014, the Company recorded net gains on residential whole loans held at fair value of $59.7 million, $17.7 million and $116,000, respectively. The following table presents the components of Net gain on residential whole loans held at fair value for the years ended December 31, 2016, 2015 and 2014:
|
Other Assets |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Assets [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Assets | Other Assets The following table presents the components of the Company’s Other assets at December 31, 2016 and 2015:
Real Estate Owned At December 31, 2016, the Company had 447 REO properties with an aggregate carrying value of $80.5 million. At December 31, 2015, the Company had 182 REO properties with an aggregate carrying value of $28.0 million. During the years ended December 31, 2016 and 2015, the Company reclassified 517 and 186 mortgage loans to REO at an aggregate estimated fair value less estimated selling costs of $91.9 million and $30.1 million, respectively at the time of transfer. Such transfers occur when the Company takes possession of the property by foreclosing on the borrower or completes a “deed-in-lieu of foreclosure” transaction. At December 31, 2016, $79.3 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $29.6 million of residential whole loans at carrying value and $501.8 million of residential whole loans at fair value at December 31, 2016. During the year ended December 31, 2016, the Company sold 256 REO properties for consideration of $37.9 million, realizing net gains of approximately $3.2 million. During the year ended December 31, 2015, the Company sold 63 REO properties for consideration of $6.5 million, realizing net gains of approximately $76,000. These amounts are included in Other, net on the Company’s consolidated statements of operations. The Company did not sell any REO properties during the year ended December 31, 2014. In addition, following an updated assessment of liquidation amounts expected to be realized that was performed on all REO held at the end of each quarter during the years ended December 31, 2016 and 2015, an aggregate downward adjustment of approximately $7.5 million and $3.5 million was recorded to reflect certain REO properties at the lower of cost or estimated fair value for the years ended December 31, 2016 and 2015, respectively. The following table presents the activity in the Company’s REO for the years ended December 31, 2016 and 2015:
(1) Includes net gain recorded on transfer of approximately $2.9 million and $1.7 million, respectively, for the years ended December 31, 2016 and 2015. (b) Derivative Instruments The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with its borrowings. Prior to 2015, the Company had also entered into Linked Transactions, which were not designated as hedging instruments. (See Notes 2(p) and below) The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at December 31, 2016 and 2015:
(1) Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house. (2) Cleared Swaps include Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties. Swaps Consistent with market practice, the Company has agreements with its Swap counterparties that provide for the posting of collateral based on the fair values of its derivative contracts. Through this margining process, either the Company or its derivative counterparty may be required to pledge cash or securities as collateral. In addition, Swaps novated to and cleared by a central clearing house are subject to initial margin requirements. Certain derivative contracts provide for cross collateralization with repurchase agreements with the same counterparty. A number of the Company’s Swap contracts include financial covenants, which, if breached, could cause an event of default or early termination event to occur under such agreements. Such financial covenants include minimum net worth requirements and maximum debt-to-equity ratios. If the Company were to cause an event of default or trigger an early termination event pursuant to one of its Swap contracts, the counterparty to such agreement may have the option to terminate all of its outstanding Swap contracts with the Company and, if applicable, any close-out amount due to the counterparty upon termination of the Swap contracts would be immediately payable by the Company. The Company was in compliance with all of its financial covenants through December 31, 2016. At December 31, 2016, the aggregate fair value of assets needed to immediately settle Swap contracts that were in a liability position to the Company, if so required, was approximately $48.0 million, including accrued interest payable of approximately $1.0 million. The following table presents the assets pledged as collateral against the Company’s Swap contracts at December 31, 2016 and 2015:
The Company’s derivative hedging instruments, or a portion thereof, could become ineffective in the future if the associated repurchase agreements that such derivatives hedge fail to exist or fail to have terms that match those of the derivatives that hedge such borrowings. At December 31, 2016, all of the Company’s derivatives were deemed effective for hedging purposes and no derivatives were terminated during the years ended December 31, 2016 and 2015. The Company’s Swaps designated as hedging transactions have the effect of modifying the repricing characteristics of the Company’s repurchase agreements and cash flows for such liabilities. To date, no cost has been incurred at the inception of a Swap (except for certain transaction fees related to entering into Swaps cleared though a central clearing house), pursuant to which the Company agrees to pay a fixed rate of interest and receive a variable interest rate, generally based on one-month or three-month London Interbank Offered Rate (“LIBOR”), on the notional amount of the Swap. The Company did not recognize any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness during any of the three years ended December 31, 2016. At December 31, 2016, the Company had Swaps designated in hedging relationships with an aggregate notional amount of $2.9 billion, which had net unrealized losses of $46.7 million, and extended 35 months on average with a maximum term of approximately 80 months. The following table presents certain information with respect to the Company’s Swap activity during the year ended December 31, 2016:
The following table presents information about the Company’s Swaps at December 31, 2016 and 2015:
(1) Each maturity category reflects contractual amortization and/or maturity of notional amounts. (2) Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively. (3) At December 31, 2016, reflects one Swap with a maturity date of July 2023. The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the years ended December 31, 2016, 2015 and 2014:
Impact of Derivative Hedging Instruments on AOCI The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the years ended December 31, 2016, 2015 and 2014:
Counterparty Credit Risk from Use of Swaps By using Swaps, the Company is exposed to counterparty credit risk if counterparties to the derivative contracts do not perform as expected. If a counterparty fails to perform, the Company’s counterparty credit risk is equal to the amount reported as a derivative asset on its consolidated balance sheets to the extent that amount exceeds collateral obtained from the counterparty or, if in a net liability position, the extent to which collateral posted exceeds the liability to the counterparty. The amounts reported as a derivative asset/(liability) are derivative contracts in a gain/(loss) position, and to the extent subject to master netting arrangements, net of derivatives in a loss/(gain) position with the same counterparty and collateral received/(pledged). The Company attempts to minimize counterparty credit risk through credit approvals, limits, monitoring procedures, executing master netting arrangements and obtaining collateral, where appropriate. Counterparty credit risk related to the Company’s Swaps is considered in determining the fair value of such derivatives and in its assessment of hedge effectiveness. Linked Transactions Prior to January 1, 2015, the Company’s Linked Transactions had been evaluated on a combined basis, reported as forward (derivative) instruments and presented as assets on the Company’s consolidated balance sheets at fair value. The fair value of Linked Transactions reflected the value of the underlying Non-Agency MBS, linked repurchase agreement borrowings and accrued interest receivable/payable on such instruments. The Company’s Linked Transactions were not designated as hedging instruments and, as a result, the change in the fair value and net interest income from Linked Transactions had been reported in Other Income, net on the Company’s consolidated statements of operations. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. An entity is required to present changes in accounting for transactions outstanding on the effective date as a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Accordingly, on adoption of the new standard on January 1, 2015, the Company reclassified $1.9 billion of Non-Agency MBS and $4.6 million of CRT securities that were previously reported as a component of Linked Transactions to Non-Agency MBS and CRT securities, respectively on the consolidated balance sheet. In addition, liabilities of $1.5 billion that were previously presented as a component of Linked Transactions were reclassified to Repurchase agreements on the consolidated balance sheet. Furthermore, an amount of $4.5 million representing net unrealized gains on securities previously reported as a component of Linked Transactions as of December 31, 2014 was reclassified from Accumulated deficit to AOCI. These reclassification adjustments had no net impact on the Company’s overall Total Stockholders’ Equity. The following table presents certain information about the components of the unrealized net gains and net interest income from Linked Transactions included in the Company’s consolidated statements of operations for the year ended December 31, 2014:
c) Interest Receivable The following table presents the Company’s interest receivable by investment category at December 31, 2016 and 2015:
|
Repurchase Agreements and Other Advances |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase Agreements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase Agreements and Other Advances | Repurchase Agreements and Other Advances Repurchase Agreements The Company’s repurchase agreements are accounted for as secured borrowings and are collateralized by the Company’s MBS, U.S. Treasury securities (obtained as part of a reverse repurchase agreement), CRT securities, residential whole loans and cash, and bear interest that is generally LIBOR-based. (See Notes 2(k) and 7) At December 31, 2016, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 19 days and an effective repricing period of 12 months, including the impact of related Swaps. At December 31, 2015, the Company’s borrowings under repurchase agreements had a weighted average remaining term-to-interest rate reset of 21 days and an effective repricing period of 18 months, including the impact of related Swaps. The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at December 31, 2016 and 2015:
(1) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount (2) Includes $172.4 million and $570.5 million of Legacy Non-Agency MBS acquired from consolidated VIEs at December 31, 2016 and 2015, respectively, that are eliminated from the Company’s consolidated balance sheets. (3) Excludes $210,000 and $1.3 million of unamortized debt issuance costs at December 31, 2016 and 2015, respectively. The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at December 31, 2016 and 2015:
The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at December 31, 2016 and does not reflect the impact of derivative contracts that hedge such repurchase agreements:
The Company had repurchase agreements with 31 and 27 counterparties at December 31, 2016 and 2015, respectively. The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at December 31, 2016:
(1) As rated at December 31, 2016 by S&P, Moody’s and Fitch, Inc., respectively. The counterparty rating presented is the lowest published for these entities. (2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities. (3) Includes $295.3 million at risk with Wells Fargo Bank, NA and $93.2 million at risk with Wells Fargo Securities LLC. (4) Includes $238.2 million at risk with RBC Barbados, $30.4 million at risk with Royal Bank of Canada and $5.7 million at risk with RBC Capital Markets LLC. Counterparty ratings are not published for RBC Barbados and RBC Capital Markets LLC. (5) Includes $141.8 million at risk with Credit Suisse AG, Cayman Islands and $49.8 million at risk with Credit Suisse. Counterparty ratings are not published for Credit Suisse AG, Cayman Islands. (6) Includes Non-Agency MBS pledged as collateral with contemporaneous repurchase and reverse repurchase agreements. FHLB Advances As of December 31, 2016 and 2015, MFA Insurance had $215.0 million and $1.5 billion in outstanding long-term secured FHLB advances with a weighted average borrowing rate of 0.78% and 0.50%, respectively. At December 31, 2016, the FHLB advances had a weighted average term to maturity of 3.67 years. However, MFA Insurance is required by amendments to FHLB membership regulations to terminate its membership and repay the outstanding advances by February 19, 2017. The Company’s FHLB advances outstanding at December 31, 2016 were all repaid in January 2017. Interest payable on outstanding FHLB advances at December 31, 2016 and 2015 totaled approximately $42,000 and $508,000, respectively, and is included in Other liabilities on the Company’s consolidated balance sheets. |
Collateral Positions |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transfers and Servicing [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Collateral Positions | Collateral Positions The Company pledges securities or cash as collateral to its counterparties pursuant to its borrowings under repurchase agreements, FHLB advances and its derivative contracts that are in an unrealized loss position, and it receives securities or cash as collateral pursuant to financing provided under reverse repurchase agreements and certain of its derivative contracts in an unrealized gain position. The Company exchanges collateral with its counterparties based on changes in the fair value, notional amount and term of the associated repurchase agreements, FHLB advances and derivative contracts, as applicable. Through this margining process, either the Company or its counterparty may be required to pledge cash or securities as collateral. In addition, Swaps novated to and cleared by a central clearing house are subject to initial margin requirements. When the Company’s pledged collateral exceeds the required margin, the Company may initiate a reverse margin call, at which time the counterparty may either return the excess collateral, or provide collateral to the Company in the form of cash or equivalent securities. The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements, derivative hedging instruments and FHLB advances at December 31, 2016 and 2015:
(1) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets. (2) Includes $172.4 million and $570.5 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2016 and 2015, respectively, that are eliminated from the Company’s consolidated balance sheets. (3) In addition, at December 31, 2016 and 2015, $688.2 million and $726.7 million of Legacy Non-Agency MBS, respectively, are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty. The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and other advances, and derivative hedging instruments at December 31, 2016:
(1) Includes Agency MBS pledged under FHLB advances with an aggregate fair value of $227.2 million, aggregate amortized cost of $226.6 million and aggregate accrued interest of approximately $597,000 at December 31, 2016. (2) Includes $172.4 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2016, that are eliminated from the Company’s consolidated balance sheets. (3) In addition, at December 31, 2016, $688.2 million of Legacy Non-Agency MBS are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty. (4) Includes residential whole loans held at carrying value with an aggregate fair value of $440.8 million and aggregate amortized cost of $427.9 million and residential whole loans held at fair value with an aggregate fair value and amortized cost of $732.4 million. (5) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets. |
Offsetting Assets and Liabilities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting Assets and Liabilities | Offsetting Assets and Liabilities The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at December 31, 2016 and 2015: Offsetting of Financial Assets and Derivative Assets
Offsetting of Financial Liabilities and Derivative Liabilities
(1) Amounts disclosed in the Financial Instruments column of the table above represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements and other advances, and derivative transactions. Amounts disclosed in the Cash Collateral Pledged column of the table above represent amounts pledged as collateral against derivative transactions and repurchase agreements, and exclude excess collateral of $6.9 million and $47,000 at December 31, 2016 and 2015, respectively. (2) The fair value of securities pledged against the Company’s Swaps was $32.5 million and $38.6 million at December 31, 2016 and 2015, respectively. (3) The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $10.5 billion and $11.3 billion at December 31, 2016 and 2015, respectively. (4) Excludes $210,000 and $1.3 million of unamortized debt issuance costs at December 31, 2016 and 2015, respectively. Nature of Setoff Rights In the Company’s consolidated balance sheets, all balances associated with the repurchase agreement and derivative transactions are presented on a gross basis. Certain of the Company’s repurchase agreement and derivative transactions are governed by underlying agreements that generally provide for a right of setoff in the event of default or in the event of a bankruptcy of either party to the transaction. For one repurchase agreement counterparty, the underlying agreements provide for an unconditional right of setoff. |
Senior Notes |
12 Months Ended |
---|---|
Dec. 31, 2016 | |
Debt Disclosure [Abstract] | |
Senior Notes | Senior Notes On April 11, 2012, the Company issued $100.0 million in aggregate principal amount of its Senior Notes in an underwritten public offering. The total net proceeds to the Company from the offering of the Senior Notes were approximately $96.6 million, after deducting offering expenses and the underwriting discount. The Senior Notes bear interest at a fixed rate of 8.00% per year, paid quarterly in arrears on January 15, April 15, July 15 and October 15 of each year and will mature on April 15, 2042. The Senior Notes have an effective interest rate, including the impact of amortization to interest expense of debt issuance costs, of 8.31%. The Company may redeem the Senior Notes, in whole or in part, at any time on or after April 15, 2017, at a redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest to, but not excluding, the redemption date. The Senior Notes are the Company’s senior unsecured obligations and are subordinate to all of the Company’s secured indebtedness, which includes the Company’s repurchase agreements, obligation to return securities obtained as collateral, and other financing arrangements, to the extent of the value of the collateral securing such indebtedness. |
Other Liabilities |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Liabilities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Liabilities | Other Liabilities The following table presents the components of the Company’s Other liabilities at December 31, 2016 and 2015:
|
Commitments and Contingencies |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies | Commitments and Contingencies Lease Commitments The Company pays monthly rent pursuant to two operating leases. The lease term for the Company’s headquarters in New York, New York extends through May 31, 2020. The lease provides for aggregate cash payments ranging over time of approximately $2.5 million per year, paid on a monthly basis, exclusive of escalation charges. In addition, as part of this lease agreement, the Company has provided the landlord a $785,000 irrevocable standby letter of credit fully collateralized by cash. The letter of credit may be drawn upon by the landlord in the event that the Company defaults under certain terms of the lease. In addition, the Company has a lease through December 31, 2021 for its off-site back-up facility located in Rockville Centre, New York, which provides for, among other things, lease payments totaling approximately $32,000, annually. The Company recognized lease expense of $2.5 million, $2.6 million and $2.5 million for the years ended December 31, 2016, 2015 and 2014, respectively, which is included in Other general and administrative expense within the consolidated statements of operations. At December 31, 2016, the contractual minimum rental payments (exclusive of possible rent escalation charges and normal recurring charges for maintenance, insurance and taxes) were as follows:
|
Stockholders' Equity |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity | Stockholders’ Equity (a) Preferred Stock On April 15, 2013, the Company completed the issuance of 8.0 million shares of its 7.50% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”) with a par value of $0.01 per share, and a liquidation preference of $25.00 per share plus accrued and unpaid dividends, in an underwritten public offering. The Company’s Series B Preferred Stock is entitled to receive a dividend at a rate of 7.50% per year on the $25.00 liquidation preference before the Company’s common stock is paid any dividends and is senior to the Company’s common stock with respect to distributions upon liquidation, dissolution or winding up. Dividends on the Series B Preferred Stock are payable quarterly in arrears on or about March 31, June 30, September 30 and December 31 of each year. The Series B Preferred Stock is redeemable at $25.00 per share plus accrued and unpaid dividends (whether or not authorized or declared) exclusively at the Company’s option commencing on April 15, 2018 (subject to the Company’s right, under limited circumstances, to redeem the Series B Preferred Stock prior to that date in order to preserve its qualification as a REIT) and upon certain specified change in control transactions in which the Company’s common stock and the acquiring or surviving entity common securities would not be listed on the New York Stock Exchange (the “NYSE”), the NYSE MKT or NASDAQ, or any successor exchange. The Series B Preferred Stock generally does not have any voting rights, subject to an exception in the event the Company fails to pay dividends on such stock for six or more quarterly periods (whether or not consecutive). Under such circumstances, the Series B Preferred Stock will be entitled to vote to elect two additional directors to the Company’s Board of Directors (the “Board”), until all unpaid dividends have been paid or declared and set apart for payment. In addition, certain material and adverse changes to the terms of the Series B Preferred Stock cannot be made without the affirmative vote of holders of at least 66 2/3% of the outstanding shares of Series B Preferred Stock. The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2014 through December 31, 2016:
(b) Dividends on Common Stock The following table presents cash dividends declared by the Company on its common stock from January 1, 2014 through December 31, 2016:
(1) At December 31, 2016, the Company had accrued dividends and dividend equivalents payable of $74.7 million related to the common stock dividend declared on December 14, 2016. In general, the Company’s common stock dividends have been characterized as ordinary income to its stockholders for income tax purposes. However, a portion of the Company’s common stock dividends may, from time to time, be characterized as capital gains or return of capital. For the years ended December 31, 2016 and 2015, a portion of the Company’s common stock dividends were deemed to be capitalized gains. For the year ended December 31, 2014, our common stock dividends were characterized as ordinary income to stockholders. (c) Discount Waiver, Direct Stock Purchase and Dividend Reinvestment Plan (“DRSPP”) On September 16, 2016, the Company filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (“SEC”) under the Securities Act of 1933, as amended (the “1933 Act”), for the purpose of registering additional common stock for sale through its DRSPP. Pursuant to Rule 462(e) of the 1933 Act, this shelf registration statement became effective automatically upon filing with the SEC and, when combined with the unused portion of the Company’s previous DRSPP shelf registration statements, registered an aggregate of 15 million shares of common stock. The Company’s DRSPP is designed to provide existing stockholders and new investors with a convenient and economical way to purchase shares of common stock through the automatic reinvestment of dividends and/or optional cash investments. At December 31, 2016, 14.5 million shares of common stock remained available for issuance pursuant to the DRSPP shelf registration statement. During the years ended December 31, 2016, 2015 and 2014, the Company issued 653,793, 162,373 and 4,526,855 shares of common stock through the DRSPP, raising net proceeds of approximately $4.7 million, $1.2 million and $35.6 million, respectively. From the inception of the DRSPP in September 2003 through December 31, 2016, the Company issued 31,382,785 shares pursuant to the DRSPP, raising net proceeds of $262.9 million. (d) Stock Repurchase Program As previously disclosed, in August 2005, the Company’s Board authorized a stock repurchase program (the “Repurchase Program”) to repurchase up to 4.0 million shares of its outstanding common stock. The Board reaffirmed such authorization in May 2010. In December 2013, the Board increased the number of shares authorized under the Repurchase Program to an aggregate of 10.0 million. Such authorization does not have an expiration date and, at present, there is no intention to modify or otherwise rescind such authorization. Subject to applicable securities laws, repurchases of common stock under the Repurchase Program are made at times and in amounts as the Company deems appropriate, (including, in our discretion, through the use of one or more plans adopted under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) using available cash resources. Shares of common stock repurchased by the Company under the Repurchase Program are cancelled and, until reissued by the Company, are deemed to be authorized but unissued shares of the Company’s common stock. The Repurchase Program may be suspended or discontinued by the Company at any time and without prior notice. The Company did not repurchase any shares of its common stock during the three years ended December 31, 2016. At December 31, 2016, 6,616,355 shares remained authorized for repurchase under the Repurchase Program. (e) Accumulated Other Comprehensive Income/(Loss) The following table presents changes in the balances of each component of the Company’s AOCI for the years ended December 31, 2016, 2015 and 2014:
(1) See separate table below for details about these reclassifications. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss). The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the years ended December 31, 2016, 2015, and 2014:
At December 31, 2016 and 2015, the Company had unrealized losses recorded in AOCI of $1.7 million and $1.3 million, respectively, on securities for which OTTI had been recognized in earnings in prior periods. |
EPS Calculation |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS Calculation | EPS Calculation The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the years ended December 31, 2016, 2015 and 2014:
(1) At December 31, 2016, the Company had an aggregate of 2.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the year ended December 31, 2016, as their inclusion would have been anti-dilutive. These equity instruments were comprised of approximately 29,000 shares of restricted common stock with a weighted average grant date fair value of $7.12 and approximately $2.0 million RSUs with a weighted average grant date fair value of $6.85. These equity instruments may have a dilutive impact on future EPS. |
Equity Compensation, Employment Agreements and Other Benefit Plans |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation Related Costs [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Compensation, Employment Agreements and Other Benefit Plans | Equity Compensation, Employment Agreements and Other Benefit Plans (a) Equity Compensation Plan In accordance with the terms of the Company’s Equity Compensation Plan (the “Equity Plan”), which was adopted by the Company’s stockholders on May 21, 2015 (and which amended and restated the Company’s 2010 Equity Compensation Plan), directors, officers and employees of the Company and any of its subsidiaries and other persons expected to provide significant services for the Company and any of its subsidiaries are eligible to receive grants of stock options (“Options”), restricted stock, RSUs, dividend equivalent rights and other stock-based awards under the Equity Plan. Subject to certain exceptions, stock-based awards relating to a maximum of 12.0 million shares of common stock may be granted under the Equity Plan; forfeitures and/or awards that expire unexercised do not count towards this limit. At December 31, 2016, approximately 8.2 million shares of common stock remained available for grant in connection with stock-based awards under the Equity Plan. A participant may generally not receive stock-based awards in excess of 1.5 million shares of common stock in any one year and no award may be granted to any person who, assuming exercise of all Options and payment of all awards held by such person, would own or be deemed to own more than 9.8% of the outstanding shares of the Company’s common stock. Unless previously terminated by the Board, awards may be granted under the Equity Plan until May 20, 2025. Dividend Equivalents A dividend equivalent is a right to receive a distribution equal to the dividend distributions that would be paid on a share of the Company’s common stock. Dividend equivalents may be granted as a separate instrument or may be a right associated with the grant of another award (e.g., an RSU) under the Equity Plan, and they are paid in cash or other consideration at such times and in accordance with such rules, as the Compensation Committee of the Board (the “Compensation Committee”) shall determine in its discretion. Payments made on the Company’s outstanding dividend equivalent rights that have been granted as a separate instrument are charged to Stockholders’ Equity when common stock dividends are declared to the extent that such equivalents are expected to vest. The Company made payments in respect of such separate instruments of approximately $5,000, $16,000 and $69,000 during the years ended December 31, 2016, 2015 and 2014, respectively. At December 31, 2016, there were no dividend equivalent rights outstanding, which had been awarded separately from, but in connection with, grants of RSUs made in prior years. The following table presents information about the Company’s dividend equivalents rights awarded as separate instruments at and for each of the years ended December 31, 2016, 2015 and 2014:
The weighted average grant date fair value of the dividend equivalent rights in the above table is $2.77. The determination of the weighted average grant date fair value of these awards required the Company to estimate certain valuation inputs. In determining the fair value for these awards granted in 2011, the Company applied: (i) a weighted average volatility estimate of approximately 31%, which was determined considering historic volatility in the price of Company’s common stock over the six-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 2.23% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 13%. Options Pursuant to Section 422(b) of the Code, in order for Options granted under the Equity Plan and vesting in any one calendar year to qualify as an incentive stock option (“ISO”) for tax purposes, the market value of the common stock to be received upon exercise of such Options as determined on the date of grant shall not exceed $100,000 during such calendar year. The exercise price of an ISO may not be lower than 100% (or 110% in the case of an ISO granted to a 10% stockholder) of the fair market value of the Company’s common stock on the date of grant. The exercise price for any other type of Option issued under the Equity Plan may not be less than the fair market value on the date of grant. Each Option is exercisable after the period or periods specified in the award agreement, which will generally not exceed ten years from the date of grant. The Company did not grant any stock options during the three years ended December 31, 2016. At December 31, 2016, the Company had no Options outstanding. The following table presents information about the Company’s Options at and for the year ended December 31, 2014:
Restricted Stock At December 31, 2016 and December 31, 2015, the Company had unrecognized compensation expense of approximately $203,000 and $807,000, respectively, related to the unvested shares of restricted common stock. The Company had accrued dividends payable of approximately $55,000 and $193,000 on unvested shares of restricted stock at December 31, 2016 and December 31, 2015, respectively. The total fair value of restricted shares vested during the years ended December 31, 2016, 2015 and 2014 was approximately $4.3 million, $4.3 million and $5.7 million, respectively. The unrecognized compensation expense at December 31, 2016 is expected to be recognized over a weighted average period of one year. The following table presents information with respect to the Company’s restricted stock for the years ended December 31, 2016, 2015 and 2014:
(1) The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date. (2) All restrictions associated with restricted stock are removed on vesting. Restricted Stock Units Under the terms of the Equity Plan, RSUs are instruments that provide the holder with the right to receive, subject to the satisfaction of conditions set by the Compensation Committee at the time of grant, a payment of a specified value, which may be a share of the Company’s common stock, the fair market value of a share of the Company’s common stock, or such fair market value to the extent in excess of an established base value, on the applicable settlement date. Although the Equity Plan permits the Company to issue RSUs that can settle in cash, all of the Company’s outstanding RSUs as of December 31, 2016 are designated to be settled in shares of the Company’s common stock. All RSUs outstanding at December 31, 2016 may be entitled to receive dividend equivalent payments depending on the terms and conditions of the award either in cash at the time dividends are paid by the Company, or for certain performance-based RSU awards, as a grant of stock at the time such awards are settled. At December 31, 2016 and 2015, the Company had unrecognized compensation expense of $3.6 million and $4.0 million, respectively, related to RSUs. The unrecognized compensation expense at December 31, 2016 is expected to be recognized over a weighted average period of 1.6 years. A 0% forfeiture rate was assumed with respect to unvested RSUs at December 31, 2016. The following table presents information with respect to the Company’s RSUs during the years ended December 31, 2016, 2015 and 2014:
(1) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 615,000 of these awards granted in 2016, the Company applied: (i) a weighted average volatility estimate of approximately 17%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 1.20% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 11%. The weighted average grant date fair value for the remaining 113,195 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $7.20. There are no post vesting conditions on these awards. (2) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 582,500 of these awards granted in 2015, the Company applied: (i) a weighted average volatility estimate of approximately 18%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.90% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 9%. The weighted average grant date fair value for the remaining 99,554 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.93 to $7.97. There are no post vesting conditions on these awards. (3) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 547,600 of these awards granted in 2014, the Company applied: (i) a weighted average volatility estimate of approximately 22%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.73% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 8%. The weighted average grant date fair value for the remaining 83,215 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.19 to $8.16. There are no post vesting conditions on these awards. Expense Recognized for Equity-Based Compensation Instruments The following table presents the Company’s expenses related to its equity-based compensation instruments for the years ended December 31, 2016, 2015 and 2014:
(1) RSU expense for the year ended December 31, 2014 includes approximately $500,000 for a one-time grant to the Company’s chief executive officer. (b) Employment Agreements At December 31, 2016, the Company had employment agreements with four of its officers, with varying terms that provide for, among other things, base salary, bonus and change-in-control payments upon the occurrence of certain triggering events. (c) Deferred Compensation Plans The Company administers deferred compensation plans for its senior officers and non-employee directors (collectively, the “Deferred Plans”), pursuant to which participants may elect to defer up to 100% of certain cash compensation. The Deferred Plans are designed to align participants’ interests with those of the Company’s stockholders. Amounts deferred under the Deferred Plans are considered to be converted into “stock units” of the Company. Stock units do not represent stock of the Company, but rather are a liability of the Company that changes in value as would equivalent shares of the Company’s common stock. Deferred compensation liabilities are settled in cash at the termination of the deferral period, based on the value of the stock units at that time. The Deferred Plans are non-qualified plans under the Employee Retirement Income Security Act of 1974 and, as such, are not funded. Prior to the time that the deferred accounts are settled, participants are unsecured creditors of the Company. The Company’s liability for stock units in the Deferred Plans is based on the market price of the Company’s common stock at the measurement date. The following table presents the Company’s expenses related to its Deferred Plans for its non-employee directors and senior officers for the years ended December 31, 2016, 2015 and 2014:
The Company distributed cash of $122,000, $109,000 and $119,000 to the participants of the Deferred Plans during the years ended December 31, 2016, 2015 and 2014, respectively. The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through December 31, 2016 and 2015 that had not been distributed and the Company’s associated liability for such deferrals at December 31, 2016 and 2015:
(1) Represents the cumulative amounts that were deferred by participants through December 31, 2016 and 2015, which had not been distributed through such respective date. (d) Savings Plan The Company sponsors a tax-qualified employee savings plan (the “Savings Plan”) in accordance with Section 401(k) of the Code. Subject to certain restrictions, all of the Company’s employees are eligible to make tax deferred contributions to the Savings Plan subject to limitations under applicable law. Participant’s accounts are self-directed and the Company bears the costs of administering the Savings Plan. The Company matches 100% of the first 3% of eligible compensation deferred by employees and 50% of the next 2%, subject to a maximum as provided by the Code. The Company has elected to operate the Savings Plan under the applicable safe harbor provisions of the Code, whereby among other things, the Company must make contributions for all participating employees and all matches contributed by the Company immediately vest 100%. For the years ended December 31, 2016, 2015 and 2014, the Company recognized expenses for matching contributions of $359,000, $309,000 and $237,000, respectively. |
Fair Value of Financial Instruments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments | Fair Value of Financial Instruments A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of valuation hierarchy are defined as follows: Level 1 — Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2 — Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level 3 — Inputs to the valuation methodology are unobservable and significant to the fair value measurement. The following describes the valuation methodologies used for the Company’s financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy. Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral The fair value of U.S. Treasury securities obtained as collateral and the associated obligation to return securities obtained as collateral are based upon prices obtained from a third-party pricing service, which are indicative of market activity. Securities obtained as collateral are classified as Level 1 in the fair value hierarchy. MBS and CRT securities The Company determines the fair value of its Agency MBS, based upon prices obtained from third-party pricing services, which are indicative of market activity and repurchase agreement counterparties. For Agency MBS, the valuation methodology of the Company’s third-party pricing services incorporate commonly used market pricing methods, trading activity observed in the marketplace and other data inputs. The methodology also considers the underlying characteristics of each security, which are also observable inputs, including: collateral vintage, coupon, maturity date, loan age, reset date, collateral type, periodic and life cap, geography, and prepayment speeds. Management analyzes pricing data received from third-party pricing services and compares it to other indications of fair value including data received from repurchase agreement counterparties and its own observations of trading activity observed in the marketplace. In determining the fair value of its Non-Agency MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. In valuing Non-Agency MBS, the Company understands that pricing services use observable inputs that include, in addition to trading activity observed in the marketplace, loan delinquency data, credit enhancement levels and vintage, which are taken into account to assign pricing factors such as spread and prepayment assumptions. For tranches of Legacy Non-Agency MBS that are cross-collateralized, performance of all collateral groups involved in the tranche are considered. The Company collects and considers current market intelligence on all major markets, including benchmark security evaluations and bid-lists from various sources, when available. The Company’s MBS and CRT securities are valued using various market data points as described above, which management considers directly or indirectly observable parameters. Accordingly, the Company’s MBS and CRT securities are classified as Level 2 in the fair value hierarchy. Residential Whole Loans, at Fair Value The Company determines the fair value of its residential whole loans held at fair value after considering valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans trading activity observed in the marketplace. The Company’s residential whole loans held at fair value are classified as Level 3 in the fair value hierarchy. Swaps The Company determines the fair value of non-centrally cleared Swaps considering valuations obtained from a third-party pricing service. For Swaps that are cleared by a central clearing house, valuations provided by the clearing house are used. All valuations obtained are tested with internally developed models that apply readily observable market parameters. The Company considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each derivative agreement, from the perspective of both the Company and its counterparties. All of the Company’s Swaps are subject either to bilateral collateral arrangements, or for cleared Swaps, to the clearing house’s margin requirements. Consequently, no credit valuation adjustment was made in determining the fair value of such instruments. Swaps are classified as Level 2 in the fair value hierarchy. The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of December 31, 2016 and 2015, on the consolidated balance sheets by the valuation hierarchy, as previously described: Fair Value at December 31, 2016
Fair Value at December 31, 2015
Changes in Level 3 Assets Measured at Fair Value on a Recurring Basis The following table presents additional information for the years ended December 31, 2016 and 2015 about the Company’s residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:
The Company did not transfer any assets or liabilities from one level to another during the years ended December 31, 2016 and 2015. Fair Value Methodology for Level 3 Financial Instruments The following tables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of December 31, 2016 and 2015:
(1) Excludes approximately $45.4 million and $117.6 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at December 31, 2016 and 2015, respectively. (2) Amounts are weighted based on the fair value of the underlying loan. (3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately $320,000 and $305,000 as of December 31, 2016 and 2015, respectively. The following table presents the difference between the fair value and the aggregate unpaid principal balance of the Company’s residential whole loans for which the fair value option was elected at December 31, 2016 and 2015:
Changes to the valuation methodologies used with respect to the Company’s financial instruments are reviewed by management to ensure any such changes result in appropriate exit price valuations. The Company will refine its valuation methodologies as markets and products develop and pricing methodologies evolve. The methods described above may produce fair value estimates that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with those used by market participants, the use of different methodologies, or assumptions, to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The Company uses inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced. The Company reviews the classification of its financial instruments within the fair value hierarchy on a quarterly basis, and management may conclude that its financial instruments should be reclassified to a different level in the future. The following table presents the carrying values and estimated fair values of the Company’s financial instruments at December 31, 2016 and 2015:
(1) Carrying value of Senior Notes, Securitized debt and certain Repurchase agreements is net of associated debt issuance costs. In addition to the methodologies used to determine the fair value of the Company’s financial assets and liabilities reported at fair value on a recurring basis, as previously described, the following methods and assumptions were used by the Company in arriving at the fair value of the Company’s other financial instruments presented in the above table: Residential Whole Loans at Carrying Value: The Company determines the fair value of its residential whole loans held at carrying value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the marketplace. The Company’s residential whole loans held at carrying value are classified as Level 3 in the fair value hierarchy. Cash and Cash Equivalents and Restricted Cash: Cash and cash equivalents and restricted cash are comprised of cash held in overnight money market investments and demand deposit accounts. At December 31, 2016 and 2015, the Company’s money market funds were invested in securities issued by the U.S. Government, or its agencies, instrumentalities, and sponsored entities, and repurchase agreements involving the securities described above. Given the overnight term and assessed credit risk, the Company’s investments in money market funds are determined to have a fair value equal to their carrying value. Repurchase Agreements: The fair value of repurchase agreements reflects the present value of the contractual cash flows discounted at market interest rates at the valuation date for repurchase agreements with a term equivalent to the remaining term to interest rate repricing, which may be at maturity. Such interest rates are estimated based on LIBOR rates observed in the market. The Company’s repurchase agreements are classified as Level 2 in the fair value hierarchy. FHLB Advances: FHLB advances reflect collateralized borrowings at variable market interest rates that reset on a monthly basis. Accordingly, the carrying amount of FHLB advances are considered to approximate fair value. The Company’s FHLB advances are classified as Level 2 in the fair value hierarchy. Securitized Debt: In determining the fair value of securitized debt, management considers a number of observable market data points, including prices obtained from pricing services and brokers as well as dialogue with market participants. Accordingly, the Company’s securitized debt is classified as Level 2 in the fair value hierarchy. Senior Notes: The fair value of the Senior Notes is determined using the end of day market price quoted on the NYSE at the reporting date. The Company’s Senior Notes are classified as Level 1 in the fair value hierarchy. The Company holds REO at the lower of the current carrying amount or fair value less estimated selling costs. At December 31, 2016, the Company’s REO had an aggregate carrying value of $80.5 million and aggregate estimated fair value of $91.1 million. The Company’s REO is classified as Level 3 in the fair value hierarchy. |
Use of Special Purpose Entities and Variable Interest Entities |
12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||
Use of Special Purpose Entities and Variable Interest Entities | |||||||||
Use of Special Purpose Entities and Variable Interest Entities | Use of Special Purpose Entities and Variable Interest Entities A Special Purpose Entity (“SPE”) is an entity designed to fulfill a specific limited need of the company that organized it. SPEs are often used to facilitate transactions that involve securitizing financial assets or resecuritizing previously securitized financial assets. The objective of such transactions may include obtaining non-recourse financing, obtaining liquidity or refinancing the underlying securitized financial assets on improved terms. Securitization involves transferring assets to a SPE to convert all or a portion of those assets into cash before they would have been realized in the normal course of business, through the SPE’s issuance of debt or equity instruments. Investors in an SPE usually have recourse only to the assets in the SPE and, depending on the overall structure of the transaction, may benefit from various forms of credit enhancement such as over-collateralization in the form of excess assets in the SPE, priority with respect to receipt of cash flows relative to holders of other debt or equity instruments issued by the SPE, or a line of credit or other form of liquidity agreement that is designed with the objective of ensuring that investors receive principal and/or interest cash flow on the investment in accordance with the terms of their investment agreement. Resecuritization transactions The Company has in prior years entered into several resecuritization transactions that resulted in the Company consolidating as VIEs the SPEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred. See Note 2(r) for a discussion of the accounting policies applied to the consolidation of VIEs and transfers of financial assets in connection with resecuritization transactions. The Company has engaged in resecuritization transactions primarily for the purpose of obtaining non-recourse financing on a portion of its Non-Agency MBS portfolio, as well as refinancing a portion of its Non-Agency MBS portfolio on improved terms. Notwithstanding the Company’s participation in these transactions, the risks facing the Company are largely unchanged as the Company remains economically exposed to the first loss position on the underlying MBS transferred to the VIEs. The activities that can be performed by an entity created to facilitate a resecuritization transaction are generally specified in the entity’s formation documents. Those documents do not permit the entity, any beneficial interest holder in the entity, or any other party associated with the entity to cause the entity to sell or replace the assets held by the entity, or limit such ability to when specific events of default occur. The Company concluded that the entities created to facilitate these resecuritization transactions are VIEs. The Company then completed an analysis of whether each VIE created to facilitate the resecuritization transaction should be consolidated by the Company, based on consideration of its involvement in each VIE, including the design and purpose of the SPE, and whether its involvement reflected a controlling financial interest that resulted in the Company being deemed the primary beneficiary of each VIE. In determining whether the Company would be considered the primary beneficiary, the following factors were assessed:
Based on its evaluation of the factors discussed above, including its involvement in the purpose and design of the entity, the Company determined that it was required to consolidate each VIE created to facilitate these resecuritization transactions. As of December 31, 2016 and 2015, the aggregate fair value of the Non-Agency MBS that were resecuritized as described above was $174.4 million and $598.3 million, respectively. These assets are included in the Company’s consolidated balance sheets and disclosed as “Non-Agency MBS transferred to consolidated VIEs, at fair value”. During the year ended December 31, 2016, the principal balance for the WFMLT Series 2012-RR1 A1 Bond was paid-off, thereby reducing the aggregate outstanding balance of credit support provided for the senior Non-Agency MBS sold to third-party investors in resecuritization transactions (“Senior Bonds”) issued by consolidated VIEs to zero. As of December 31, 2015, the aggregate outstanding balance of Senior Bonds issued by consolidated VIEs was $22.1 million. These Senior Bonds are included in Other liabilities on the Company’s consolidated balance sheets and disclosed as “Securitized debt.” During the first quarter of 2016, the Company entered into an agreement to amend the Trust Agreement of the DMSI 2010-RS2 Trust (the “Trust”) in order to facilitate the unwind of this resecuritization transaction. Concurrent with the amendment to the Trust Agreement, the Company entered into a transaction to exchange the remaining beneficial interests issued by the Trust and held by the Company for the underlying securities that had previously been transferred to and held by the Trust. During the third quarter of 2016 and subsequent to completion of any final Trust distributions, the remaining beneficial interests were cancelled and the Trust was terminated. For financial reporting purposes, the exchange transaction and termination of this financing structure did not result in any gain or loss to the Company as this resecuritization was accounted for as a financing transaction. However, for purposes of determining REIT taxable income, this resecuritization transaction was originally accounted for as a sale of the underlying securities to the Trust and acquisition of beneficial interests issued by the Trust. Because the fair value of the underlying securities received exceeded the Company’s tax basis in the remaining beneficial interests at the exchange date, the unwind of this resecuritization structure resulted in the Company recognizing taxable income currently estimated to be approximately $70.9 million or $0.19 per common share. In addition, the underlying securities originally transferred as part of this resecuritization are reported as Non-Agency MBS in the Company’s consolidated balance sheets at December 31, 2016 and interest income from the underlying securities from the date of exchange transaction through December 31, 2016 is reported as Interest income from Non-Agency MBS in the Company’s consolidated statements of operations. Prior to the completion of the Company’s first resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or QSPEs and other than acquiring MBS issued by such entities, had no other involvement with VIEs or QSPEs. Residential Whole Loans Included on the Company’s consolidated balance sheets as of December 31, 2016 and 2015 are a total of $1.4 billion and $895.1 million of residential whole loans, of which approximately $590.5 million and $271.8 million are reported at carrying value and $814.7 million and $623.3 million are reported at fair value, respectively. The inclusion of these assets arises from the Company’s 100% equity interest in certain trusts established to acquire the loans. Based on its evaluation of its 100% interest in these trusts and other factors, the Company has determined that the trusts are required to be consolidated for financial reporting purposes. During 2016, 2015 and 2014, the Company recognized interest income from residential whole loans reported at carrying value of approximately $23.9 million, $16.0 million and $4.1 million, respectively, which is included in Interest Income on the Company’s consolidated statements of operations. In addition, the Company recognized net gains on residential whole loans held at fair value during 2016, 2015 and 2014 of approximately $59.7 million, $17.7 million and $116,000, respectively, which amounts are included in Other Income, net on the Company’s consolidated statements of operations. (See Note 4) |
Summary of Quarterly Results of Operations (Unaudited) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarterly Financial Information Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Quarterly Results of Operations (Unaudited) | Summary of Quarterly Results of Operations (Unaudited)
|
Schedule IV - Mortgage Loans on Real Estate |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage Loans on Real Estate [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule IV - Mortgage Loans on Real Estate | Mortgage Loans on Real Estate December 31, 2016
Reconciliation of Balance Sheet Reported Amounts of Mortgage Loans on Real Estate The following table summarizes the changes in the carrying amounts of residential whole loans during the year ended December 31, 2016:
|
Summary of Significant Accounting Policies (Policies) |
12 Months Ended |
---|---|
Dec. 31, 2016 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Consolidation | Basis of Presentation and Consolidation The accompanying consolidated financial statements of the Company have been prepared on the accrual basis of accounting in accordance with U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although the Company’s estimates contemplate current conditions and how it expects them to change in the future, it is reasonably possible that actual conditions could differ from those estimates, which could materially impact the Company’s results of operations and its financial condition. Management has made significant estimates in several areas, including other-than-temporary impairment (“OTTI”) on MBS (See Note 3), valuation of MBS and CRT securities (See Notes 3 and 15), income recognition and valuation of residential whole loans (See Notes 4 and 15), valuation of derivative instruments (See Notes 5(b) and 15) and income recognition on certain Non-Agency MBS (defined below) purchased at a discount. (See Note 3) In addition, estimates are used in the determination of taxable income used in the assessment of REIT compliance and contingent liabilities for related taxes, penalties and interest. (See Note 2(o)) Actual results could differ from those estimates. The Company has one reportable segment as it manages its business and analyzes and reports its results of operations on the basis of one operating segment; investing, on a leveraged basis, in residential mortgage assets. The consolidated financial statements of the Company include the accounts of all subsidiaries; all intercompany accounts and transactions have been eliminated. In addition, the Company consolidates the remaining special purpose entities created to facilitate resecuritization transactions completed in prior years and the acquisition of residential whole loans. Certain prior period amounts have been reclassified to conform to the current period presentation. |
MBS (including Non-Agency MBS transferred to consolidated VIEs) and CRT Securities | MBS (including Non-Agency MBS transferred to consolidated VIEs) and CRT Securities The Company has investments in residential MBS that are issued or guaranteed as to principal and/or interest by a federally chartered corporation, such as the Federal National Mortgage Association (“Fannie Mae”) or the Federal Home Loan Mortgage Corporation (“Freddie Mac”), or an agency of the U.S. Government, such as the Government National Mortgage Association (“Ginnie Mae”) (collectively, “Agency MBS”), and residential MBS that are not guaranteed by any agency of the U.S. Government or any federally chartered corporation (“Non-Agency MBS”). In addition, the Company has investments in CRT securities that are issued by Fannie Mae and Freddie Mac. The coupon payments on CRT securities are paid by Fannie Mae and Freddie Mac and the principal payments received are based on the performance of loans in a reference pool of previously securitized MBS. As the loans in the underlying reference pool are paid, the principal balance of the CRT securities is paid. As an investor in a CRT security, the Company may incur a loss if certain defined credit events occur, including, for certain CRT securities, if the loans in the reference pool experience delinquencies exceeding specified thresholds. Designation The Company generally intends to hold its MBS until maturity; however, from time to time, it may sell any of its securities as part of the overall management of its business. As a result, all of the Company’s MBS are designated as “available-for-sale” (“AFS”) and, accordingly, are carried at their fair value with unrealized gains and losses excluded from earnings (except when an OTTI is recognized, as discussed below) and reported in Accumulated other comprehensive income/(loss) (“AOCI”), a component of Stockholders’ Equity. Upon the sale of an AFS security, any unrealized gain or loss is reclassified out of AOCI to earnings as a realized gain or loss using the specific identification method. The Company has elected the fair value option for certain of its CRT securities as it considers this method of accounting to more appropriately reflect the risk sharing structure of these securities. Such securities are carried at their fair value with changes in fair value included in earnings for the period and reported in Other Income, net on the Company’s consolidated statement of operations. Revenue Recognition, Premium Amortization and Discount Accretion Interest income on securities is accrued based on the outstanding principal balance and their contractual terms. Premiums and discounts associated with Agency MBS and Non-Agency MBS assessed as high credit quality at the time of purchase are amortized into interest income over the life of such securities using the effective yield method. Adjustments to premium amortization are made for actual prepayment activity. Interest income on the Non-Agency MBS that were purchased at a discount to par value and/or are considered to be of less than high credit quality is recognized based on the security’s effective interest rate which is the security’s internal rate of return (“IRR”). The IRR is determined using management’s estimate of the projected cash flows for each security, which are based on the Company’s observation of current information and events and include assumptions related to fluctuations in interest rates, prepayment speeds and the timing and amount of credit losses. On at least a quarterly basis, the Company reviews and, if appropriate, makes adjustments to its cash flow projections based on input and analysis received from external sources, internal models, and its judgment about interest rates, prepayment rates, the timing and amount of credit losses, and other factors. Changes in cash flows from those originally projected, or from those estimated at the last evaluation, may result in a prospective change in the IRR/ interest income recognized on these securities or in the recognition of OTTIs. (See Note 3) Based on the projected cash flows from the Company’s Non-Agency MBS purchased at a discount to par value, a portion of the purchase discount may be designated as non-accretable purchase discount (“Credit Reserve”), which effectively mitigates the Company’s risk of loss on the mortgages collateralizing such MBS and is not expected to be accreted into interest income. The amount designated as Credit Reserve may be adjusted over time, based on the actual performance of the security, its underlying collateral, actual and projected cash flow from such collateral, economic conditions and other factors. If the performance of a security with a Credit Reserve is more favorable than forecasted, a portion of the amount designated as Credit Reserve may be reallocated to accretable discount and recognized into interest income over time. Conversely, if the performance of a security with a Credit Reserve is less favorable than forecasted, the amount designated as Credit Reserve may be increased, or impairment charges and write-downs of such securities to a new cost basis could result. Determination of Fair Value for MBS and CRT Securities In determining the fair value of the Company’s MBS and CRT securities, management considers a number of observable market data points, including prices obtained from pricing services, brokers and repurchase agreement counterparties, dialogue with market participants, as well as management’s observations of market activity. (See Note 15) Impairments/OTTI When the fair value of an AFS security is less than its amortized cost at the balance sheet date, the security is considered impaired. The Company assesses its impaired securities on at least a quarterly basis and designates such impairments as either “temporary” or “other-than-temporary.” If the Company intends to sell an impaired security, or it is more likely than not that it will be required to sell the impaired security before its anticipated recovery, then the Company must recognize an OTTI through charges to earnings equal to the entire difference between the investment’s amortized cost and its fair value at the balance sheet date. If the Company does not expect to sell an other-than-temporarily impaired security, only the portion of the OTTI related to credit losses is recognized through charges to earnings with the remainder recognized through AOCI on the consolidated balance sheets. Impairments recognized through other comprehensive income/(loss) (“OCI”) do not impact earnings. Following the recognition of an OTTI through earnings, a new cost basis is established for the security and may not be adjusted for subsequent recoveries in fair value through earnings. However, OTTIs recognized through charges to earnings may be accreted back to the amortized cost basis of the security on a prospective basis through interest income. The determination as to whether an OTTI exists and, if so, the amount of credit impairment recognized in earnings is subjective, as such determinations are based on factual information available at the time of assessment as well as the Company’s estimates of the future performance and cash flow projections. As a result, the timing and amount of OTTIs constitute material estimates that are susceptible to significant change. (See Note 3) Non-Agency MBS that are assessed to be of less than high credit quality and on which impairments are recognized have experienced, or are expected to experience, credit-related adverse cash flow changes. The Company’s estimate of cash flows for its Non-Agency MBS is based on its review of the underlying mortgage loans securing the MBS. The Company considers information available about the past and expected future performance of underlying mortgage loans, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, percentage of non-performing loans, Fair Isaac Corporation (“FICO”) scores at loan origination, year of origination, loan-to-value ratios (“LTVs”), geographic concentrations, as well as reports by credit rating agencies, such as Moody’s Investors Services, Inc. (“Moody’s”), Standard & Poor’s Corporation (“S&P”) or Fitch, Inc. (collectively with Moody’s and S&P, “Rating Agencies”), general market assessments, and dialogue with market participants. As a result, significant judgment is used in the Company’s analysis to determine the expected cash flows for its Non-Agency MBS. In determining the OTTI related to credit losses for securities that were purchased at significant discounts to par and/or are considered to be of less than high credit quality, the Company compares the present value of the remaining cash flows expected to be collected at the purchase date (or last date previously revised) against the present value of the cash flows expected to be collected at the current financial reporting date. The discount rate used to calculate the present value of expected future cash flows is the current yield used for income recognition purposes. Impairment assessment for Non-Agency MBS and CRT securities that were purchased at prices close to par and/or are otherwise considered to be of high credit quality involves comparing the present value of the remaining cash flows expected to be collected against the amortized cost of the security at the assessment date. The discount rate used to calculate the present value of the expected future cash flows is based on the instrument’s IRR. Balance Sheet Presentation The Company’s MBS and CRT securities pledged as collateral against repurchase agreements, Federal Home Loan Bank advances and Swaps are included on the consolidated balance sheets with the fair value of the securities pledged disclosed parenthetically. Purchases and sales of securities are recorded on the trade date. |
Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral | Securities Obtained and Pledged as Collateral/Obligation to Return Securities Obtained as Collateral The Company has obtained securities as collateral under collateralized financing arrangements in connection with its financing strategy for Non-Agency MBS. Securities obtained as collateral in connection with these transactions are recorded on the Company’s consolidated balance sheets as an asset along with a liability representing the obligation to return the collateral obtained, at fair value. While beneficial ownership of securities obtained remains with the counterparty, the Company has the right to transfer the collateral obtained or to pledge it as part of a subsequent collateralized financing transaction. (See Note 2(k) for Repurchase Agreements and Reverse Repurchase Agreements) |
Residential Whole Loans | Residential Whole Loans Residential whole loans included in the Company’s consolidated balance sheets are comprised of pools of fixed and adjustable rate residential mortgage loans acquired through consolidated trusts in secondary market transactions generally at discounted purchase prices. The accounting model utilized by the Company is determined at the time each loan package is initially acquired and is generally based on the delinquency status of the majority of the underlying borrowers in the package at acquisition. The accounting model described below under “Residential Whole Loans at Carrying Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of less than 60 days at the acquisition date. The accounting model described below under “Residential Whole Loans at Fair Value” is typically utilized by the Company for loans where the underlying borrower has a delinquency status of 60 days or more at the acquisition date. The accounting model initially applied is not subsequently changed. The Company’s residential whole loans pledged as collateral against repurchase agreements are included in the consolidated balance sheets with amounts pledged disclosed parenthetically. Purchases and sales of residential whole loans are recorded on the trade date, with amounts recorded reflecting management’s current estimate of assets that will be acquired or disposed at the closing of the transaction. This estimate is subject to revision at the closing of the transaction, pending the outcome of due diligence performed prior to closing. Recorded amounts of residential whole loans for which the closing of the purchase transaction is yet to occur are not eligible to be pledged as collateral against any repurchase agreement financing until the closing of the purchase transaction. Residential Whole Loans at Carrying Value Notwithstanding that the majority of these loans are considered to be performing substantially in accordance with their current contractual terms and conditions, the Company has elected to account for these loans as credit impaired as they were acquired at discounted prices that reflect, in part, the impaired credit history of the borrower. Substantially all of the borrowers have previously experienced payment delinquencies and the amount owed on the mortgage loan may exceed the value of the property pledged as collateral. Consequently, the Company has assessed that these loans have a higher likelihood of default than newly originated mortgage loans with LTVs of 80% or less to creditworthy borrowers. The Company believes that amounts paid to acquire these loans represent fair market value at the date of acquisition. Such loans are initially recorded at fair value with no allowance for loan losses. Subsequent to acquisition, the recorded amount reflects the original investment amount, plus accretion of interest income, less principal and interest cash flows received. These loans are presented on the Company’s consolidated balance sheets at carrying value, which reflects the recorded amount reduced by any allowance for loan losses established subsequent to acquisition. Under the application of this accounting model, the Company may aggregate into pools loans acquired in the same fiscal quarter that are assessed as having similar risk characteristics. For each pool established, or on an individual loans basis for loans not aggregated into pools, the Company estimates at acquisition and periodically on at least a quarterly basis, the principal and interest cash flows expected to be collected. The difference between the cash flows expected to be collected and the carrying amount of the loans is referred to as the “accretable yield.” This amount is accreted as interest income over the life of the loans using an effective interest rate (level yield) methodology. Interest income recorded each period reflects the amount of accretable yield recognized and not the coupon interest payments received on the underlying loans. The difference between contractually required principal and interest payments and the cash flows expected to be collected is referred to as the “non-accretable difference,” and includes estimates of both the effect of prepayments and expected credit losses over the life of the underlying loans. A decrease in expected cash flows in subsequent periods may indicate impairment at the pool and/or individual loan level, thus requiring the establishment of an allowance for loan losses by a charge to the provision for loan losses. The allowance for loan losses represents the present value of cash flows expected at acquisition, adjusted for any increases due to changes in estimated cash flows, that are subsequently no longer expected to be received at the relevant measurement date. A significant increase in expected cash flows in subsequent periods first reduces any previously recognized allowance for loan losses and then will result in a recalculation in the amount of accretable yield. The adjustment of accretable yield due to a significant increase in expected cash flows is accounted for prospectively as a change in estimate and results in reclassification from nonaccretable difference to accretable yield. (See Notes 4 and 16) Residential Whole Loans at Fair Value Certain of the Company’s residential whole loans are presented at fair value on its consolidated balance sheets as a result of a fair value election made at time of acquisition. Given the significant uncertainty associated with estimating the timing of and amount of cash flows associated with these loans that will be collected, and that the cash flows ultimately collected may be dependent on the value of the property securing the loan, the Company considers that accounting for these loans at fair value should result in a better reflection over time of the economic returns from these loans. The Company determines the fair value of its residential whole loans held at fair value after considering portfolio valuations obtained from a third-party who specializes in providing valuations of residential mortgage loans and trading activity observed in the marketplace. Subsequent changes in fair value are reported in current period earnings and presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash received reflecting coupon payments on residential whole loans held at fair value is not included in Interest Income, but rather is presented in Net gain on residential whole loans held at fair value on the Company’s consolidated statements of operations. Cash outflows associated with loan related advances made by the Company on behalf of the borrower are included in the basis of the loan and are reflected in Net gain on residential whole loans held at fair value. (See Notes 4 and 15) |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents include cash on deposit with financial institutions and investments in money market funds, all of which have original maturities of three months or less. Cash and cash equivalents may also include cash pledged as collateral to the Company by its repurchase agreement and/or Swap counterparties as a result of reverse margin calls (i.e., margin calls made by the Company). The Company did not hold any cash pledged by its counterparties at December 31, 2016 or 2015. |
Restricted Cash | Restricted Cash Restricted cash represents the Company’s cash held by its counterparties as collateral or otherwise in connection with the Company’s Swaps and/or repurchase agreements. Restricted cash is not available to the Company for general corporate purposes, but may be applied against amounts due to counterparties to the Company’s repurchase agreements and/or Swaps, or may be returned to the Company when the related collateral requirements are exceeded or at the maturity of the Swap or repurchase agreement. |
Goodwill | Goodwill At December 31, 2016 and 2015, the Company had goodwill of $7.2 million, which represents the unamortized portion of the excess of the fair value of its common stock issued over the fair value of net assets acquired in connection with its formation in 1998. Goodwill is tested for impairment at least annually, or more frequently under certain circumstances, at the entity level. Through December 31, 2016, the Company had not recognized any impairment against its goodwill. |
Real Estate Owned (REO) | Real Estate Owned (“REO”) REO represents real estate acquired by the Company, including through foreclosure, deed in lieu of foreclosure, or purchased in connection with the acquisition of residential whole loans. REO acquired through foreclosure or deed in lieu of foreclosure is initially recorded at fair value less estimated selling costs. REO acquired in connection with the acquisition of residential whole loans is initially recorded at its purchase price. Subsequent to acquisition, REO is reported, at each reporting date, at the lower of the current carrying amount or fair value less estimated selling costs and for presentation purposes is included in Other assets on the Company’s consolidated balance sheets. Changes in fair value that result in an adjustment to the reported amount of an REO property that has a fair value at or below its carrying amount are reported in Other Income, net on the Company’s consolidated statements of operations. (See Note 5(a)) |
Depreciation | Depreciation Leasehold Improvements and Other Depreciable Assets Depreciation is computed on the straight-line method over the estimated useful life of the related assets or, in the case of leasehold improvements, over the shorter of the useful life or the lease term. Furniture, fixtures, computers and related hardware have estimated useful lives ranging from five to eight years at the time of purchase. |
Resecuritization and Senior Notes Related Costs | Resecuritization and Other Debt Issuance Costs Resecuritization related costs are costs associated with the issuance of beneficial interests by consolidated VIEs and incurred by the Company in connection with various resecuritization transactions completed by the Company. Other debt issuance and related costs include costs incurred by the Company in connection with issuing Senior Notes and certain other repurchase agreement financings. These costs may include underwriting, rating agency, legal, accounting and other fees. Such costs, which reflect deferred charges, are included on the Company’s consolidated balance sheets as a direct deduction from the corresponding debt liability. These deferred charges are amortized as an adjustment to interest expense using the effective interest method. For resecuritization financings, amortization is based upon the actual repayments of the associated beneficial interests issued to third parties. For Senior Notes and other repurchase agreement financings, such costs are amortized over the shorter of the period to the expected or stated legal maturity of the debt instruments. The Company periodically reviews the recoverability of these deferred costs and in the event an impairment charge is required, such amount will be included in Operating and Other Expense on the Company’s consolidated statements of operations. |
Repurchase Agreements and Other Advances | Repurchase Agreements and Other Advances Repurchase Agreements The Company finances the holdings of a significant portion of its residential mortgage assets with repurchase agreements. Under repurchase agreements, the Company sells securities to a lender and agrees to repurchase the same securities in the future for a price that is higher than the original sale price. The difference between the sale price that the Company receives and the repurchase price that the Company pays represents interest paid to the lender. Although legally structured as sale and repurchase transactions, the Company accounts for repurchase agreements as secured borrowings. Under its repurchase agreements, the Company pledges its securities as collateral to secure the borrowing, which is equal in value to a specified percentage of the fair value of the pledged collateral, while the Company retains beneficial ownership of the pledged collateral. At the maturity of a repurchase financing, unless the repurchase financing is renewed with the same counterparty, the Company is required to repay the loan, including any accrued interest and concurrently receives back its pledged collateral from the lender. With the consent of the lender, the Company may renew a repurchase financing at the then prevailing financing terms. Margin calls, whereby a lender requires that the Company pledge additional securities or cash as collateral to secure borrowings under its repurchase financing with such lender, are routinely experienced by the Company when the value of the MBS pledged as collateral declines as a result of principal amortization and prepayments or due to changes in market interest rates, spreads or other market conditions. The Company also may make margin calls on counterparties when collateral values increase. The Company’s repurchase financings typically have terms ranging from one month to six months at inception, but may also have longer or shorter terms. Should a counterparty decide not to renew a repurchase financing at maturity, the Company must either refinance elsewhere or be in a position to satisfy the obligation. If, during the term of a repurchase financing, a lender should default on its obligation, the Company might experience difficulty recovering its pledged assets which could result in an unsecured claim against the lender for the difference between the amount loaned to the Company plus interest due to the counterparty and the fair value of the collateral pledged by the Company to such lender, including accrued interest receivable or such collateral. (See Notes 6, 7 and 15) In addition to the repurchase agreement financing arrangements discussed above, as part of its financing strategy for Non-Agency MBS, the Company has entered into contemporaneous repurchase and reverse repurchase agreements with a single counterparty. Under a typical reverse repurchase agreement, the Company buys securities from a borrower for cash and agrees to sell the same securities in the future for a price that is higher than the original purchase price. The difference between the purchase price the Company originally paid and the sale price represents interest received from the borrower. In contrast, the contemporaneous repurchase and reverse repurchase transactions effectively resulted in the Company pledging Non-Agency MBS as collateral to the counterparty in connection with the repurchase agreement financing and obtaining U.S. Treasury securities as collateral from the same counterparty in connection with the reverse repurchase agreement. No net cash was exchanged between the Company and counterparty at the inception of the transactions. Securities obtained and pledged as collateral are recorded as an asset on the Company’s consolidated balance sheets. Interest income is recorded on the reverse repurchase agreement and interest expense is recorded on the repurchase agreement on an accrual basis. Both the Company and the counterparty have the right to make daily margin calls based on changes in the value of the collateral obtained and/or pledged. The Company’s liability to the counterparty in connection with this financing arrangement is recorded on the Company’s consolidated balance sheets and disclosed as “Obligation to return securities obtained as collateral, at fair value.” (See Note 2(c)) |
Federal Home Loan Bank (“FHLB”) Advances | Federal Home Loan Bank (“FHLB”) Advances FHLB advances are secured financing transactions and are carried at their contractual amounts. The ability to borrow from the FHLB is subject to the Company’s continued creditworthiness, pledging of sufficient eligible collateral to secure advances, and compliance with certain agreements with the FHLB. The amount of collateral pledged to the FHLB to secure advances is subject to periodic adjustment based on changes in the fair value of the collateral. Accrued interest payable on FHLB advances is included in Other liabilities on the Company’s consolidated balance sheets. (See Notes 6, 7 and 15) In addition, as a condition to membership in the FHLB, the Company’s wholly-owned subsidiary, MFA Insurance, Inc. (“MFA Insurance”) is required to purchase and hold a certain amount of FHLB stock, which is based, in part, upon the outstanding principal balance of advances from the FHLB. FHLB stock is considered a non-marketable investment, is carried at cost and is subject to recoverability testing under applicable accounting standards. This stock can only be redeemed or sold at its par value, and only to the FHLB. Accordingly, when evaluating FHLB stock for impairment, the Company considers the ultimate recoverability of the par value rather than recognizing temporary declines in value. FHLB stock is included in Other assets on the Company’s consolidated balance sheets. |
Equity-Based Compensation | Equity-Based Compensation Compensation expense for equity-based awards that are subject to vesting conditions, is recognized ratably over the vesting period of such awards, based upon the fair value of such awards at the grant date. With respect to awards granted in 2009 and prior years, the Company applied a zero forfeiture rate for these awards, as they were granted to a limited number of employees, and historical forfeitures have been minimal. Forfeitures, or an indication that forfeitures are expected to occur, may result in a revised forfeiture rate and would be accounted for prospectively as a change in estimate. From 2011 through 2013, the Company granted certain restricted stock units (“RSUs”) that vested annually over a one or three-year period, provided that certain criteria were met, which were based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. Starting in January 2014, the Company has made annual grants of RSUs certain of which cliff vest after a three-year period and others of which cliff vest after a three-year period, subject to the achievement of certain performance criteria based on a formula tied to the Company’s achievement of average total stockholder return during that three-year period. The features in these awards related to the attainment of total stockholder return over a specified period constitute a “market condition” which impacts the amount of compensation expense recognized for these awards. Specifically, the uncertainty regarding the achievement of the market condition was reflected in the grant date fair valuation of the RSUs, which in addition to estimates regarding the amount of RSUs expected to be forfeited during the associated service period, determined the amount of compensation expense recognized. The amount of compensation expense recognized was not dependent on whether the market condition was or will be achieved, while differences in actual forfeiture experience relative to estimated forfeitures results in adjustments to the timing and amount of compensation expense recognized. The Company has awarded dividend equivalents that may be granted as a separate instrument or may be a right associated with the grant of another equity-based award. Compensation expense for separately awarded dividend equivalents is based on the grant date fair value of such awards and is recognized over the vesting period. Payments pursuant to these dividend equivalents are charged to Stockholders’ Equity. Payments pursuant to dividend equivalents that are attached to equity-based awards are charged to Stockholders’ Equity to the extent that the attached equity awards are expected to vest. Compensation expense is recognized for payments made for dividend equivalents to the extent that the attached equity awards do not or are not expected to vest and grantees are not required to return payments of dividends or dividend equivalents to the Company. (See Notes 2(m) and 14) |
Earnings per Common Share ("EPS") | Earnings per Common Share (“EPS”) Basic EPS is computed using the two-class method, which includes the weighted-average number of shares of common stock outstanding during the period and other securities that participate in dividends, such as the Company’s unvested restricted stock and RSUs that have non-forfeitable rights to dividends and dividend equivalents attached to/associated with RSUs and vested stock options to arrive at total common equivalent shares. In applying the two-class method, earnings are allocated to both shares of common stock and securities that participate in dividends based on their respective weighted-average shares outstanding for the period. For the diluted EPS calculation, common equivalent shares are further adjusted for the effect of dilutive unexercised stock options and RSUs outstanding that are unvested and have dividends that are subject to forfeiture using the treasury stock method. Under the treasury stock method, common equivalent shares are calculated assuming that all dilutive common stock equivalents are exercised and the proceeds, along with future compensation expenses associated with such instruments, are used to repurchase shares of the Company’s outstanding common stock at the average market price during the reported period. (See Note 13) |
Comprehensive Income/(Loss) | Comprehensive Income/(Loss) The Company’s comprehensive income/(loss) available to common stock and participating securities includes net income, the change in net unrealized gains/(losses) on its AFS securities and derivative hedging instruments, (to the extent that such changes are not recorded in earnings), adjusted by realized net gains/(losses) reclassified out of AOCI for sold AFS securities and de-designated derivative hedging instruments and is reduced by dividends declared on the Company’s preferred stock and issuance costs of redeemed preferred stock. |
U.S. Federal Income Taxes | U.S. Federal Income Taxes The Company has elected to be taxed as a REIT under the provisions of the Internal Revenue Code of 1986, as amended, (the “Code”) and the corresponding provisions of state law. The Company expects to operate in a manner that will enable it to satisfy the various requirements to maintain its status as a REIT for federal income tax purposes. In order to maintain its status as a REIT, the Company must, among other things, distribute at least 90% of its REIT taxable income (excluding net long-term capital gains) to stockholders in the timeframe permitted by the Code. As long as the Company maintains its status as a REIT, the Company will not be subject to regular federal income tax to the extent that it distributes 100% of its REIT taxable income (including net long-term capital gains) to its stockholders within the permitted timeframe. Should this not occur, the Company would be subject to federal taxes at prevailing corporate tax rates on the difference between its REIT taxable income and the amounts deemed to be distributed for that tax year. As the Company’s objective is to distribute 100% of its REIT taxable income to its stockholders within the permitted timeframe, no provision for current or deferred income taxes has been made in the accompanying consolidated financial statements. Should the Company incur a liability for corporate income tax, such amounts would be recorded as REIT income tax expense on the Company’s consolidated statements of operations. Furthermore, if the Company fails to distribute during each calendar year, or by the end of January following the calendar year in the case of distributions with declaration and record dates falling in the last three months of the calendar year, at least the sum of (i) 85% of its REIT ordinary income for such year, (ii) 95% of its REIT capital gain income for such year, and (iii) any undistributed taxable income from prior periods, the Company would be subject to a 4% nondeductible excise tax on the excess of the required distribution over the amounts actually distributed. To the extent that the Company incurs interest, penalties or related excise taxes in connection with its tax obligations, including as a result of its assessment of uncertain tax positions, such amounts will be included in Operating and Other Expense on the Company’s consolidated statements of operations. In addition, the Company has elected to treat certain of its subsidiaries as a TRS. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. Generally, a TRS is subject to U.S. federal, state and local corporate income taxes. Since a portion of the Company’s business may be conducted through one or more TRS, its income earned by TRS may be subject to corporate income taxation. To maintain the Company’s REIT election, no more than 25% (or, for 2018 and subsequent taxable years, 20%) of the value of a REIT’s assets at the end of each calendar quarter may consist of stock or securities in TRS. For purposes of the determination of U. S. federal and state income taxes, the Company’s subsidiaries that elected to be treated as a TRS record current or deferred income taxes based on differences (both permanent and timing) between the determination of their taxable income and net income under GAAP. No deferred tax benefit was recorded by the Company in 2016 or 2015, as a valuation allowance for the full amount of the associated deferred tax asset was recognized as its recovery is not considered more likely than not. Based on its analysis of any potential uncertain tax positions, the Company concluded that it does not have any material uncertain tax positions that meet the relevant recognition or measurement criteria as of December 31, 2016, 2015 or 2014. The Company filed its 2015 tax return prior to September 15, 2016. The Company’s tax returns for tax years 2011 and 2013 through 2015 are open to examination. |
Derivative Financial Instruments | Derivative Financial Instruments The Company may use a variety of derivative instruments to economically hedge a portion of its exposure to market risks, including interest rate risk and prepayment risk. The objective of the Company’s risk management strategy is to reduce fluctuations in net book value over a range of interest rate scenarios. In particular, the Company attempts to mitigate the risk of the cost of its variable rate liabilities increasing during a period of rising interest rates. The Company’s derivative instruments are currently comprised of Swaps, which are designated as cash flow hedges against the interest rate risk associated with its borrowings. Prior to 2015, the Company’s derivative financial instruments also included Linked Transactions, which were not designated as hedging instruments. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting. (See Note 5(b)) Swaps The Company documents its risk-management policies, including objectives and strategies, as they relate to its hedging activities and the relationship between the hedging instrument and the hedged liability for all Swaps designated as hedging transactions. The Company assesses, both at inception of a hedge and on a quarterly basis thereafter, whether or not the hedge is “highly effective.” Swaps are carried on the Company’s consolidated balance sheets at fair value, in Other assets, if their fair value is positive, or in Other liabilities, if their fair value is negative. Changes in the fair value of the Company’s Swaps designated in hedging transactions are recorded in OCI provided that the hedge remains effective. Changes in fair value for any ineffective amount of a Swap are recognized in earnings. The Company has not recognized any change in the value of its existing Swaps designated as hedges through earnings as a result of hedge ineffectiveness. The Company discontinues hedge accounting on a prospective basis and recognizes changes in fair value through earnings when: (i) it is determined that the derivative is no longer effective in offsetting cash flows of a hedged item (including forecasted transactions); (ii) it is no longer probable that the forecasted transaction will occur; or (iii) it is determined that designating the derivative as a hedge is no longer appropriate. Although permitted under certain circumstances, the Company does not offset cash collateral receivables or payables against its net derivative positions. (See Notes 5(b), 7 and 15) Linked Transactions Prior to 2015, it was presumed that the initial transfer of a financial asset (i.e., the purchase of an MBS by the Company) and contemporaneous repurchase financing of such security with the same counterparty were considered part of the same arrangement, or a “linked transaction,” unless certain criteria were met. The two components of a linked transaction (security purchase and repurchase financing) were not reported separately but were evaluated on a combined basis and reported as a forward (derivative) contract and were presented as “Linked Transactions” on the Company’s consolidated balance sheets. Changes in the fair value of the assets and liabilities underlying Linked Transactions and associated interest income and expense were reported as “Unrealized net gains/(losses) and net interest income from Linked Transactions” on the Company’s consolidated statements of operations and were not included in OCI. However, if certain criteria were met, the initial transfer (i.e., the purchase of a security by the Company) and repurchase financing were not treated as a Linked Transaction and would have been evaluated and reported separately as an MBS purchase and MBS repurchase financing. When or if a transaction was no longer considered to be linked, the security and repurchase financing were reported on a gross basis. In this case, the fair value of the MBS at the time the transactions were no longer considered linked became the cost basis of the MBS, and the income recognition yield for such MBS was calculated prospectively using this new cost basis. New accounting guidance that was effective for the Company on January 1, 2015 prospectively eliminated the use of Linked Transaction accounting as described above. This resulted in changes subsequent to January 1, 2015 to the presentation of assets and liabilities, and revenues and expenses of Non-Agency MBS and associated repurchase agreements that had been accounted for as Linked Transactions prior to that date. The changes include the presentation of Non-Agency MBS and associated repurchase agreements as separate assets and liabilities, rather than on a combined basis on the Company’s consolidated balance sheets. In addition, starting in 2015, interest income related to the securities and interest expense related to the associated repurchase agreements are separately presented and included in the determination of the Company’s net interest income on its consolidated statement of operations. Further, the previous treatment of Linked Transactions as forward (derivative) instruments recorded at fair value at the end of each period, with changes in fair value included in net income, was discontinued and effective January 1, 2015, MBS that were previously accounted for as components of Linked Transactions are accounted for on a consistent basis with other MBS held by the Company as AFS securities. (See Note 5(b)) |
Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities | Fair Value Measurements and the Fair Value Option for Financial Assets and Financial Liabilities The Company’s presentation of fair value for its financial assets and liabilities is determined within a framework that stipulates that the fair value of a financial asset or liability is an exchange price in an orderly transaction between market participants to sell the asset or transfer the liability in the market in which the reporting entity would transact for the asset or liability, that is, the principal or most advantageous market for the asset or liability. The transaction to sell the asset or transfer the liability is a hypothetical transaction at the measurement date, considered from the perspective of a market participant that holds the asset or owes the liability. This definition of fair value focuses on exit price and prioritizes the use of market-based inputs over entity-specific inputs when determining fair value. In addition, the framework for measuring fair value establishes a three-level hierarchy for fair value measurements based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. In addition to the financial instruments that it is required to report at fair value, the Company has elected the fair value option for certain of its residential whole loans and CRT securities at time of acquisition. Subsequent changes in the fair value of these loans and CRT securities are reported in Net gain on residential whole loans held at fair value and Other income, net respectively on the Company’s consolidated statements of operations. A decision to elect the fair value option for an eligible financial instrument, which may be made on an instrument by instrument basis, is irrevocable. (See Notes 2(d), 4 and 15) |
Variable Interest Entities | Variable Interest Entities An entity is referred to as a VIE if it meets at least one of the following criteria: (i) the entity has equity that is insufficient to permit the entity to finance its activities without additional subordinated financial support of other parties; or (ii) as a group, the holders of the equity investment at risk lack (a) the power to direct the activities of an entity that most significantly impact the entity’s economic performance; (b) the obligation to absorb the expected losses; or (c) the right to receive the expected residual returns; or (iii) have disproportional voting rights and the entity’s activities are conducted on behalf of the investor that has disproportionately few voting rights. The Company consolidates a VIE when it has both the power to direct the activities that most significantly impact the economic performance of the VIE and a right to receive benefits or absorb losses of the entity that could be potentially significant to the VIE. The Company is required to reconsider its evaluation of whether to consolidate a VIE each reporting period, based upon changes in the facts and circumstances pertaining to the VIE. The Company has in prior years entered into several resecuritization transactions which resulted in the Company consolidating the VIEs that were created to facilitate the transactions and to which the underlying assets in connection with the resecuritizations were transferred. In determining the accounting treatment to be applied to these resecuritization transactions, the Company concluded that the entities used to facilitate these transactions were VIEs and that they should be consolidated. If the Company had determined that consolidation was not required, it would have then assessed whether the transfer of the underlying assets would qualify as a sale or should be accounted for as secured financings under GAAP. Prior to the completion of its initial resecuritization transaction in October 2010, the Company had not transferred assets to VIEs or Qualifying Special Purpose Entities (“QSPEs”) and other than acquiring MBS issued by such entities, had no other involvement with VIEs or QSPEs. (See Note 16) The Company also includes on its consolidated balance sheets certain financial assets and liabilities that are acquired/issued by trusts and /or other special purpose entities that have been evaluated as being required to be consolidated by the Company under the applicable accounting guidance. |
Offering Costs Related to Issuance and Redemption of Preferred Stock | Offering Costs Related to Issuance and Redemption of Preferred Stock Offering costs related to issuance of preferred stock are recorded as a reduction in Additional paid-in capital, a component of Stockholders’ Equity, at the time such preferred stock is issued. On redemption of preferred stock, any excess of the fair value of the consideration transferred to the holders of the preferred stock over the carrying amount of the preferred stock in the Company’s consolidated balance sheets is included in the determination of Net Income Available to Common Stock and Participating Securities in the calculation of EPS. |
New Accounting Standards and Interpretations | New Accounting Standards and Interpretations Accounting Standards Adopted in 2016 Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-03, Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with the presentation of debt issued at a discount. The recognition and measurement guidance of debt issuance costs are not affected by the amendments in this ASU. ASU 2015-03 requires retrospective application and was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. While the Company’s adoption of ASU 2015-03 beginning on January 1, 2016, did not have a material impact on the Company’s financial position, it did result in changes, subsequent to adoption, to the presentation of assets and liabilities prior to that date. On adoption of the new standard on January 1, 2016, the Company reclassified debt issuance costs of $3.3 million related to Senior Notes, $1.3 million related to repurchase agreements and $189,000 related to its Securitized debt from Other assets and presented them as a reduction in the corresponding liability on its consolidated balance sheet. Consolidation - Amendments to the Consolidation Analysis In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis (“ASU 2015-02”). The amendments in this ASU change the way reporting enterprises evaluate whether (a) they should consolidate limited partnerships and similar entities, (b) fees paid to a decision maker or service provider are variable interests in a VIE, and (c) variable interests in a VIE held by related parties of the reporting enterprise require the reporting enterprise to consolidate the VIE. It also eliminates the VIE consolidation model based on majority exposure to variability that applied to certain investment companies and similar entities. At the effective date, all previous consolidation analyses that the guidance affects must be reconsidered. ASU 2015-02 was effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. The Company’s adoption of ASU 2015-02 on January 1, 2016 did not have an impact on the Company’s consolidated financial statements. Presentation of Financial Statements - Going Concern In August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). The amendments in this ASU provide guidance in GAAP about management’s responsibility to evaluate whether there is a substantial doubt about an entity’s going concern and to provide related footnote disclosures. In connection with preparing financial statements for each annual and interim reporting period, an entity’s management should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). ASU 2014-15 was effective for the Company for the annual period ending after December 15, 2016, and for annual and interim periods thereafter. The adoption of ASU 2014-15 did not have any impact on the Company’s financial position or financial statement disclosures. |
MBS and CRT Securities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about MBS and CRT Securities | The following tables present certain information about the Company’s MBS and CRT securities at December 31, 2016 and 2015: December 31, 2016
December 31, 2015
(1) Discount designated as Credit Reserve and amounts related to OTTI are generally not expected to be accreted into interest income. Amounts disclosed at December 31, 2016 reflect Credit Reserve of $675.6 million and OTTI of $18.6 million. Amounts disclosed at December 31, 2015 reflect Credit Reserve of $766.0 million and OTTI of $21.5 million. (2) Includes principal payments receivable of $2.6 million and $1.0 million at December 31, 2016 and 2015, respectively, which are not included in the Principal/Current Face. (3) Based on management’s current estimates of future principal cash flows expected to be received. (4) At December 31, 2016, 3 Year Step-up securities had a $2.7 billion Principal/Current face, $2.7 billion amortized cost and $2.7 billion fair value. At December 31, 2015, 3 Year Step-up securities had a $2.6 billion Principal/Current face, $2.6 billion amortized cost and $2.6 billion fair value. (5) At December 31, 2016 and 2015, the Company expected to recover approximately 89% and 89%, respectively, of the then-current face amount of Non-Agency MBS. (6) Amounts disclosed at December 31, 2016 includes CRT securities with a fair value of $271.2 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $12.7 million and net unrealized losses of approximately $3,000 at December 31, 2016. Amounts disclosed at December 31, 2015 includes CRT securities with a fair value of $62.2 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $332,000, gross unrealized losses of approximately $555,000 and net unrealized losses of approximately $223,000 at December 31, 2015. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about MBS and CRT Securities that were in an unrealized loss position | The following table presents information about the Company’s MBS and CRT securities that were in an unrealized loss position at December 31, 2016:
(1) Based on management’s current estimates of future principal cash flows expected to be received. (2) Amounts disclosed at December 31, 2016 includes CRT securities with a fair value of $2.5 million for which the fair value option has been elected. Such securities have unrealized losses of $3,000 at December 31, 2016. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of composition of OTTI charges recorded | The following table presents the composition of OTTI charges recorded by the Company for the years ended December 31, 2016, 2015 and 2014:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in credit loss component of OTTI | The following table presents a roll-forward of the credit loss component of OTTI on the Company’s Non-Agency MBS for which a non-credit component of OTTI was previously recognized in OCI. Changes in the credit loss component of OTTI are presented based upon whether the current period is the first time OTTI was recorded on a security or a subsequent OTTI charge was recorded.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in the components of the purchase discount on Non-Agency MBS | The following table presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and OTTI and accretable purchase discount for the years ended December 31, 2016 and 2015:
(1) Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of impact of Available-for-Sale Securities on AOCI | The following table presents the impact of the Company’s AFS securities on its AOCI for the years ended December 31, 2016, 2015, and 2014:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of interest income on MBS and CRT Securities | The following table presents components of interest income on the Company’s MBS and CRT securities for the years ended December 31, 2016, 2015 and 2014:
(1) Includes amortization of premium paid net of accretion of purchase discount. For Agency MBS and 3 Year Step-up securities, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity. (2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield. |
Residential Whole Loans (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Residential Whole Loans [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Residential Whole Loan Pools at Carrying Value Allowance for Loan Losses Activity | The following table presents the activity in the Company’s allowance for loan losses on its residential whole loan pools at carrying value for the years ended December 31, 2016, 2015 and 2014:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Residential Whole Loans at Carrying Value Acquired During Period | The following table presents information regarding estimates of the contractually required payments, the cash flows expected to be collected, and the estimated fair value of the residential whole loans held at carrying value acquired by the Company for the years ended December 31, 2016, 2015 and 2014:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Residential Whole Loans at Carrying Value Accretable Yield Activity | The following table presents accretable yield activity for the Company’s residential whole loans held at carrying value for the years ended December 31, 2016 and 2015:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Residential Whole Loans, Fair Value | The following table presents information regarding the Company’s residential whole loans held at fair value at December 31, 2016 and 2015:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Residential Whole Loans, Fair Vale, Components of Net Income | The following table presents the components of Net gain on residential whole loans held at fair value for the years ended December 31, 2016, 2015 and 2014:
|
Other Assets (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Assets [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of other assets | The following table presents the components of the Company’s Other assets at December 31, 2016 and 2015:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of activity for real estate owned | The following table presents the activity in the Company’s REO for the years ended December 31, 2016 and 2015:
(1) Includes net gain recorded on transfer of approximately $2.9 million and $1.7 million, respectively, for the years ended December 31, 2016 and 2015. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of derivative instruments and balance sheet location | The following table presents the fair value of the Company’s derivative instruments and their balance sheet location at December 31, 2016 and 2015:
(1) Non-cleared legacy Swaps include Swaps executed and settled bilaterally with counterparties without the use of an organized exchange or central clearing house. (2) Cleared Swaps include Swaps executed bilaterally with a counterparty in the over-the-counter market but then novated to a central clearing house, whereby the central clearing house becomes the counterparty to both of the original counterparties. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of assets pledged as collateral against derivative contracts | The following table presents the assets pledged as collateral against the Company’s Swap contracts at December 31, 2016 and 2015:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about swap activity | The following table presents certain information with respect to the Company’s Swap activity during the year ended December 31, 2016:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about swaps | The following table presents information about the Company’s Swaps at December 31, 2016 and 2015:
(1) Each maturity category reflects contractual amortization and/or maturity of notional amounts. (2) Reflects the benchmark variable rate due from the counterparty at the date presented, which rate adjusts monthly or quarterly based on one-month or three-month LIBOR, respectively. (3) At December 31, 2016, reflects one Swap with a maturity date of July 2023. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of interest expense and the weighted average interest rate paid and received on swaps | The following table presents the net impact of the Company’s derivative hedging instruments on its interest expense and the weighted average interest rate paid and received for such Swaps for the years ended December 31, 2016, 2015 and 2014:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of impact of hedging instruments on AOCI | The following table presents the impact of the Company’s derivative hedging instruments on its AOCI for the years ended December 31, 2016, 2015 and 2014:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about the components of the unrealized net gains/(losses) and net interest income from Linked Transactions | The following table presents certain information about the components of the unrealized net gains and net interest income from Linked Transactions included in the Company’s consolidated statements of operations for the year ended December 31, 2014:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of company's interest receivable by investment category | The following table presents the Company’s interest receivable by investment category at December 31, 2016 and 2015:
|
Repurchase Agreements and Other Advances (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase Agreements | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Company's borrowings under repurchase agreements and associated assets pledged as collateral | The following table presents information with respect to the Company’s borrowings under repurchase agreements and associated assets pledged as collateral at December 31, 2016 and 2015:
(1) Haircut represents the percentage amount by which the collateral value is contractually required to exceed the loan amount (2) Includes $172.4 million and $570.5 million of Legacy Non-Agency MBS acquired from consolidated VIEs at December 31, 2016 and 2015, respectively, that are eliminated from the Company’s consolidated balance sheets. (3) Excludes $210,000 and $1.3 million of unamortized debt issuance costs at December 31, 2016 and 2015, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of repricing information about borrowings under repurchase agreements | The following table presents repricing information about the Company’s borrowings under repurchase agreements, which does not reflect the impact of associated derivative hedging instruments, at December 31, 2016 and 2015:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of contractual maturity information about repurchase agreements | The following table presents contractual maturity information about the Company’s borrowings under repurchase agreements, all of which are accounted for as secured borrowings, at December 31, 2016 and does not reflect the impact of derivative contracts that hedge such repurchase agreements:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about counterparty for repurchase agreements for which the entity had greater than 5% of stockholders' equity at risk | The following table presents information with respect to each counterparty under repurchase agreements for which the Company had greater than 5% of stockholders’ equity at risk in the aggregate at December 31, 2016:
(1) As rated at December 31, 2016 by S&P, Moody’s and Fitch, Inc., respectively. The counterparty rating presented is the lowest published for these entities. (2) The amount at risk reflects the difference between (a) the amount loaned to the Company through repurchase agreements, including interest payable, and (b) the cash and the fair value of the securities pledged by the Company as collateral, including accrued interest receivable on such securities. (3) Includes $295.3 million at risk with Wells Fargo Bank, NA and $93.2 million at risk with Wells Fargo Securities LLC. (4) Includes $238.2 million at risk with RBC Barbados, $30.4 million at risk with Royal Bank of Canada and $5.7 million at risk with RBC Capital Markets LLC. Counterparty ratings are not published for RBC Barbados and RBC Capital Markets LLC. (5) Includes $141.8 million at risk with Credit Suisse AG, Cayman Islands and $49.8 million at risk with Credit Suisse. Counterparty ratings are not published for Credit Suisse AG, Cayman Islands. (6) Includes Non-Agency MBS pledged as collateral with contemporaneous repurchase and reverse repurchase agreements. |
Collateral Positions (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transfers and Servicing [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of fair value of collateral pledged and collateral held | The following table summarizes the fair value of the Company’s collateral positions, which includes collateral pledged and collateral held, with respect to its borrowings under repurchase agreements, reverse repurchase agreements, derivative hedging instruments and FHLB advances at December 31, 2016 and 2015:
(1) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets. (2) Includes $172.4 million and $570.5 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2016 and 2015, respectively, that are eliminated from the Company’s consolidated balance sheets. (3) In addition, at December 31, 2016 and 2015, $688.2 million and $726.7 million of Legacy Non-Agency MBS, respectively, are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of additional information about assets Pledged as collateral pursuant to borrowings under repurchase agreements and Derivative Hedging Contracts | The following table presents detailed information about the Company’s assets pledged as collateral pursuant to its borrowings under repurchase agreements and other advances, and derivative hedging instruments at December 31, 2016:
(1) Includes Agency MBS pledged under FHLB advances with an aggregate fair value of $227.2 million, aggregate amortized cost of $226.6 million and aggregate accrued interest of approximately $597,000 at December 31, 2016. (2) Includes $172.4 million of Legacy Non-Agency MBS acquired in connection with resecuritization transactions from consolidated VIEs at December 31, 2016, that are eliminated from the Company’s consolidated balance sheets. (3) In addition, at December 31, 2016, $688.2 million of Legacy Non-Agency MBS are pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty. (4) Includes residential whole loans held at carrying value with an aggregate fair value of $440.8 million and aggregate amortized cost of $427.9 million and residential whole loans held at fair value with an aggregate fair value and amortized cost of $732.4 million. (5) Cash pledged as collateral is reported as “Restricted cash” on the Company’s consolidated balance sheets. |
Offsetting Assets and Liabilities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about certain assets that are subject to master netting arrangements (or similar agreements) | The following tables present information about certain assets and liabilities that are subject to master netting arrangements (or similar agreements) and may potentially be offset on the Company’s consolidated balance sheets at December 31, 2016 and 2015: Offsetting of Financial Assets and Derivative Assets
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of information about certain liabilities that are subject to master netting arrangements (or similar agreements) | Offsetting of Financial Liabilities and Derivative Liabilities
(1) Amounts disclosed in the Financial Instruments column of the table above represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements and other advances, and derivative transactions. Amounts disclosed in the Cash Collateral Pledged column of the table above represent amounts pledged as collateral against derivative transactions and repurchase agreements, and exclude excess collateral of $6.9 million and $47,000 at December 31, 2016 and 2015, respectively. (2) The fair value of securities pledged against the Company’s Swaps was $32.5 million and $38.6 million at December 31, 2016 and 2015, respectively. (3) The fair value of financial instruments pledged against the Company’s repurchase agreements and other advances was $10.5 billion and $11.3 billion at December 31, 2016 and 2015, respectively. (4) Excludes $210,000 and $1.3 million of unamortized debt issuance costs at December 31, 2016 and 2015, respectively. |
Other Liabilities (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Liabilities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Liabilities | The following table presents the components of the Company’s Other liabilities at December 31, 2016 and 2015:
|
Commitments and Contingencies (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of contractual minimum rental payments | At December 31, 2016, the contractual minimum rental payments (exclusive of possible rent escalation charges and normal recurring charges for maintenance, insurance and taxes) were as follows:
|
Stockholders' Equity (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of cash dividends declared on Series B preferred stock | The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2014 through December 31, 2016:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of cash dividends declared on common stock | The following table presents cash dividends declared by the Company on its common stock from January 1, 2014 through December 31, 2016:
(1) At December 31, 2016, the Company had accrued dividends and dividend equivalents payable of $74.7 million related to the common stock dividend declared on December 14, 2016. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in balances in each component of the entity's AOCI | The following table presents changes in the balances of each component of the Company’s AOCI for the years ended December 31, 2016, 2015 and 2014:
(1) See separate table below for details about these reclassifications. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss). |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Information about the significant amounts reclassified out of the entity's AOCI | The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the years ended December 31, 2016, 2015, and 2014:
|
EPS Calculation (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of reconciliation of the earnings and shares used in calculating basic and diluted EPS | The following table presents a reconciliation of the earnings and shares used in calculating basic and diluted EPS for the years ended December 31, 2016, 2015 and 2014:
(1) At December 31, 2016, the Company had an aggregate of 2.0 million equity instruments outstanding that were not included in the calculation of diluted EPS for the year ended December 31, 2016, as their inclusion would have been anti-dilutive. These equity instruments were comprised of approximately 29,000 shares of restricted common stock with a weighted average grant date fair value of $7.12 and approximately $2.0 million RSUs with a weighted average grant date fair value of $6.85. These equity instruments may have a dilutive impact on future EPS. |
Equity Compensation, Employment Agreements and Other Benefit Plans (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation Related Costs [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of dividend equivalent rights activity | The following table presents information about the Company’s dividend equivalents rights awarded as separate instruments at and for each of the years ended December 31, 2016, 2015 and 2014:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of stock options activity | The following table presents information about the Company’s Options at and for the year ended December 31, 2014:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of restricted stock activity | The following table presents information with respect to the Company’s restricted stock for the years ended December 31, 2016, 2015 and 2014:
(1) The grant date fair value of restricted stock awards is based on the closing market price of the Company’s common stock at the grant date. (2) All restrictions associated with restricted stock are removed on vesting. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of restricted stock units activity | The following table presents information with respect to the Company’s RSUs during the years ended December 31, 2016, 2015 and 2014:
(1) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 615,000 of these awards granted in 2016, the Company applied: (i) a weighted average volatility estimate of approximately 17%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 1.20% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 11%. The weighted average grant date fair value for the remaining 113,195 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date of $7.20. There are no post vesting conditions on these awards. (2) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 582,500 of these awards granted in 2015, the Company applied: (i) a weighted average volatility estimate of approximately 18%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.90% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 9%. The weighted average grant date fair value for the remaining 99,554 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.93 to $7.97. There are no post vesting conditions on these awards. (3) The weighted average grant date fair value of these awards require the Company to estimate certain valuation inputs. In determining the fair value for 547,600 of these awards granted in 2014, the Company applied: (i) a weighted average volatility estimate of approximately 22%, which was determined considering historic volatility in the price of Company’s common stock over the three-year period prior to the grant date and the implied volatility of certain exchange-traded options on the Company’s common stock at the grant date; (ii) a weighted average risk-free rate of 0.73% based on the continuously compounded constant maturity treasury rate corresponding to a maturity commensurate with the expected vesting term of the awards; and (iii) an estimated annual dividend yield of 8%. The weighted average grant date fair value for the remaining 83,215 awards with a service condition only was estimated based on the closing price of the Company’s common stock at the grant date ranging from $7.19 to $8.16. There are no post vesting conditions on these awards. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of expenses related to equity-based compensation | The following table presents the Company’s expenses related to its equity-based compensation instruments for the years ended December 31, 2016, 2015 and 2014:
(1) RSU expense for the year ended December 31, 2014 includes approximately $500,000 for a one-time grant to the Company’s chief executive officer. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of expenses related to deferred compensation plans | The following table presents the Company’s expenses related to its Deferred Plans for its non-employee directors and senior officers for the years ended December 31, 2016, 2015 and 2014:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of aggregate income deferred by participants and associated liability under deferred compensation plans | The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through December 31, 2016 and 2015 that had not been distributed and the Company’s associated liability for such deferrals at December 31, 2016 and 2015:
(1) Represents the cumulative amounts that were deferred by participants through December 31, 2016 and 2015, which had not been distributed through such respective date. |
Fair Value of Financial Instruments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of financial instruments carried at fair value by valuation hierarchy | The following tables present the Company’s financial instruments carried at fair value on a recurring basis as of December 31, 2016 and 2015, on the consolidated balance sheets by the valuation hierarchy, as previously described: Fair Value at December 31, 2016
Fair Value at December 31, 2015
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of significant unobservable inputs used in fair value measurement of residential whole loans | The following table presents additional information for the years ended December 31, 2016 and 2015 about the Company’s residential whole loans, at fair value, which are classified as Level 3 and measured at fair value on a recurring basis:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of quantitative information about significant unobservable inputs | The following tables present a summary of quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s residential whole loans held at fair value for which it has utilized Level 3 inputs to determine fair value as of December 31, 2016 and 2015:
(1) Excludes approximately $45.4 million and $117.6 million of loans for which management considers the purchase price continues to reflect the fair value of such loans at December 31, 2016 and 2015, respectively. (2) Amounts are weighted based on the fair value of the underlying loan. (3) The simple average value of the properties underlying residential whole loans held at fair value valued via a liquidation model was approximately $320,000 and $305,000 as of December 31, 2016 and 2015, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of residential whole loans, fair value and aggregate unpaid principal, fair value option elected | The following table presents the difference between the fair value and the aggregate unpaid principal balance of the Company’s residential whole loans for which the fair value option was elected at December 31, 2016 and 2015:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of carrying value and fair value of financial instruments | The following table presents the carrying values and estimated fair values of the Company’s financial instruments at December 31, 2016 and 2015:
(1) Carrying value of Senior Notes, Securitized debt and certain Repurchase agreements is net of associated debt issuance costs. |
Summary of Quarterly Results of Operations (Unaudited) (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quarterly Financial Information Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Quarterly Results of Operations (Unaudited) |
|
Summary of Significant Accounting Policies - Residential Whole Loans, Cash and Goodwill (Details) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2016
USD ($)
segment
|
Dec. 31, 2015
USD ($)
|
|
Accounting Policies [Abstract] | ||
Number of reportable segments | segment | 1 | |
Number of operating segments | segment | 1 | |
Number of days considered to classify loans delinquent (less than) | 60 days | |
LTV percentage (or less) | 80.00% | |
Overnight money market funds | $ 208,900 | $ 120,400 |
Restricted cash | 58,463 | 71,538 |
Goodwill | $ 7,189 | $ 7,189 |
Summary of Significant Accounting Policies - Depreciation (Details) - Furniture, fixtures, computers and related hardwares |
12 Months Ended |
---|---|
Dec. 31, 2016 | |
Low end of range | |
Estimated useful life of long-lived assets | |
Estimated useful life | 5 years |
High end of range | |
Estimated useful life of long-lived assets | |
Estimated useful life | 8 years |
Summary of Significant Accounting Policies - Repurchase Agreements (Details) |
12 Months Ended |
---|---|
Dec. 31, 2016 | |
Accounting Policies [Abstract] | |
Repurchase financing period, low end of range | 1 month |
Repurchase financing period, high end of range | 6 months |
Summary of Significant Accounting Policies - Equity-Based Compensation, Taxes, Derivatives (Details) |
12 Months Ended | 36 Months Ended | |
---|---|---|---|
Dec. 31, 2016
USD ($)
component
|
Dec. 31, 2014 |
Dec. 31, 2013 |
|
Share based compensation | |||
Forfeiture rate assumption for equity based awards granted in 2009 and prior years (as a percent) | 0.00% | ||
Income Tax Disclosure | |||
Percentage of annual REIT taxable income intended to be distributed to stockholders | 100.00% | ||
Income tax expense | $ | $ 0 | ||
Derivative Instruments | |||
Number of components of linked transactions | component | 2 | ||
Restricted Stock Units | |||
Share based compensation | |||
Vesting period of restricted share units (RSUs) | 3 years | 3 years | |
Restricted Stock Units | Minimum | |||
Share based compensation | |||
Vesting period of restricted share units (RSUs) | 1 year | ||
Restricted Stock Units | Maximum | |||
Share based compensation | |||
Vesting period of restricted share units (RSUs) | 3 years |
Summary of Significant Accounting Policies - New Accounting Standards and Interpretations (Details) - Accounting Standards Update 2015-03 $ in Thousands |
Dec. 31, 2016
USD ($)
|
---|---|
Senior Notes | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Debt issuance costs | $ 3,300 |
Repurchase Agreements | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Debt issuance costs | 1,300 |
Secured Debt | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Debt issuance costs | 189 |
Other Noncurrent Assets | Senior Notes | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Debt issuance costs | (3,300) |
Other Noncurrent Assets | Repurchase Agreements | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Debt issuance costs | (1,300) |
Other Noncurrent Assets | Secured Debt | |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
Debt issuance costs | $ (189) |
MBS and CRT Securities (Details) - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
|
Information about MBS and CRT securities | ||
Minimum term of fixed rate mortgages underlying MBS | 15 years | |
Principal/ Current Face | $ 10,172,893,000 | $ 11,703,896,000 |
Purchase Premiums | 138,551,000 | 172,160,000 |
Accretable Purchase Discounts | (283,799,000) | (317,930,000) |
Discount Designated as Credit Reserve and OTTI | (694,241,000) | (787,541,000) |
Amortized Cost | 9,336,008,000 | 10,771,616,000 |
Fair Value | 9,969,163,000 | 11,356,643,000 |
Gross Unrealized Gains | 669,553,000 | 656,956,000 |
Gross Unrealized Losses | (36,398,000) | (71,929,000) |
Net Unrealized Gain/(Loss) | 633,155,000 | 585,027,000 |
Principal payments receivable | 2,600,000 | 1,000,000 |
Agency MBS | ||
Information about MBS and CRT securities | ||
Principal/ Current Face | 3,581,302,000 | 4,550,403,000 |
Purchase Premiums | 135,182,000 | 172,087,000 |
Accretable Purchase Discounts | (51,000) | (59,000) |
Discount Designated as Credit Reserve and OTTI | 0 | 0 |
Amortized Cost | 3,719,037,000 | 4,723,462,000 |
Fair Value | 3,738,497,000 | 4,752,244,000 |
Gross Unrealized Gains | 50,653,000 | 69,207,000 |
Gross Unrealized Losses | (31,193,000) | (40,425,000) |
Net Unrealized Gain/(Loss) | 19,460,000 | 28,782,000 |
Agency MBS | Fannie Mae | ||
Information about MBS and CRT securities | ||
Principal/ Current Face | 2,879,807,000 | 3,690,020,000 |
Purchase Premiums | 108,310,000 | 139,243,000 |
Accretable Purchase Discounts | (51,000) | (59,000) |
Discount Designated as Credit Reserve and OTTI | 0 | 0 |
Amortized Cost | 2,988,066,000 | 3,829,204,000 |
Fair Value | 3,014,464,000 | 3,865,485,000 |
Gross Unrealized Gains | 45,706,000 | 62,111,000 |
Gross Unrealized Losses | (19,308,000) | (25,830,000) |
Net Unrealized Gain/(Loss) | 26,398,000 | 36,281,000 |
Agency MBS | Freddie Mac | ||
Information about MBS and CRT securities | ||
Principal/ Current Face | 693,945,000 | 851,087,000 |
Purchase Premiums | 26,736,000 | 32,680,000 |
Accretable Purchase Discounts | 0 | 0 |
Discount Designated as Credit Reserve and OTTI | 0 | 0 |
Amortized Cost | 723,285,000 | 884,798,000 |
Fair Value | 716,209,000 | 877,109,000 |
Gross Unrealized Gains | 4,809,000 | 6,906,000 |
Gross Unrealized Losses | (11,885,000) | (14,595,000) |
Net Unrealized Gain/(Loss) | (7,076,000) | (7,689,000) |
Agency MBS | Ginnie Mae | ||
Information about MBS and CRT securities | ||
Principal/ Current Face | 7,550,000 | 9,296,000 |
Purchase Premiums | 136,000 | 164,000 |
Accretable Purchase Discounts | 0 | 0 |
Discount Designated as Credit Reserve and OTTI | 0 | 0 |
Amortized Cost | 7,686,000 | 9,460,000 |
Fair Value | 7,824,000 | 9,650,000 |
Gross Unrealized Gains | 138,000 | 190,000 |
Gross Unrealized Losses | 0 | 0 |
Net Unrealized Gain/(Loss) | 138,000 | 190,000 |
Non-Agency MBS | ||
Information about MBS and CRT securities | ||
Principal/ Current Face | 6,206,598,000 | 6,961,493,000 |
Purchase Premiums | 57,000 | 73,000 |
Accretable Purchase Discounts | (278,191,000) | (312,182,000) |
Discount Designated as Credit Reserve and OTTI | (694,241,000) | (787,541,000) |
Amortized Cost | 5,234,223,000 | 5,861,843,000 |
Fair Value | 5,825,816,000 | 6,420,817,000 |
Gross Unrealized Gains | 596,795,000 | 587,331,000 |
Gross Unrealized Losses | (5,202,000) | (28,357,000) |
Net Unrealized Gain/(Loss) | 591,593,000 | 558,974,000 |
Credit Reserve | 675,600,000 | 766,000,000 |
OTTI | 18,600,000 | 21,500,000 |
Non-Agency MBS | Expected to Recover Par | ||
Information about MBS and CRT securities | ||
Principal/ Current Face | 2,847,398,000 | 2,906,878,000 |
Purchase Premiums | 57,000 | 73,000 |
Accretable Purchase Discounts | (24,273,000) | (31,576,000) |
Discount Designated as Credit Reserve and OTTI | 0 | 0 |
Amortized Cost | 2,823,182,000 | 2,875,375,000 |
Fair Value | 2,847,291,000 | 2,878,532,000 |
Gross Unrealized Gains | 26,477,000 | 23,300,000 |
Gross Unrealized Losses | (2,368,000) | (20,143,000) |
Net Unrealized Gain/(Loss) | 24,109,000 | 3,157,000 |
Non-Agency MBS | Expected to Recover Less Than Par | ||
Information about MBS and CRT securities | ||
Principal/ Current Face | 3,359,200,000 | 4,054,615,000 |
Purchase Premiums | 0 | 0 |
Accretable Purchase Discounts | (253,918,000) | (280,606,000) |
Discount Designated as Credit Reserve and OTTI | (694,241,000) | (787,541,000) |
Amortized Cost | 2,411,041,000 | 2,986,468,000 |
Fair Value | 2,978,525,000 | 3,542,285,000 |
Gross Unrealized Gains | 570,318,000 | 564,031,000 |
Gross Unrealized Losses | (2,834,000) | (8,214,000) |
Net Unrealized Gain/(Loss) | $ 567,484,000 | $ 555,817,000 |
Current face amount of non-Agency MBS expected to be recovered (percent) | 89.00% | 89.00% |
Total MBS | ||
Information about MBS and CRT securities | ||
Principal/ Current Face | $ 9,787,900,000 | $ 11,511,896,000 |
Purchase Premiums | 135,239,000 | 172,160,000 |
Accretable Purchase Discounts | (278,242,000) | (312,241,000) |
Discount Designated as Credit Reserve and OTTI | (694,241,000) | (787,541,000) |
Amortized Cost | 8,953,260,000 | 10,585,305,000 |
Fair Value | 9,564,313,000 | 11,173,061,000 |
Gross Unrealized Gains | 647,448,000 | 656,538,000 |
Gross Unrealized Losses | (36,395,000) | (68,782,000) |
Net Unrealized Gain/(Loss) | 611,053,000 | 587,756,000 |
CRT securities | ||
Information about MBS and CRT securities | ||
Principal/ Current Face | 384,993,000 | 192,000,000 |
Purchase Premiums | 3,312,000 | 0 |
Accretable Purchase Discounts | (5,557,000) | (5,689,000) |
Discount Designated as Credit Reserve and OTTI | 0 | 0 |
Amortized Cost | 382,748,000 | 186,311,000 |
Fair Value | 404,850,000 | 183,582,000 |
Gross Unrealized Gains | 22,105,000 | 418,000 |
Gross Unrealized Losses | (3,000) | (3,147,000) |
Net Unrealized Gain/(Loss) | $ 22,102,000 | (2,729,000) |
3 Year Step-up securities | ||
Information about MBS and CRT securities | ||
Basis points for coupon step-up | 300.00% | |
Coupon step-up period | 36 months | |
Principal/ Current Face | $ 2,700,000,000 | 2,600,000,000 |
Amortized Cost | 2,700,000,000 | 2,600,000,000 |
Fair Value | 2,700,000,000 | 2,600,000,000 |
Debt Securities | CRT securities | ||
Information about MBS and CRT securities | ||
Fair Value | 271,200,000 | 62,200,000 |
Gross Unrealized Gains | 12,700,000 | 332,000 |
Gross Unrealized Losses | (3,000) | (555,000) |
Net Unrealized Gain/(Loss) | $ (3,000) | $ (223,000) |
MBS and CRT Securities (Details 2) $ in Thousands |
3 Months Ended | 12 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2014
USD ($)
|
Dec. 31, 2016
USD ($)
Security
|
Sep. 30, 2016
USD ($)
|
Jun. 30, 2016
USD ($)
|
Mar. 31, 2016
USD ($)
|
Dec. 31, 2015
USD ($)
|
Sep. 30, 2015
USD ($)
|
Jun. 30, 2015
USD ($)
|
Mar. 31, 2015
USD ($)
|
Dec. 31, 2016
USD ($)
Security
|
Dec. 31, 2015
USD ($)
|
Dec. 31, 2014
USD ($)
|
|
Fair Value | ||||||||||||
Less than 12 months | $ 1,388,390 | $ 1,388,390 | ||||||||||
12 months or more | 1,472,268 | 1,472,268 | ||||||||||
Total | 2,860,658 | 2,860,658 | ||||||||||
Unrealized Losses | ||||||||||||
Less than 12 months | 9,784 | 9,784 | ||||||||||
12 months or more | 26,614 | 26,614 | ||||||||||
Total | $ 36,398 | $ 36,398 | ||||||||||
Number of Securities | ||||||||||||
Less than 12 Months | Security | 151 | 151 | ||||||||||
12 Months or more | Security | 249 | 249 | ||||||||||
Unrealized losses | $ 36,398 | $ 71,929 | $ 36,398 | $ 71,929 | ||||||||
OTTI charges recorded | ||||||||||||
Total OTTI losses | (1,255) | (525) | $ 0 | |||||||||
OTTI recognized in/(reclassified from) OCI | 770 | (180) | 0 | |||||||||
Net Impairment Losses Recognized in Earnings | 0 | $ (485) | $ 0 | $ 0 | 0 | $ 0 | $ (298) | $ (407) | (485) | (705) | 0 | |
Roll-forward of the credit loss component of OTTI | ||||||||||||
Credit loss component of OTTI at beginning of period | 36,820 | 36,115 | 36,820 | 36,115 | 36,115 | |||||||
Additions for credit related OTTI not previously recognized | 314 | 461 | 0 | |||||||||
Subsequent additional credit related OTTI recorded | 171 | 244 | 0 | |||||||||
Credit loss component of OTTI at end of period | $ 36,115 | 37,305 | 36,820 | 37,305 | 36,820 | 36,115 | ||||||
Changes in the components of the purchase discount on Non-Agency MBS | ||||||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 4,500 | 0 | 4,537 | 0 | ||||||||
Accumulated other comprehensive income from MBS and CRT securities: | ||||||||||||
Unrealized gain on AFS securities at beginning of period | 585,250 | 813,515 | 585,250 | 813,515 | 752,912 | |||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 4,500 | 0 | 4,537 | 0 | ||||||||
Reclassification adjustment for MBS sales included in net income | (36,922) | (37,207) | (34,948) | |||||||||
Reclassification adjustment for OTTI included in net income | (485) | (705) | 0 | |||||||||
Change in AOCI from AFS securities | 35,153 | (228,265) | 60,603 | |||||||||
Balance at end of period | 813,515 | 620,403 | 585,250 | 620,403 | 585,250 | 813,515 | ||||||
Agency MBS | ||||||||||||
Fair Value | ||||||||||||
Less than 12 months | 657,429 | 657,429 | ||||||||||
12 months or more | 1,181,517 | 1,181,517 | ||||||||||
Total | 1,838,946 | 1,838,946 | ||||||||||
Unrealized Losses | ||||||||||||
Less than 12 months | 8,045 | 8,045 | ||||||||||
12 months or more | 23,148 | 23,148 | ||||||||||
Total | $ 31,193 | $ 31,193 | ||||||||||
Number of Securities | ||||||||||||
Less than 12 Months | Security | 123 | 123 | ||||||||||
12 Months or more | Security | 221 | 221 | ||||||||||
Unrealized losses | $ 31,193 | 40,425 | $ 31,193 | 40,425 | ||||||||
Accumulated other comprehensive income from MBS and CRT securities: | ||||||||||||
Unrealized (loss)/gain on MBS, net | (9,322) | (51,332) | 65,739 | |||||||||
MBS and CRT securities Interest Income | ||||||||||||
Coupon interest | 119,966 | 147,066 | 189,355 | |||||||||
Effective yield adjustment | (36,897) | (41,231) | (46,812) | |||||||||
Interest income | 83,069 | 105,835 | 142,543 | |||||||||
Agency MBS | Fannie Mae | ||||||||||||
Fair Value | ||||||||||||
Less than 12 months | 380,834 | 380,834 | ||||||||||
12 months or more | 933,019 | 933,019 | ||||||||||
Total | 1,313,853 | 1,313,853 | ||||||||||
Unrealized Losses | ||||||||||||
Less than 12 months | 3,207 | 3,207 | ||||||||||
12 months or more | 16,101 | 16,101 | ||||||||||
Total | $ 19,308 | $ 19,308 | ||||||||||
Number of Securities | ||||||||||||
Less than 12 Months | Security | 76 | 76 | ||||||||||
12 Months or more | Security | 156 | 156 | ||||||||||
Unrealized losses | $ 19,308 | 25,830 | $ 19,308 | 25,830 | ||||||||
Agency MBS | Freddie Mac | ||||||||||||
Fair Value | ||||||||||||
Less than 12 months | 276,595 | 276,595 | ||||||||||
12 months or more | 248,498 | 248,498 | ||||||||||
Total | 525,093 | 525,093 | ||||||||||
Unrealized Losses | ||||||||||||
Less than 12 months | 4,838 | 4,838 | ||||||||||
12 months or more | 7,047 | 7,047 | ||||||||||
Total | $ 11,885 | $ 11,885 | ||||||||||
Number of Securities | ||||||||||||
Less than 12 Months | Security | 47 | 47 | ||||||||||
12 Months or more | Security | 65 | 65 | ||||||||||
Unrealized losses | $ 11,885 | 14,595 | $ 11,885 | 14,595 | ||||||||
Non-Agency MBS | ||||||||||||
Fair Value | ||||||||||||
Less than 12 months | 728,458 | 728,458 | ||||||||||
12 months or more | 290,751 | 290,751 | ||||||||||
Total | 1,019,209 | 1,019,209 | ||||||||||
Unrealized Losses | ||||||||||||
Less than 12 months | 1,736 | 1,736 | ||||||||||
12 months or more | 3,466 | 3,466 | ||||||||||
Total | $ 5,202 | $ 5,202 | ||||||||||
Number of Securities | ||||||||||||
Less than 12 Months | Security | 27 | 27 | ||||||||||
12 Months or more | Security | 28 | 28 | ||||||||||
Unrealized losses | $ 5,202 | 28,357 | $ 5,202 | 28,357 | ||||||||
OTTI losses | (485) | (705) | 0 | |||||||||
Accumulated other comprehensive income from MBS and CRT securities: | ||||||||||||
Unrealized (loss)/gain on MBS, net | 81,882 | (143,558) | 29,812 | |||||||||
Sales of MBS | ||||||||||||
Proceeds from sale of mortgage backed securities (MBS) categorized as available-for-sale | 85,600 | 70,700 | 123,900 | |||||||||
Gain (loss) on sales of mortgage backed securities (MBS) | 35,800 | 34,900 | 37,500 | |||||||||
Non-Agency MBS | Discount Designated as Credit Reserve and OTTI | ||||||||||||
Changes in the components of the purchase discount on Non-Agency MBS | ||||||||||||
Balance at beginning of period | (787,541) | (900,557) | (787,541) | (900,557) | ||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | (15,543) | ||||||||||
Impact of RMBS Issuer settlement | 0 | 0 | ||||||||||
Accretion of discount | 0 | 0 | ||||||||||
Realized credit losses | 64,217 | 80,821 | ||||||||||
Purchases | (25,999) | (1,200) | ||||||||||
Sales | 17,863 | 8,525 | ||||||||||
Net impairment losses recognized in earnings | (485) | (705) | ||||||||||
Transfers/release of credit reserve | 37,704 | 41,118 | ||||||||||
Balance at end of period | (900,557) | (694,241) | (787,541) | (694,241) | (787,541) | (900,557) | ||||||
Accumulated other comprehensive income from MBS and CRT securities: | ||||||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | (15,543) | ||||||||||
Non-Agency MBS | Accretable Discount | ||||||||||||
Changes in the components of the purchase discount on Non-Agency MBS | ||||||||||||
Balance at beginning of period | $ (312,182) | $ (399,564) | (312,182) | (399,564) | ||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | 1,832 | ||||||||||
Impact of RMBS Issuer settlement | (59,900) | 0 | ||||||||||
Accretion of discount | 80,548 | 93,173 | ||||||||||
Realized credit losses | 0 | 0 | ||||||||||
Purchases | 13,094 | (4,925) | ||||||||||
Sales | 37,953 | 38,420 | ||||||||||
Net impairment losses recognized in earnings | 0 | 0 | ||||||||||
Transfers/release of credit reserve | (37,704) | (41,118) | ||||||||||
Balance at end of period | $ (399,564) | (278,191) | (312,182) | (278,191) | (312,182) | (399,564) | ||||||
Accumulated other comprehensive income from MBS and CRT securities: | ||||||||||||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | 1,832 | ||||||||||
Non-Agency MBS | Expected to Recover Par | ||||||||||||
Fair Value | ||||||||||||
Less than 12 months | 691,114 | 691,114 | ||||||||||
12 months or more | 196,431 | 196,431 | ||||||||||
Total | 887,545 | 887,545 | ||||||||||
Unrealized Losses | ||||||||||||
Less than 12 months | 1,426 | 1,426 | ||||||||||
12 months or more | 942 | 942 | ||||||||||
Total | $ 2,368 | $ 2,368 | ||||||||||
Number of Securities | ||||||||||||
Less than 12 Months | Security | 19 | 19 | ||||||||||
12 Months or more | Security | 14 | 14 | ||||||||||
Unrealized losses | $ 2,368 | 20,143 | $ 2,368 | 20,143 | ||||||||
Non-Agency MBS | Expected to Recover Less Than Par | ||||||||||||
Fair Value | ||||||||||||
Less than 12 months | 37,344 | 37,344 | ||||||||||
12 months or more | 94,320 | 94,320 | ||||||||||
Total | 131,664 | 131,664 | ||||||||||
Unrealized Losses | ||||||||||||
Less than 12 months | 310 | 310 | ||||||||||
12 months or more | 2,524 | 2,524 | ||||||||||
Total | $ 2,834 | $ 2,834 | ||||||||||
Number of Securities | ||||||||||||
Less than 12 Months | Security | 8 | 8 | ||||||||||
12 Months or more | Security | 14 | 14 | ||||||||||
Unrealized losses | $ 2,834 | 8,214 | $ 2,834 | 8,214 | ||||||||
Total MBS | ||||||||||||
Fair Value | ||||||||||||
Less than 12 months | 1,385,887 | 1,385,887 | ||||||||||
12 months or more | 1,472,268 | 1,472,268 | ||||||||||
Total | 2,858,155 | 2,858,155 | ||||||||||
Unrealized Losses | ||||||||||||
Less than 12 months | 9,781 | 9,781 | ||||||||||
12 months or more | 26,614 | 26,614 | ||||||||||
Total | $ 36,395 | $ 36,395 | ||||||||||
Number of Securities | ||||||||||||
Less than 12 Months | Security | 150 | 150 | ||||||||||
12 Months or more | Security | 249 | 249 | ||||||||||
Unrealized losses | $ 36,395 | 68,782 | $ 36,395 | 68,782 | ||||||||
Legacy Non-Agency MBS | ||||||||||||
MBS and CRT securities Interest Income | ||||||||||||
Coupon interest | 154,057 | 183,349 | 212,073 | |||||||||
Effective yield adjustment | 78,443 | 91,003 | 103,491 | |||||||||
Interest income | 232,500 | 274,352 | 315,564 | |||||||||
3 Year Step-up securities | ||||||||||||
MBS and CRT securities Interest Income | ||||||||||||
Coupon interest | 100,032 | 87,429 | 898 | |||||||||
Effective yield adjustment | 2,108 | 1,789 | (132) | |||||||||
Interest income | 102,140 | 89,218 | 766 | |||||||||
CRT securities | ||||||||||||
Fair Value | ||||||||||||
Less than 12 months | 2,503 | 2,503 | ||||||||||
12 months or more | 0 | 0 | ||||||||||
Total | 2,503 | 2,503 | ||||||||||
Unrealized Losses | ||||||||||||
Less than 12 months | 3 | 3 | ||||||||||
12 months or more | 0 | 0 | ||||||||||
Total | $ 3 | $ 3 | ||||||||||
Number of Securities | ||||||||||||
Less than 12 Months | Security | 1 | 1 | ||||||||||
12 Months or more | Security | 0 | 0 | ||||||||||
Unrealized losses | $ 3 | 3,147 | $ 3 | 3,147 | ||||||||
MBS and CRT securities Interest Income | ||||||||||||
Coupon interest | 13,023 | 5,844 | 665 | |||||||||
Effective yield adjustment | 1,747 | 728 | 107 | |||||||||
Interest income | 14,770 | 6,572 | $ 772 | |||||||||
Debt Securities | CRT securities | ||||||||||||
Fair Value | ||||||||||||
Total | 2,500 | 2,500 | ||||||||||
Number of Securities | ||||||||||||
Unrealized losses | $ 3 | $ 555 | 3 | $ 555 | ||||||||
Countrywide | ||||||||||||
Changes in the components of the purchase discount on Non-Agency MBS | ||||||||||||
Proceeds from legal settlements | 61,800 | |||||||||||
Citigroup | ||||||||||||
Changes in the components of the purchase discount on Non-Agency MBS | ||||||||||||
Proceeds from legal settlements | $ 7,000 |
Residential Whole Loans - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
|
Residential Whole Loans [Abstract] | ||||||||||||
Residential Whole Loans | $ 1,400,000 | $ 895,100 | $ 1,400,000 | $ 895,100 | ||||||||
Equity interest in certificates | 100.00% | 100.00% | ||||||||||
Residential whole loans at carrying value | $ 590,540 | 271,845 | $ 590,540 | 271,845 | ||||||||
Allowance for loan leases | 990 | 1,165 | 990 | 1,165 | $ 137 | $ 0 | ||||||
(Reversal of provisions)/provisions for loan losses | (175) | 1,028 | 137 | |||||||||
Net gain on residential whole loans held at fair value | $ 14,632 | $ 18,701 | $ 14,470 | $ 11,881 | $ 6,899 | $ 5,565 | $ 3,224 | $ 2,034 | $ 59,684 | $ 17,722 | $ 116 |
Residential Whole Loans at Carrying Value-Provision for Loan Losses (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Allowance for Loan and Lease Losses [Roll Forward] | |||
Balance at the beginning of period | $ 1,165 | $ 137 | $ 0 |
(Reversal of provisions)/provisions for loan losses | (175) | 1,028 | 137 |
Balance at the end of period | $ 990 | $ 1,165 | $ 137 |
Residential Whole Loans at Carrying Value (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
|
Residential Whole Loans [Abstract] | ||
Contractually required principal and interest | $ 662,747 | $ 160,806 |
Contractual cash flows not expected to be collected (non-accretable yield) | (117,694) | (27,040) |
Expected cash flows to be collected | 545,053 | 133,766 |
Interest component of expected cash flows (accretable yield) | (181,534) | (51,413) |
Fair value at the date of acquisition | $ 363,519 | $ 82,353 |
Residential Whole Loans at Carrying Value Accretable Yield Rollforward (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
|
Residential Whole Loans [Roll Forward] | ||
Accretable yield, beginning balance | $ 175,271 | $ 133,012 |
Additions | 181,534 | 51,413 |
Accretion | (23,916) | (15,511) |
Reclassifications from non-accretable difference, net | 1,490 | 6,357 |
Accretable yield, ending balance | $ 334,379 | $ 175,271 |
Residential Whole Loans - Fair Value (Details) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2016
USD ($)
loan
|
Dec. 31, 2015
USD ($)
loan
|
|
Mortgage Loans on Real Estate [Line Items] | ||
Outstanding principal balance | $ | $ 966,276 | $ 786,330 |
Aggregate fair value | $ | $ 814,682 | $ 623,276 |
Residential whole loans | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number of loans | loan | 7,038 | |
Residential whole loans | Estimated fair value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number of loans | loan | 3,812 | 3,143 |
Residential Whole Loans-Fair Value Components of Net Income (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Residential Whole Loans [Abstract] | |||||||||||
Coupon payments and other income received | $ 23,017 | $ 9,304 | $ 504 | ||||||||
Net unrealized gains/(losses) | 31,254 | 6,539 | (427) | ||||||||
Net gain on payoff/liquidation of loans | 5,413 | 1,879 | 39 | ||||||||
Total | $ 14,632 | $ 18,701 | $ 14,470 | $ 11,881 | $ 6,899 | $ 5,565 | $ 3,224 | $ 2,034 | $ 59,684 | $ 17,722 | $ 116 |
Other Assets (Details) - USD ($) $ in Thousands |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
---|---|---|---|
Other Assets [Abstract] | |||
REO | $ 80,503 | $ 28,026 | $ 5,492 |
Interest receivable | 27,795 | 29,002 | |
Swaps, at fair value | 233 | 1,127 | |
Goodwill | 7,189 | 7,189 | |
Prepaid and other assets | 164,575 | 101,455 | |
Total Other Assets | $ 280,295 | $ 166,799 |
Other Assets - Real Estate Owned (Details) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016
USD ($)
property
|
Dec. 31, 2015
USD ($)
property
|
Dec. 31, 2014
USD ($)
property
|
|
Real Estate Owned Properties [Line Items] | |||
Number of real estate owned properties | property | 447 | 182 | |
Other real estate | $ 80,500 | $ 28,000 | |
Number of real estate properties reclassified to REO during period | property | 517 | 186 | |
Transfer from residential whole loans (1) | $ 91,896 | $ 30,104 | $ 2,904 |
Residential Whole Loans acquired through foreclosure ordered in lieu | $ 79,300 | ||
Number of REO properties sold during period | property | 256 | 63 | 0 |
Proceeds from sale of real estate owned | $ 37,900 | $ 6,500 | |
Gains/(losses) on sales of real estate owned | 3,229 | 76 | $ 0 |
Adjustments to record at lower of cost or fair value | 7,527 | 3,475 | |
Estimated fair value | |||
Real Estate Owned Properties [Line Items] | |||
Transfer from residential whole loans (1) | 91,900 | $ 30,100 | |
Mortgage loans in process of foreclosure | 501,800 | ||
Carrying value | |||
Real Estate Owned Properties [Line Items] | |||
Mortgage loans in process of foreclosure | $ 29,600 |
Other Assets - Real Estate Owned - Activity (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Real Estate Owned [Roll Forward] | |||
Balance at beginning of period | $ 28,026 | $ 5,492 | |
Adjustments to record at lower of cost or fair value | (7,527) | (3,475) | |
Transfer from residential whole loans | 91,896 | 30,104 | $ 2,904 |
Purchases and capital improvements | 2,825 | 2,461 | |
Disposals | (34,717) | (6,556) | |
Balance at end of period | 80,503 | 28,026 | $ 5,492 |
Gain recorded on transfer from residential whole loans to real estate owned | $ 2,900 | $ 1,700 |
Other Assets - Derivative Instruments (Details) - USD ($) $ in Thousands |
Dec. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Derivative Instruments | ||
Derivative assets, fair value | $ 233 | $ 1,127 |
Non-cleared Interest Rate Swap | Hedging | Assets | ||
Derivative Instruments | ||
Notional amount of derivative assets | 350,000 | 450,000 |
Derivative assets, fair value | 233 | 1,127 |
Non-cleared Interest Rate Swap | Hedging | Liabilities | ||
Derivative Instruments | ||
Notional amount of derivative liabilities | 0 | 50,000 |
Derivative liabilities, at fair value | 0 | (59) |
Cleared Interest Rate Swap | Hedging | Liabilities | ||
Derivative Instruments | ||
Notional amount of derivative liabilities | 2,550,000 | 2,550,000 |
Derivative liabilities, at fair value | $ (46,954) | $ (70,467) |
Other Assets - Derivative Instruments (Details 2) $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016
USD ($)
|
Sep. 30, 2016
USD ($)
|
Jun. 30, 2016
USD ($)
|
Mar. 31, 2016
USD ($)
|
Dec. 31, 2015
USD ($)
|
Sep. 30, 2015
USD ($)
|
Jun. 30, 2015
USD ($)
|
Mar. 31, 2015
USD ($)
|
Dec. 31, 2016
USD ($)
derivative
|
Dec. 31, 2015
USD ($)
derivative
|
Dec. 31, 2014
USD ($)
|
Dec. 31, 2016
USD ($)
|
Dec. 31, 2015
USD ($)
|
|
Derivative [Line Items] | |||||||||||||
Assets Pledged | $ 10,620,406 | $ 11,410,397 | |||||||||||
Number of terminated derivatives | derivative | 0 | 0 | |||||||||||
Net unrealized gains (losses) | $ (46,721) | $ (69,399) | $ (69,399) | $ (59,062) | $ (69,399) | $ (59,062) | $ (15,217) | (46,721) | (69,399) | ||||
Interest expense attributable to Swaps | 49,868 | $ 48,167 | $ 47,720 | 47,600 | 46,456 | $ 43,703 | $ 42,849 | 43,940 | 193,355 | 176,948 | 159,808 | ||
AOCI from derivative hedging instruments: | |||||||||||||
Balance at beginning of period | $ (69,399) | $ (59,062) | (69,399) | (59,062) | (15,217) | ||||||||
Unrealized gain/(loss) on Swaps, net | 22,678 | (10,337) | (44,292) | ||||||||||
Balance at end of period | (46,721) | $ (69,399) | $ (46,721) | (69,399) | (59,062) | ||||||||
Interest Rate Contract | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate fair value of assets needed to immediately settle | 48,000 | ||||||||||||
Associated accrued interest payable | 1,000 | ||||||||||||
Assets Pledged | 86,317 | 109,142 | |||||||||||
Interest Rate Contract | Agency MBS, at fair value | |||||||||||||
Derivative [Line Items] | |||||||||||||
Assets Pledged | 32,468 | 38,569 | |||||||||||
Interest Rate Contract | Restricted cash | |||||||||||||
Derivative [Line Items] | |||||||||||||
Assets Pledged | 53,849 | 70,573 | |||||||||||
Swaps, at fair value | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 2,900,000 | $ 3,050,000 | |||||||||||
Average maturity term of swaps | 35 months | ||||||||||||
Weighted average fixed-pay rate | 1.87% | 1.82% | |||||||||||
Weighted Average Variable Interest Rate | 0.72% | 0.34% | |||||||||||
Interest expense attributable to Swaps | $ 40,898 | $ 53,759 | $ 69,842 | ||||||||||
Weighted average Swap rate paid | 1.82% | 1.86% | 1.93% | ||||||||||
Weighted average Swap rate received | 0.48% | 0.19% | 0.16% | ||||||||||
Swaps, at fair value | Within 30 days | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 0 | $ 50,000 | |||||||||||
Weighted average fixed-pay rate | 0.00% | 2.13% | |||||||||||
Weighted Average Variable Interest Rate | 0.00% | 0.42% | |||||||||||
Swaps, at fair value | Over 30 days to 3 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 50,000 | $ 0 | |||||||||||
Weighted average fixed-pay rate | 0.67% | 0.00% | |||||||||||
Weighted Average Variable Interest Rate | 0.64% | 0.00% | |||||||||||
Swaps, at fair value | Over 3 months to 6 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 300,000 | $ 0 | |||||||||||
Weighted average fixed-pay rate | 0.57% | 0.00% | |||||||||||
Weighted Average Variable Interest Rate | 0.66% | 0.00% | |||||||||||
Swaps, at fair value | Over 6 months to 12 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 0 | $ 100,000 | |||||||||||
Weighted average fixed-pay rate | 0.00% | 0.48% | |||||||||||
Weighted Average Variable Interest Rate | 0.00% | 0.32% | |||||||||||
Swaps, at fair value | Over 12 months to 24 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 550,000 | $ 350,000 | |||||||||||
Weighted average fixed-pay rate | 1.49% | 0.58% | |||||||||||
Weighted Average Variable Interest Rate | 0.71% | 0.27% | |||||||||||
Swaps, at fair value | Over 24 months to 36 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 200,000 | $ 550,000 | |||||||||||
Weighted average fixed-pay rate | 1.71% | 1.49% | |||||||||||
Weighted Average Variable Interest Rate | 0.76% | 0.32% | |||||||||||
Swaps, at fair value | Over 36 months to 48 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 1,500,000 | $ 200,000 | |||||||||||
Weighted average fixed-pay rate | 2.22% | 1.71% | |||||||||||
Weighted Average Variable Interest Rate | 0.74% | 0.42% | |||||||||||
Swaps, at fair value | Over 48 months to 60 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 200,000 | $ 1,500,000 | |||||||||||
Weighted average fixed-pay rate | 2.20% | 2.22% | |||||||||||
Weighted Average Variable Interest Rate | 0.75% | 0.36% | |||||||||||
Swaps, at fair value | Over 60 months to 72 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 0 | $ 200,000 | |||||||||||
Weighted average fixed-pay rate | 0.00% | 2.20% | |||||||||||
Weighted Average Variable Interest Rate | 0.00% | 0.30% | |||||||||||
Swaps, at fair value | Over 72 months to 84 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 100,000 | $ 0 | |||||||||||
Weighted average fixed-pay rate | 2.75% | 0.00% | |||||||||||
Weighted Average Variable Interest Rate | 0.74% | 0.00% | |||||||||||
Swaps, at fair value | Over 84 months | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount of derivatives | $ 0 | $ 100,000 | |||||||||||
Weighted average fixed-pay rate | 0.00% | 2.75% | |||||||||||
Weighted Average Variable Interest Rate | 0.00% | 0.40% | |||||||||||
Swaps, at fair value | Hedging | |||||||||||||
Derivative [Line Items] | |||||||||||||
Net unrealized gains (losses) | (46,700) | $ (46,700) | $ (46,700) | ||||||||||
AOCI from derivative hedging instruments: | |||||||||||||
Balance at end of period | $ (46,700) | $ (46,700) | |||||||||||
Swaps, at fair value | Minimum | LIBOR | |||||||||||||
Derivative [Line Items] | |||||||||||||
Derivative, variable interest rate, term | 1 month | ||||||||||||
Swaps, at fair value | Maximum | |||||||||||||
Derivative [Line Items] | |||||||||||||
Maximum maturity term of swaps | 80 months | ||||||||||||
Swaps, at fair value | Maximum | LIBOR | |||||||||||||
Derivative [Line Items] | |||||||||||||
Derivative, variable interest rate, term | 3 months | ||||||||||||
New Swaps: | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount | $ 0 | ||||||||||||
Weighted average fixed-pay rate | 0.00% | ||||||||||||
Number of new Swaps | derivative | 0 | ||||||||||||
Swaps amortized/expired: | |||||||||||||
Derivative [Line Items] | |||||||||||||
Aggregate notional amount | $ 150,000 | ||||||||||||
Swaps amortized/expired: | YTD | |||||||||||||
Derivative [Line Items] | |||||||||||||
Weighted average fixed-pay rate | 1.03% |
Other Assets - Derivative Instruments (Details 3) - USD ($) $ in Thousands |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2014 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Other Assets [Abstract] | ||||
MBS securities recorded upon adoption of revised accounting standard | $ 1,900,000 | |||
CRT securities recorded upon adoption of revised accounting standard | 4,600 | |||
Repurchase agreements recorded upon adoption of revised accounting standard for repurchase agreement financing | $ 0 | 1,519,593 | $ 0 | |
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | $ 4,500 | $ 0 | $ 4,537 | $ 0 |
Other Assets - Derivative Instruments (Details 4) - Linked Transactions $ in Thousands |
12 Months Ended |
---|---|
Dec. 31, 2014
USD ($)
| |
Derivative [Line Items] | |
Interest income attributable to MBS underlying Linked Transactions | $ 24,443 |
Interest expense attributable to linked repurchase agreement borrowings underlying Linked Transactions | (8,028) |
Change in fair value of Linked Transactions included in earnings | 677 |
Unrealized net gains and net interest income from Linked Transactions | $ 17,092 |
Other Assets - Interest Receivable (Details) - USD ($) $ in Thousands |
Dec. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Interest receivable by investment category | ||
Total interest receivable | $ 27,795 | $ 29,002 |
Total MBS | ||
Interest receivable by investment category | ||
Total interest receivable | 22,653 | 26,629 |
Fannie Mae | ||
Interest receivable by investment category | ||
Total interest receivable | 7,402 | 8,999 |
Freddie Mac | ||
Interest receivable by investment category | ||
Total interest receivable | 1,802 | 2,177 |
Ginnie Mae | ||
Interest receivable by investment category | ||
Total interest receivable | 14 | 15 |
Non-Agency MBS | ||
Interest receivable by investment category | ||
Total interest receivable | 13,435 | 15,438 |
Residential whole loans | ||
Interest receivable by investment category | ||
Total interest receivable | 4,415 | 2,259 |
CRT securities | ||
Interest receivable by investment category | ||
Total interest receivable | 254 | 92 |
Money market and other investments | ||
Interest receivable by investment category | ||
Total interest receivable | $ 473 | $ 22 |
Repurchase Agreements and Other Advances (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2016 |
|
Repurchase Agreements | |||
Unamortized debt issuance expense | $ 210 | $ 1,300 | |
Total repurchase agreements less debt issuance costs | $ 8,472,268 | ||
Repurchase agreements | |||
Repurchase Agreements | |||
Weighted average remaining term-to-interest rate reset of borrowings under repurchase agreements | 19 days | 21 days | |
Effective repricing period | 12 months | 18 months | |
Repurchase agreements | $ 8,472,478 | $ 7,888,902 | $ 8,472,478 |
Unamortized debt issuance expense | 210 | 1,280 | |
Total repurchase agreements less debt issuance costs | $ 8,472,268 | $ 7,887,622 | |
Weighted Average Interest Rate | 1.79% | 1.48% | |
Repurchase agreements | Within 30 days | |||
Repurchase Agreements | |||
Repurchase agreements | $ 7,284,062 | $ 7,054,483 | |
Weighted Average Interest Rate | 1.77% | 1.44% | |
Repurchase agreements | Over 30 days to 3 months | |||
Repurchase Agreements | |||
Repurchase agreements | $ 1,188,416 | $ 734,955 | |
Weighted Average Interest Rate | 1.91% | 1.79% | |
Repurchase agreements | Over 3 months to 12 months | |||
Repurchase Agreements | |||
Repurchase agreements | $ 0 | $ 99,464 | |
Weighted Average Interest Rate | 0.00% | 2.36% | |
Repurchase agreements | Agency MBS | |||
Repurchase Agreements | |||
Repurchase agreements | $ 3,095,020 | $ 2,727,542 | 3,095,020 |
Fair Value of assets pledged as collateral under repurchase agreements | $ 3,280,689 | $ 2,881,049 | |
Weighted average haircut rate | 4.67% | 4.67% | |
Repurchase agreements | Non-Agency MBS | |||
Repurchase Agreements | |||
Repurchase agreements | $ 1,690,937 | $ 1,960,222 | 1,690,937 |
Fair Value of assets pledged as collateral under repurchase agreements | $ 2,317,708 | $ 2,818,968 | |
Weighted average haircut rate | 24.01% | 25.84% | |
Non-Agency MBS acquired from consolidated VIEs | $ 172,400 | $ 570,500 | |
Repurchase agreements | 3 Year Step-up securities | |||
Repurchase Agreements | |||
Repurchase agreements | 2,078,684 | 2,080,163 | 2,078,684 |
Fair Value of assets pledged as collateral under repurchase agreements | $ 2,660,491 | $ 2,625,866 | |
Weighted average haircut rate | 22.28% | 21.05% | |
Repurchase agreements | U.S. Treasuries | |||
Repurchase Agreements | |||
Repurchase agreements | $ 504,572 | $ 504,760 | 504,572 |
Fair Value of assets pledged as collateral under repurchase agreements | $ 510,767 | $ 507,443 | |
Weighted average haircut rate | 1.60% | 1.60% | |
Repurchase agreements | CRT securities | |||
Repurchase Agreements | |||
Repurchase agreements | $ 271,205 | $ 128,465 | 271,205 |
Fair Value of assets pledged as collateral under repurchase agreements | $ 357,488 | $ 170,352 | |
Weighted average haircut rate | 23.22% | 25.04% | |
Repurchase agreements | Residential whole loans | |||
Repurchase Agreements | |||
Repurchase agreements | $ 832,060 | $ 487,750 | $ 832,060 |
Fair Value of assets pledged as collateral under repurchase agreements | $ 1,175,088 | $ 684,136 | |
Weighted average haircut rate | 25.03% | 27.69% |
Repurchase Agreements and Other Advances (Details 2) $ in Thousands |
Dec. 31, 2016
USD ($)
counterparty
|
Sep. 30, 2016
USD ($)
|
Dec. 31, 2015
USD ($)
counterparty
|
---|---|---|---|
Information about MBS and CRT securities | |||
Gross amount of recognized liabilities for repurchase agreements in Note 8 | $ 8,472,268 | ||
Amounts related to repurchase agreements not included in offsetting disclosure in Note 8 | 0 | ||
Unamortized debt issuance expense | $ 210 | $ 1,300 | |
Repurchase agreements, number of counterparties | counterparty | 31 | 27 | |
Threshold percent of stockholders' equity at risk with single counterparty to repurchase agreements or Linked Transactions (greater than) | 5.00% | ||
Repurchase agreements | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 8,472,478 | $ 8,472,478 | $ 7,888,902 |
Weighted Average Interest Rate | 1.79% | 1.48% | |
Gross amount of recognized liabilities for repurchase agreements in Note 8 | $ 8,472,268 | $ 7,887,622 | |
Unamortized debt issuance expense | 210 | 1,280 | |
Repurchase agreements | Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 3,095,020 | 3,095,020 | 2,727,542 |
Repurchase agreements | Non-Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 1,690,937 | 1,690,937 | 1,960,222 |
Repurchase agreements | 3 Year Step-up securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 2,078,684 | 2,078,684 | 2,080,163 |
Repurchase agreements | U.S. Treasuries | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 504,572 | 504,572 | 504,760 |
Repurchase agreements | CRT securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 271,205 | 271,205 | 128,465 |
Repurchase agreements | Residential whole loans | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 832,060 | $ 832,060 | $ 487,750 |
Overnight | Repurchase agreements | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 0 | ||
Weighted Average Interest Rate | 0.00% | ||
Overnight | Repurchase agreements | Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 0 | ||
Overnight | Repurchase agreements | Non-Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Overnight | Repurchase agreements | 3 Year Step-up securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Overnight | Repurchase agreements | U.S. Treasuries | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Overnight | Repurchase agreements | CRT securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Overnight | Repurchase agreements | Residential whole loans | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Within 30 days | Repurchase agreements | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 5,926,375 | ||
Weighted Average Interest Rate | 1.67% | ||
Within 30 days | Repurchase agreements | Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 2,768,277 | ||
Within 30 days | Repurchase agreements | Non-Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 1,006,956 | ||
Within 30 days | Repurchase agreements | 3 Year Step-up securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 1,379,254 | ||
Within 30 days | Repurchase agreements | U.S. Treasuries | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 504,572 | ||
Within 30 days | Repurchase agreements | CRT securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 267,316 | ||
Within 30 days | Repurchase agreements | Residential whole loans | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Over 30 days to 90 days | Repurchase agreements | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 1,349,588 | ||
Weighted Average Interest Rate | 1.76% | ||
Over 30 days to 90 days | Repurchase agreements | Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 326,743 | ||
Over 30 days to 90 days | Repurchase agreements | Non-Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 433,244 | ||
Over 30 days to 90 days | Repurchase agreements | 3 Year Step-up securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 467,873 | ||
Over 30 days to 90 days | Repurchase agreements | U.S. Treasuries | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Over 30 days to 90 days | Repurchase agreements | CRT securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 3,889 | ||
Over 30 days to 90 days | Repurchase agreements | Residential whole loans | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 117,839 | ||
Over 90 days to 12 months | Repurchase agreements | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 1,196,515 | ||
Weighted Average Interest Rate | 2.72% | ||
Over 90 days to 12 months | Repurchase agreements | Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 0 | ||
Over 90 days to 12 months | Repurchase agreements | Non-Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 250,737 | ||
Over 90 days to 12 months | Repurchase agreements | 3 Year Step-up securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 231,557 | ||
Over 90 days to 12 months | Repurchase agreements | U.S. Treasuries | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Over 90 days to 12 months | Repurchase agreements | CRT securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Over 90 days to 12 months | Repurchase agreements | Residential whole loans | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 714,221 | ||
Over 12 months | Repurchase agreements | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 0 | ||
Weighted Average Interest Rate | 0.00% | ||
Over 12 months | Repurchase agreements | Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 0 | ||
Over 12 months | Repurchase agreements | Non-Agency MBS | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Over 12 months | Repurchase agreements | 3 Year Step-up securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Over 12 months | Repurchase agreements | U.S. Treasuries | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Over 12 months | Repurchase agreements | CRT securities | |||
Information about MBS and CRT securities | |||
Repurchase agreements | 0 | ||
Over 12 months | Repurchase agreements | Residential whole loans | |||
Information about MBS and CRT securities | |||
Repurchase agreements | $ 0 |
Repurchase Agreements and Other Advances (Details 3) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
|
FHLB Advances | ||
Long-term federal home loan bank advances | $ 215,000 | $ 1,500,000 |
Federal home loan bank, advances, maturity period, variable rate | 3 years 8 months 1 day | |
Accrued interest payable | $ 14,129 | 16,949 |
Wells Fargo | ||
Repurchase agreements counterparty risk | ||
Amount at risk | $ 388,455 | |
Weighted Average Months to Maturity for Repurchase Agreements | 4 months | |
Percent of Stockholders’ Equity | 12.80% | |
Wells Fargo Bank | ||
Repurchase agreements counterparty risk | ||
Amount at risk | $ 295,300 | |
Wells Fargo Securities LLC | ||
Repurchase agreements counterparty risk | ||
Amount at risk | 93,200 | |
RBC | ||
Repurchase agreements counterparty risk | ||
Amount at risk | $ 274,261 | |
Weighted Average Months to Maturity for Repurchase Agreements | 1 month | |
Percent of Stockholders’ Equity | 9.00% | |
RBC Barbados | ||
Repurchase agreements counterparty risk | ||
Amount at risk | $ 238,200 | |
Royal Bank of Canada | ||
Repurchase agreements counterparty risk | ||
Amount at risk | 30,400 | |
RBC Capital Markets LLC | ||
Repurchase agreements counterparty risk | ||
Amount at risk | 5,700 | |
Goldman Sachs | ||
Repurchase agreements counterparty risk | ||
Amount at risk | $ 211,377 | |
Weighted Average Months to Maturity for Repurchase Agreements | 2 months | |
Percent of Stockholders’ Equity | 7.00% | |
Credit Suisse | ||
Repurchase agreements counterparty risk | ||
Amount at risk | $ 191,594 | |
Weighted Average Months to Maturity for Repurchase Agreements | 3 months | |
Percent of Stockholders’ Equity | 6.30% | |
Credit Suisse AG | ||
Repurchase agreements counterparty risk | ||
Amount at risk | $ 141,800 | |
Credit Suisse Cayman Islands | ||
Repurchase agreements counterparty risk | ||
Amount at risk | 49,800 | |
UBS | ||
Repurchase agreements counterparty risk | ||
Amount at risk | $ 167,127 | |
Weighted Average Months to Maturity for Repurchase Agreements | 6 months | |
Percent of Stockholders’ Equity | 5.50% | |
Federal Home Loan Bank Advances | ||
FHLB Advances | ||
Accrued interest payable | $ 42 | $ 508 |
Weighted average | ||
FHLB Advances | ||
Federal home loan bank, weighted average interest rate | 0.78% | 0.50% |
Collateral Positions (Details) - USD ($) $ in Thousands |
Dec. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | $ 10,620,406 | $ 11,410,397 |
Collateral Held | 510,767 | 507,443 |
Derivative Hedging Instruments | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 86,317 | 109,142 |
Collateral Held | 0 | 0 |
Repurchase Agreement Borrowings | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 10,306,845 | 9,688,779 |
Collateral Held | 0 | 0 |
Federal Home Loan Bank Advances | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 227,244 | 1,612,476 |
Collateral Held | 0 | 0 |
Reverse Repurchase Agreements | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 0 | 0 |
Collateral Held | 510,767 | 507,443 |
Agency MBS | Derivative Hedging Instruments | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 32,468 | 38,569 |
Collateral Held | 0 | 0 |
Agency MBS | Repurchase Agreement Borrowings | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 3,280,689 | 2,881,049 |
Collateral Held | 0 | 0 |
Agency MBS | Federal Home Loan Bank Advances | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 227,244 | 1,612,476 |
Collateral Held | 0 | 0 |
Legacy Non-Agency MBS | Repurchase Agreement Borrowings | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 2,317,708 | 2,818,968 |
Collateral Held | 0 | 0 |
3 Year Step-up securities | Repurchase Agreement Borrowings | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 2,660,491 | 2,625,866 |
Collateral Held | 0 | 0 |
U.S. Treasury securities | Repurchase Agreement Borrowings | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 510,767 | 507,443 |
Collateral Held | 0 | 0 |
U.S. Treasury securities | Reverse Repurchase Agreements | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 0 | 0 |
Collateral Held | 510,767 | 507,443 |
CRT securities | Repurchase Agreement Borrowings | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 357,488 | 170,352 |
Collateral Held | 0 | 0 |
Residential whole loans | Repurchase Agreement Borrowings | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 1,175,088 | 684,136 |
Collateral Held | 0 | 0 |
Cash | Derivative Hedging Instruments | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 53,849 | 70,573 |
Collateral Held | 0 | 0 |
Cash | Repurchase Agreement Borrowings | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Assets Pledged | 4,614 | 965 |
Collateral Held | 0 | 0 |
Non-Agency MBS | Repurchase Agreement Borrowings | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Non-Agency MBS acquired from consolidated VIEs | 172,400 | 570,500 |
Non-Agency MBS pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty | $ 688,200 | $ 726,700 |
Collateral Positions (Details 2) $ in Thousands |
Dec. 31, 2016
USD ($)
|
---|---|
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Total Fair Value of Assets Pledged and Accrued Interest | $ 10,643,058 |
Assets Pledged Under Repurchase Agreements and Other Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 10,534,089 |
Amortized Cost | 10,002,330 |
Accrued Interest on Pledged Assets | 22,585 |
Derivative Hedging Instruments | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 86,317 |
Amortized Cost | 87,065 |
Accrued Interest on Pledged Assets | 67 |
Agency MBS | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Total Fair Value of Assets Pledged and Accrued Interest | 3,549,122 |
Agency MBS | Assets Pledged Under Repurchase Agreements and Other Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 3,507,933 |
Amortized Cost | 3,488,904 |
Accrued Interest on Pledged Assets | 8,654 |
Agency MBS | Assets Pledged Under Repurchase Agreements and Other Advances | Federal Home Loan Bank Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 227,200 |
Amortized Cost | 226,600 |
Accrued Interest on Pledged Assets | 597 |
Agency MBS | Derivative Hedging Instruments | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 32,468 |
Amortized Cost | 33,216 |
Accrued Interest on Pledged Assets | 67 |
Legacy Non-Agency MBS | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Total Fair Value of Assets Pledged and Accrued Interest | 2,326,321 |
Legacy Non-Agency MBS | Assets Pledged Under Repurchase Agreements and Other Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 2,317,708 |
Amortized Cost | 1,841,401 |
Accrued Interest on Pledged Assets | 8,613 |
Non-Agency MBS pledged as collateral in connection with contemporaneous repurchase and reverse repurchase agreements entered into with a single counterparty | 688,200 |
Legacy Non-Agency MBS | Derivative Hedging Instruments | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
3 Year Step-up securities | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Total Fair Value of Assets Pledged and Accrued Interest | 2,662,339 |
3 Year Step-up securities | Assets Pledged Under Repurchase Agreements and Other Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 2,660,491 |
Amortized Cost | 2,657,726 |
Accrued Interest on Pledged Assets | 1,848 |
3 Year Step-up securities | Derivative Hedging Instruments | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
U.S. Treasury securities | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Total Fair Value of Assets Pledged and Accrued Interest | 510,767 |
U.S. Treasury securities | Assets Pledged Under Repurchase Agreements and Other Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 510,767 |
Amortized Cost | 510,767 |
Accrued Interest on Pledged Assets | 0 |
U.S. Treasury securities | Derivative Hedging Instruments | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
CRT securities | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Total Fair Value of Assets Pledged and Accrued Interest | 357,710 |
CRT securities | Assets Pledged Under Repurchase Agreements and Other Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 357,488 |
Amortized Cost | 336,706 |
Accrued Interest on Pledged Assets | 222 |
CRT securities | Derivative Hedging Instruments | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
Residential whole loans | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Total Fair Value of Assets Pledged and Accrued Interest | 1,178,336 |
Residential whole loans | Assets Pledged Under Repurchase Agreements and Other Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 1,175,088 |
Amortized Cost | 1,162,212 |
Accrued Interest on Pledged Assets | 3,248 |
Residential whole loans | Derivative Hedging Instruments | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 0 |
Amortized Cost | 0 |
Accrued Interest on Pledged Assets | 0 |
Cash | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Total Fair Value of Assets Pledged and Accrued Interest | 58,463 |
Cash | Assets Pledged Under Repurchase Agreements and Other Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 4,614 |
Amortized Cost | 4,614 |
Accrued Interest on Pledged Assets | 0 |
Cash | Derivative Hedging Instruments | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 53,849 |
Amortized Cost | 53,849 |
Accrued Interest on Pledged Assets | 0 |
Fair Value, Estimate Not Practicable, Carrying (Reported) Amount | Residential whole loans | Assets Pledged Under Repurchase Agreements and Other Advances | |
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |
Fair Value | 440,800 |
Amortized Cost | 427,900 |
Total Fair Value of Assets Pledged and Accrued Interest | $ 732,400 |
Offsetting Assets and Liabilities (Details) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2016
USD ($)
counterparty
|
Dec. 31, 2015
USD ($)
|
|
Derivative hedging instruments, at fair value | ||
Gross Amounts of Recognized Assets | $ 233 | $ 1,127 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Assets Presented in the Consolidated Balance Sheets | 233 | 1,127 |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||
Financial Instruments | (233) | (1,127) |
Cash Collateral Received | 0 | 0 |
Net Amount | 0 | 0 |
Swaps, at fair value | ||
Gross Amounts of Recognized Liabilities | 46,954 | 70,526 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets | 46,954 | 70,526 |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||
Financial Instruments | 0 | 0 |
Cash Collateral Pledged | (46,954) | (70,526) |
Net Amount | 0 | 0 |
Repurchase agreements and other advances | ||
Gross Amounts of Recognized Liabilities | 8,687,478 | 9,388,902 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets | 8,687,478 | 9,388,902 |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||
Financial Instruments | (8,682,864) | (9,387,937) |
Cash Collateral Pledged | (4,614) | (965) |
Net Amount | 0 | 0 |
Total | ||
Gross Amounts of Recognized Liabilities | 8,734,432 | 9,459,428 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Liabilities Presented in the Consolidated Balance Sheets | 8,734,432 | 9,459,428 |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||
Financial Instruments | (8,682,864) | (9,387,937) |
Cash Collateral Pledged | (51,568) | (71,491) |
Net Amount | 0 | 0 |
Additional disclosures | ||
Derivatives, excess collateral | 6,900 | 47 |
Fair value of securities pledged against the swaps | 32,500 | 38,600 |
Fair value of securities pledged against the repurchase agreements | 10,500,000 | 11,300,000 |
Unamortized debt issuance expense | $ 210 | 1,300 |
Number of repurchase agreement counterparties with unconditional right of setoff | counterparty | 1 | |
Swaps | ||
Derivative hedging instruments, at fair value | ||
Gross Amounts of Recognized Assets | $ 233 | 1,127 |
Gross Amounts Offset in the Consolidated Balance Sheets | 0 | 0 |
Net Amounts of Assets Presented in the Consolidated Balance Sheets | 233 | 1,127 |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||
Financial Instruments | (233) | (1,127) |
Cash Collateral Received | 0 | 0 |
Net Amount | $ 0 | $ 0 |
Senior Notes (Details) - Senior Unsecured Notes - USD ($) |
12 Months Ended | |
---|---|---|
Apr. 11, 2012 |
Dec. 31, 2016 |
|
Senior Notes | ||
Aggregate principal amount | $ 100,000,000.0 | |
Proceed from senior notes net of offering expenses and underwriting discount | $ 96,600,000 | |
Stated interest rate | 8.00% | |
Effective interest rate | 8.31% | |
Redemption price as percentage of principal amount | 100.00% |
Other Liabilities (Details) - USD ($) $ in Thousands |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
---|---|---|---|
Other Liabilities [Abstract] | |||
Accrued interest payable | $ 14,129 | $ 16,949 | |
Swaps, at fair value | 46,954 | 70,526 | |
Dividends and dividend equivalents declared and unpaid | 74,657 | 74,575 | $ 74,529 |
Securitized debt | 0 | 21,868 | |
Accrued expenses and other liabilities | 19,612 | 19,610 | |
Total Other Liabilities | $ 155,352 | $ 203,528 |
Commitments and Contingencies (Details) |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016
USD ($)
lease
|
Dec. 31, 2015
USD ($)
|
Dec. 31, 2014
USD ($)
|
|
Lease Commitments | |||
Number of operating leases | lease | 2 | ||
Lease expense | $ 2,500,000 | $ 2,600,000 | $ 2,500,000 |
Minimum Rental Payments | |||
2017 | 2,553,000 | ||
2018 | 2,553,000 | ||
2019 | 2,553,000 | ||
2020 | 1,082,000 | ||
2021 | 32,000 | ||
Total | 8,773,000 | ||
Corporate headquarters | |||
Lease Commitments | |||
Aggregate cash payments, operating leases | 2,500,000 | ||
Irrevocable standby letter of credit provided to landlord | 785,000 | ||
Off-site back-up facility | |||
Lease Commitments | |||
Aggregate cash payments, operating leases | $ 32,000 |
Stockholders' Equity (Details) $ / shares in Units, $ in Thousands |
12 Months Ended | 48 Months Ended | 160 Months Ended | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 14, 2016
$ / shares
|
Nov. 22, 2016
$ / shares
|
Sep. 15, 2016
$ / shares
|
Aug. 12, 2016
$ / shares
|
Jun. 14, 2016
$ / shares
|
May 18, 2016
$ / shares
|
Mar. 11, 2016
$ / shares
|
Feb. 12, 2016
$ / shares
|
Dec. 09, 2015
$ / shares
|
Nov. 19, 2015
$ / shares
|
Sep. 17, 2015
$ / shares
|
Aug. 24, 2015
$ / shares
|
Jun. 15, 2015
$ / shares
|
May 18, 2015
$ / shares
|
Mar. 13, 2015
$ / shares
|
Feb. 13, 2015
$ / shares
|
Dec. 09, 2014
$ / shares
|
Nov. 21, 2014
$ / shares
|
Sep. 17, 2014
$ / shares
|
Aug. 25, 2014
$ / shares
|
Jun. 13, 2014
$ / shares
|
May 19, 2014
$ / shares
|
Mar. 10, 2014
$ / shares
|
Feb. 14, 2014
$ / shares
|
Apr. 15, 2013
$ / shares
shares
|
Dec. 31, 2016
USD ($)
quarter
director
$ / shares
shares
|
Dec. 31, 2015
USD ($)
$ / shares
shares
|
Dec. 31, 2014
USD ($)
shares
|
Dec. 31, 2016
USD ($)
$ / shares
shares
|
Dec. 31, 2016
USD ($)
$ / shares
shares
|
Dec. 31, 2013
shares
|
Aug. 08, 2013
shares
|
Aug. 31, 2005
shares
|
|
Dividends on Preferred Stock | |||||||||||||||||||||||||||||||||
Preferred stock, shares issued (in shares) | 8,000,000 | 8,000,000 | 8,000,000 | 8,000,000 | |||||||||||||||||||||||||||||
Preferred stock, dividend rate (as a percent) | 7.50% | 7.50% | 7.50% | ||||||||||||||||||||||||||||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||
Maximum quarters without dividends to get voting rights, in quarters | quarter | 6 | ||||||||||||||||||||||||||||||||
Minimum percentage of preferred shareholders required for approval | 66.67% | ||||||||||||||||||||||||||||||||
Dividends on Common Stock | |||||||||||||||||||||||||||||||||
Common stock, cash dividends declared (in dollars per share) | $ / shares | $ 0.20 | $ 0.20 | $ 0.20 | $ 0.20 | $ 0.20 | $ 0.20 | $ 0.20 | $ 0.20 | $ 0.20 | $ 0.20 | $ 0.20 | $ 0.20 | |||||||||||||||||||||
Dividends payable | $ | $ 74,657 | $ 74,575 | $ 74,529 | $ 74,657 | $ 74,657 | ||||||||||||||||||||||||||||
Common stock, shares authorized (in shares) | 886,950,000 | 886,950,000 | 886,950,000 | 886,950,000 | |||||||||||||||||||||||||||||
Number of shares authorized to be repurchased under the Repurchase Program (in shares) | 10,000,000.0 | 4,000,000.0 | |||||||||||||||||||||||||||||||
Number of shares repurchased through the Company's publicly announced stock repurchase program (in shares) | 0 | ||||||||||||||||||||||||||||||||
Number of remaining shares authorized to be repurchased under the Repurchase Program (in shares) | 6,616,355 | 6,616,355 | 6,616,355 | ||||||||||||||||||||||||||||||
DRSPP | |||||||||||||||||||||||||||||||||
Dividends on Common Stock | |||||||||||||||||||||||||||||||||
Common stock, shares authorized (in shares) | 15,000,000 | ||||||||||||||||||||||||||||||||
Shares of common stock authorized and available for issuance | 14,500,000.0 | 14,500,000.0 | 14,500,000.0 | ||||||||||||||||||||||||||||||
Shares issued | 653,793 | 162,373 | 4,526,855 | 31,382,785 | |||||||||||||||||||||||||||||
Net proceeds | $ | $ 4,700 | $ 1,200 | $ 35,600 | $ 262,900 | |||||||||||||||||||||||||||||
Series B Preferred Stock | |||||||||||||||||||||||||||||||||
Dividends on Preferred Stock | |||||||||||||||||||||||||||||||||
Preferred stock, cash dividends declared (in dollars per share) | $ / shares | $ 0.46875 | $ 0.46875 | $ 0.46875 | $ 0.46875 | $ 0.46875 | $ 0.46875 | $ 0.46875 | $ 0.46875 | $ 0.46875 | $ 0.46875 | $ 0.46875 | $ 0.46875 | |||||||||||||||||||||
Preferred Stock | Series B Preferred Stock | |||||||||||||||||||||||||||||||||
Dividends on Preferred Stock | |||||||||||||||||||||||||||||||||
Preferred stock, shares issued (in shares) | 8,000,000.0 | ||||||||||||||||||||||||||||||||
Preferred stock, dividend rate (as a percent) | 7.50% | 7.50% | |||||||||||||||||||||||||||||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.01 | ||||||||||||||||||||||||||||||||
Preferred stock, liquidation preference (in dollars per share) | $ / shares | 25.00 | $ 25.00 | $ 25.00 | $ 25.00 | |||||||||||||||||||||||||||||
Preferred stock, redemption price (in dollars per share) | $ / shares | $ 25.00 | ||||||||||||||||||||||||||||||||
Number of additional directors that can be elected by preferred stock holders | director | 2 |
Stockholders' Equity - AOCI (Details) - USD ($) $ in Thousands |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2014 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
AOCI, beginning balance | $ 515,851 | |||
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | $ 4,500 | 0 | $ 4,537 | $ 0 |
AOCI, ending balance | 573,682 | 515,851 | ||
Net Unrealized Gain/(Loss) on AFS Securities | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
AOCI, beginning balance | 585,250 | 813,515 | 752,912 | |
OCI before reclassifications | 72,560 | (194,890) | 95,551 | |
Amounts reclassified from AOCI | (37,407) | (37,912) | (34,948) | |
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | 4,537 | 0 | |
Net OCI during the period | 35,153 | (228,265) | 60,603 | |
AOCI, ending balance | 813,515 | 620,403 | 585,250 | 813,515 |
Net Unrealized Gain/(Loss) on Swaps | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
AOCI, beginning balance | (69,399) | (59,062) | (15,217) | |
OCI before reclassifications | 22,678 | (10,337) | (44,292) | |
Amounts reclassified from AOCI | 0 | 0 | 447 | |
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | 0 | 0 | |
Net OCI during the period | 22,678 | (10,337) | (43,845) | |
AOCI, ending balance | (59,062) | (46,721) | (69,399) | (59,062) |
Accumulated Other Comprehensive Income | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
AOCI, beginning balance | 515,851 | 754,453 | 737,695 | |
OCI before reclassifications | 95,238 | (205,227) | 51,259 | |
Amounts reclassified from AOCI | (37,407) | (37,912) | (34,501) | |
Cumulative effect adjustment on adoption of revised accounting standard for repurchase agreement financing | 0 | 4,537 | 0 | |
Net OCI during the period | 57,831 | (238,602) | 16,758 | |
AOCI, ending balance | $ 754,453 | $ 573,682 | $ 515,851 | $ 754,453 |
Stockholders' Equity - AOCI Reclassifications (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Realized gain on sale of securities | $ (36,922) | $ (37,207) | $ (34,948) | ||||||||
OTTI recognized in earnings | $ 0 | $ (485) | $ 0 | $ 0 | $ 0 | $ 0 | $ (298) | $ (407) | (485) | (705) | 0 |
Total Swaps designated as cash flow hedges | 0 | 0 | 447 | ||||||||
Accumulated Other Comprehensive Income/(Loss) | |||||||||||
Unrealized losses recorded in AOCI on securities for which Other-than-temporary impairments had been recognized in earnings in prior periods | $ 1,700 | $ 1,300 | 1,700 | 1,300 | |||||||
Available for sale MBS | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Total reclassifications for period | (37,407) | (37,912) | (34,948) | ||||||||
Amounts Reclassified from AOCI | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
OTTI recognized in earnings | (485) | (705) | 0 | ||||||||
Total AFS Securities | (37,407) | (37,912) | (34,948) | ||||||||
Total Swaps designated as cash flow hedges | 0 | 0 | 447 | ||||||||
Total reclassifications for period | (37,407) | (37,912) | (34,501) | ||||||||
Amounts Reclassified from AOCI | De-designated Swaps | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Total Swaps designated as cash flow hedges | 0 | 0 | 447 | ||||||||
Amounts Reclassified from AOCI | Available for sale MBS | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Realized gain on sale of securities | $ (36,922) | $ (37,207) | $ (34,948) |
EPS Calculation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | 12 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
||||
Numerator: | ||||||||||||||
Net income | $ 72,637 | $ 83,011 | $ 78,950 | $ 78,070 | $ 73,471 | $ 79,510 | $ 78,071 | $ 82,174 | $ 312,668 | $ 313,226 | $ 313,504 | |||
Dividends declared on preferred stock | (15,000) | (15,000) | (15,000) | |||||||||||
Dividends, dividend equivalents and undistributed earnings allocated to participating securities | (1,628) | (1,539) | (1,106) | |||||||||||
Net income available to common stockholders - basic and diluted | $ 296,040 | $ 296,687 | $ 297,398 | |||||||||||
Denominator: | ||||||||||||||
Weighted average common shares for basic and diluted earnings per share | 371,122 | 372,114 | 369,048 | [1] | ||||||||||
Basic and diluted earnings per share (in dollars per share) | $ 0.18 | $ 0.21 | $ 0.20 | $ 0.20 | $ 0.19 | $ 0.20 | $ 0.20 | $ 0.21 | $ 0.80 | $ 0.80 | $ 0.81 | |||
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares) | 2,000 | |||||||||||||
Restricted common stock | ||||||||||||||
Denominator: | ||||||||||||||
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares) | 29 | |||||||||||||
Weighted average grant date fair value (in dollars per share) | 7.12 | $ 7.12 | ||||||||||||
Restricted Stock Units | ||||||||||||||
Denominator: | ||||||||||||||
Anti-dilutive securities excluded from diluted earnings per share calculations (in shares) | 2,000 | |||||||||||||
Weighted average grant date fair value (in dollars per share) | $ 6.85 | $ 6.85 | ||||||||||||
|
Equity Compensation, Employment Agreements and Other Benefit Plans (Details) - USD ($) |
12 Months Ended | 48 Months Ended | |||||
---|---|---|---|---|---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2016 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Share based compensation | |||||||
Maximum shares authorized for grant (in shares) | 12,000,000 | ||||||
Shares available for grant | 8,200,000 | ||||||
Weighted Average Exercise Price | |||||||
Accrued Dividends Payable | $ 74,657,000 | $ 74,575,000 | $ 74,529,000 | ||||
Fair value assumptions | |||||||
Expense related to equity-based compensation instruments | $ 9,162,000 | $ 7,832,000 | $ 8,585,000 | ||||
DER | |||||||
Share based compensation | |||||||
Payments attributable to DERs | $ 5,000 | $ 16,000 | $ 69,000 | ||||
Number of shares outstanding (in shares) | 8,215 | 24,402 | 218,225 | 0 | 0 | 8,215 | 24,402 |
Activity and related information | |||||||
Outstanding at beginning of year (in shares) | 8,215 | 24,402 | 218,225 | ||||
Granted (in shares) | 0 | 0 | 0 | ||||
Cancelled, forfeited or expired (in shares) | (8,215) | (16,187) | (193,823) | ||||
Outstanding at end of year (in shares) | 0 | 8,215 | 24,402 | 0 | |||
Weighted Average Grant Date Fair Value | |||||||
Granted (in dollars per share) | $ 2.77 | ||||||
Fair value assumptions | |||||||
Weighted average volatility estimated (as a percent) | 31.00% | ||||||
Expected term | 6 years | ||||||
Weighted average risk-free rate (as a percent) | 2.23% | ||||||
Estimated annual dividend yield (as a percent) | 13.00% | ||||||
Expense related to equity-based compensation instruments | $ 44,000 | $ 82,000 | $ 146,000 | ||||
Stock options | |||||||
Activity and related information | |||||||
Period to determine market value of the common stock to qualify as an incentive stock option for tax purposes | 1 year | ||||||
Maximum grant date market value of the common stock to be received upon exercise of options in one calendar year | $ 100,000 | ||||||
Exercise price of an ISO relative to fair market value on the grant date, minimum (as a percent) | 100.00% | ||||||
Exercise price of an ISO granted to a 10% stockholder relative to fair market value on the grant date, minimum (as a percent) | 110.00% | ||||||
Percentage of stockholders to whom 110% of ISO is granted | 10.00% | ||||||
Maximum period for exercise of stock options | 10 years | ||||||
Aggregate intrinsic value of total stock options Outstanding | $ 0 | ||||||
Stock options activity | |||||||
Outstanding at beginning of year (in shares) | 0 | 5,000 | |||||
Granted (in shares) | 0 | 0 | |||||
Cancelled, forfeited or expired (in shares) | (5,000) | ||||||
Exercised (in shares) | 0 | ||||||
Outstanding at end of year (in shares) | 0 | ||||||
Options exercisable at end of year (in shares) | 0 | ||||||
Weighted Average Exercise Price | |||||||
Outstanding at beginning of year (in dollars per share) | $ 0.00 | $ 8.40 | |||||
Granted (in dollars per share) | 0.00 | ||||||
Cancelled, forfeited or expired (in dollars per share) | 8.40 | ||||||
Exercised (in dollars per share) | 0.00 | ||||||
Outstanding at end of year (in dollars per share) | $ 0.00 | ||||||
Options exercisable at end of year (in dollars per share) | $ 0.00 | ||||||
Restricted Stock | |||||||
Share based compensation | |||||||
Number of shares outstanding (in shares) | 110,920 | 243,948 | 443,967 | 28,968 | 28,968 | 110,920 | 243,948 |
Activity and related information | |||||||
Outstanding at beginning of year (in shares) | 110,920 | 243,948 | 443,967 | ||||
Granted (in shares) | 487,216 | 497,007 | 491,797 | ||||
Vested (in shares) | (567,851) | (629,212) | (690,397) | ||||
Cancelled, forfeited or expired (in shares) | (1,317) | (823) | (1,419) | ||||
Outstanding at end of year (in shares) | 28,968 | 110,920 | 243,948 | 28,968 | |||
Weighted Average Exercise Price | |||||||
Unrecognized compensation cost | $ 203,000 | $ 807,000 | |||||
Accrued Dividends Payable | $ 55,000 | $ 193,000 | |||||
Total fair value of stock vested | $ 4,300,000 | $ 4,300,000 | $ 5,700,000 | ||||
Period for recognizing unrecognized compensation cost | 1 year | ||||||
Weighted Average Grant Date Fair Value | |||||||
Outstanding at beginning of year (in dollars per share) | $ 7.41 | $ 7.48 | $ 7.50 | ||||
Granted (in dollars per share) | 7.66 | 6.83 | 8.29 | ||||
Vested (in dollars per share) | 7.64 | 6.98 | 8.07 | ||||
Cancelled/forfeited (in dollars per share) | 7.12 | 7.74 | 7.58 | ||||
Outstanding at end of year (in dollars per share) | $ 7.12 | $ 7.41 | $ 7.48 | $ 7.12 | |||
Fair value assumptions | |||||||
Expense related to equity-based compensation instruments | $ 4,326,000 | $ 4,373,000 | $ 5,553,000 | ||||
Restricted Stock Units | |||||||
Share based compensation | |||||||
Number of shares outstanding (in shares) | 1,875,730 | 1,218,474 | 777,818 | 2,058,099 | 2,058,099 | 1,875,730 | 1,218,474 |
Activity and related information | |||||||
Outstanding at beginning of year (in shares) | 1,875,730 | 1,218,474 | 777,818 | ||||
Granted (in shares) | 728,195 | 682,054 | 630,815 | ||||
Settled (in shares) | (535,826) | (17,298) | (87,338) | ||||
Cancelled, forfeited or expired (in shares) | (10,000) | (7,500) | (102,821) | ||||
Outstanding at end of year (in shares) | 2,058,099 | 1,875,730 | 1,218,474 | 2,058,099 | |||
Vested but not settled at end of year (in shares) | 911,318 | 729,523 | 643,138 | ||||
Unvested at end of period (in shares) | 1,146,781 | 1,146,207 | 575,336 | ||||
Weighted Average Exercise Price | |||||||
Unrecognized compensation cost | $ 3,600,000 | $ 4,000,000 | |||||
Period for recognizing unrecognized compensation cost | 1 year 7 months 21 days | ||||||
Weighted average forfeiture rate of unvested RSUs (as a percent) | 0.00% | ||||||
Weighted Average Grant Date Fair Value | |||||||
Outstanding at beginning of year (in dollars per share) | $ 6.90 | $ 6.84 | $ 6.48 | ||||
Granted (in dollars per share) | 5.96 | 7.01 | 6.64 | ||||
Settled (in dollars per share) | 6.92 | 6.60 | 6.86 | ||||
Cancelled/forfeited (in dollars per share) | 6.29 | 6.85 | 2.90 | ||||
Outstanding at end of year (in dollars per share) | $ 6.57 | $ 6.90 | $ 6.84 | $ 6.57 | |||
Vested but not settled at end of year (in dollars per share) | $ 6.93 | $ 7.20 | $ 7.10 | ||||
Unvested at end of year (in dollars per share) | $ 6.28 | $ 6.71 | $ 6.54 | ||||
Fair value assumptions | |||||||
Expense related to equity-based compensation instruments | $ 4,792,000 | $ 3,377,000 | $ 2,886,000 | ||||
Restricted Stock Units | Chief Executive Officer | |||||||
Fair value assumptions | |||||||
Expense related to equity-based compensation instruments | $ 500,000 | ||||||
RSUs With Service Condition | |||||||
Share based compensation | |||||||
Number of shares outstanding (in shares) | 1,138,930 | 769,174 | 490,099 | 1,194,299 | 1,194,299 | 1,138,930 | 769,174 |
Activity and related information | |||||||
Outstanding at beginning of year (in shares) | 1,138,930 | 769,174 | 490,099 | ||||
Granted (in shares) | 420,695 | 390,804 | 357,015 | ||||
Settled (in shares) | (360,326) | (17,298) | (72,873) | ||||
Cancelled, forfeited or expired (in shares) | (5,000) | (3,750) | (5,067) | ||||
Outstanding at end of year (in shares) | 1,194,299 | 1,138,930 | 769,174 | 1,194,299 | |||
Vested but not settled at end of year (in shares) | 617,518 | 554,023 | 467,638 | ||||
Unvested at end of period (in shares) | 576,781 | 584,907 | 301,536 | ||||
Weighted Average Grant Date Fair Value | |||||||
Outstanding at beginning of year (in dollars per share) | $ 7.71 | $ 7.55 | $ 7.75 | ||||
Granted (in dollars per share) | 6.81 | 7.96 | 7.22 | ||||
Settled (in dollars per share) | 7.75 | 6.60 | 7.28 | ||||
Cancelled/forfeited (in dollars per share) | 7.32 | 7.97 | 7.36 | ||||
Outstanding at end of year (in dollars per share) | $ 7.38 | $ 7.71 | $ 7.55 | $ 7.38 | |||
Vested but not settled at end of year (in dollars per share) | $ 7.45 | $ 7.83 | $ 7.81 | ||||
Unvested at end of year (in dollars per share) | $ 7.30 | $ 7.59 | $ 7.15 | ||||
RSUs With Market and Service Conditions | |||||||
Share based compensation | |||||||
Number of shares outstanding (in shares) | 736,800 | 449,300 | 287,719 | 863,800 | 863,800 | 736,800 | 449,300 |
Activity and related information | |||||||
Outstanding at beginning of year (in shares) | 736,800 | 449,300 | 287,719 | ||||
Granted (in shares) | 307,500 | 291,250 | 273,800 | ||||
Settled (in shares) | (175,500) | 0 | (14,465) | ||||
Cancelled, forfeited or expired (in shares) | (5,000) | (3,750) | (97,754) | ||||
Outstanding at end of year (in shares) | 863,800 | 736,800 | 449,300 | 863,800 | |||
Vested but not settled at end of year (in shares) | 293,800 | 175,500 | 175,500 | ||||
Unvested at end of period (in shares) | 570,000 | 561,300 | 273,800 | ||||
Weighted Average Grant Date Fair Value | |||||||
Outstanding at beginning of year (in dollars per share) | $ 5.66 | $ 5.61 | $ 4.32 | ||||
Granted (in dollars per share) | 4.81 | 5.73 | 5.87 | ||||
Settled (in dollars per share) | 5.21 | 0.00 | 4.71 | ||||
Cancelled/forfeited (in dollars per share) | 5.27 | 5.73 | 2.67 | ||||
Outstanding at end of year (in dollars per share) | $ 5.45 | $ 5.66 | $ 5.61 | $ 5.45 | |||
Vested but not settled at end of year (in dollars per share) | $ 5.83 | $ 5.21 | $ 5.21 | ||||
Unvested at end of year (in dollars per share) | 5.25 | 5.80 | 5.87 | ||||
RSUs with Service Condition and both Service and Market Conditions | |||||||
Activity and related information | |||||||
Granted (in shares) | 615,000 | 582,500 | 547,600 | ||||
Fair value assumptions | |||||||
Weighted average volatility estimated (as a percent) | 17.00% | 18.00% | 22.00% | ||||
Expected term | 3 years | 3 years | 3 years | ||||
Weighted average risk-free rate (as a percent) | 1.20% | 0.90% | 0.73% | ||||
Estimated annual dividend yield (as a percent) | 11.00% | 9.00% | 8.00% | ||||
RSUs with Service Condition, weighted average grant date fair value based on share closing price | |||||||
Activity and related information | |||||||
Granted (in shares) | 113,195 | 99,554 | 83,215 | ||||
Fair value assumptions | |||||||
Common stock, closing price (in dollars per share) | $ 7.20 | ||||||
RSUs with Service Condition, weighted average grant date fair value based on share closing price | Minimum | |||||||
Fair value assumptions | |||||||
Common stock, closing price (in dollars per share) | 7.93 | 7.19 | |||||
RSUs with Service Condition, weighted average grant date fair value based on share closing price | Maximum | |||||||
Fair value assumptions | |||||||
Common stock, closing price (in dollars per share) | $ 7.97 | $ 8.16 | |||||
Equity Compensation Plan | |||||||
Share based compensation | |||||||
Maximum number of common shares that can be granted to participant in any one year (in shares) | 1,500,000 | ||||||
Period during which a participant can be awarded the maximum number of shares allowable under the Plan | 1 year | ||||||
Maximum percentage of common shares that can be owned or deemed to be owned by a participant (more than) | 9.80% |
Equity Compensation, Employment Agreements and Other Benefit Plans - Deferred Compensation and Savings Plans (Details) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2016
USD ($)
officer
|
Dec. 31, 2015
USD ($)
|
Dec. 31, 2014
USD ($)
|
|
Deferred compensation activity | |||
Number of officers having employment agreements with the company | officer | 4 | ||
Deferred Compensation Plans | |||
Deferred compensation activity | |||
Deferrable compensation by the employee, maximum (as a percent) | 100.00% | ||
Expenses related to Deferred Plans | $ 231 | $ (59) | $ 69 |
Cash distributed to the participants | 122 | 109 | 119 |
Undistributed income deferred | 1,066 | 601 | |
Liability Under Deferred Plans | 1,263 | 614 | |
Deferred Compensation Plans | Non-employee directors | |||
Deferred compensation activity | |||
Expenses related to Deferred Plans | 231 | (59) | 69 |
Undistributed income deferred | 1,066 | 601 | |
Liability Under Deferred Plans | $ 1,263 | 614 | |
Savings Plan | |||
Deferred compensation activity | |||
Employer contribution percentage on first 3 percent of eligible compensation deferred by employees | 100.00% | ||
Percentage of eligible compensation deferred by employees qualifying for 100 percent matching contribution | 3.00% | ||
Employer contribution percentage on next 2 percent of eligible compensation deferred by employees | 50.00% | ||
Percentage of eligible compensation deferred by employees qualifying for 50 percent matching contribution | 2.00% | ||
Percentage of employer matching contributions that vest immediately | 100.00% | ||
Expenses for matching contributions | $ 359 | $ 309 | $ 237 |
Fair Value of Financial Instruments - Assets and Liabilities on Recurring Basis (Details) - USD ($) |
Dec. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Assets: | ||
MBS and CRT securities | $ 9,969,163,000 | $ 11,356,643,000 |
Securities obtained and pledged as collateral, at fair value | 510,767,000 | 507,443,000 |
Residential whole loans, at fair value | 814,682,000 | 623,300,000 |
Swaps | 233,000 | 1,127,000 |
Liabilities: | ||
Obligation to return securities obtained as collateral | 510,767,000 | 507,443,000 |
Agency MBS | ||
Assets: | ||
MBS and CRT securities | 3,738,497,000 | 4,752,244,000 |
Non-Agency MBS | ||
Assets: | ||
MBS and CRT securities | 5,825,816,000 | 6,420,817,000 |
CRT securities | ||
Assets: | ||
MBS and CRT securities | 404,850,000 | 183,582,000 |
Level 2 | ||
Components of financial instruments carried at fair value | ||
Derivative credit risk valuation adjustment | 0 | |
Recurring basis | ||
Assets: | ||
Securities obtained and pledged as collateral, at fair value | 510,767,000 | 507,443,000 |
Swaps | 233,000 | 1,127,000 |
Total assets carried at fair value | 11,294,845,000 | 12,488,489,000 |
Liabilities: | ||
Swaps | 46,954,000 | 70,526,000 |
Obligation to return securities obtained as collateral | 510,767,000 | 507,443,000 |
Total liabilities carried at fair value | 557,721,000 | 577,969,000 |
Recurring basis | Agency MBS | ||
Assets: | ||
MBS and CRT securities | 3,738,497,000 | 4,752,244,000 |
Recurring basis | Non-Agency MBS | ||
Assets: | ||
MBS and CRT securities | 5,825,816,000 | 6,420,817,000 |
Recurring basis | CRT securities | ||
Assets: | ||
MBS and CRT securities | 404,850,000 | 183,582,000 |
Recurring basis | Residential whole loans | ||
Assets: | ||
Residential whole loans, at fair value | 814,682,000 | 623,276,000 |
Recurring basis | Level 1 | ||
Assets: | ||
Securities obtained and pledged as collateral, at fair value | 510,767,000 | 507,443,000 |
Swaps | 0 | 0 |
Total assets carried at fair value | 510,767,000 | 507,443,000 |
Liabilities: | ||
Swaps | 0 | 0 |
Obligation to return securities obtained as collateral | 510,767,000 | 507,443,000 |
Total liabilities carried at fair value | 510,767,000 | 507,443,000 |
Recurring basis | Level 1 | Agency MBS | ||
Assets: | ||
MBS and CRT securities | 0 | 0 |
Recurring basis | Level 1 | Non-Agency MBS | ||
Assets: | ||
MBS and CRT securities | 0 | 0 |
Recurring basis | Level 1 | CRT securities | ||
Assets: | ||
MBS and CRT securities | 0 | 0 |
Recurring basis | Level 1 | Residential whole loans | ||
Assets: | ||
Residential whole loans, at fair value | 0 | 0 |
Recurring basis | Level 2 | ||
Assets: | ||
Securities obtained and pledged as collateral, at fair value | 0 | 0 |
Swaps | 233,000 | 1,127,000 |
Total assets carried at fair value | 9,969,396,000 | 11,357,770,000 |
Liabilities: | ||
Swaps | 46,954,000 | 70,526,000 |
Obligation to return securities obtained as collateral | 0 | 0 |
Total liabilities carried at fair value | 46,954,000 | 70,526,000 |
Recurring basis | Level 2 | Agency MBS | ||
Assets: | ||
MBS and CRT securities | 3,738,497,000 | 4,752,244,000 |
Recurring basis | Level 2 | Non-Agency MBS | ||
Assets: | ||
MBS and CRT securities | 5,825,816,000 | 6,420,817,000 |
Recurring basis | Level 2 | CRT securities | ||
Assets: | ||
MBS and CRT securities | 404,850,000 | 183,582,000 |
Recurring basis | Level 2 | Residential whole loans | ||
Assets: | ||
Residential whole loans, at fair value | 0 | 0 |
Recurring basis | Level 3 | ||
Assets: | ||
Securities obtained and pledged as collateral, at fair value | 0 | 0 |
Swaps | 0 | 0 |
Total assets carried at fair value | 814,682,000 | 623,276,000 |
Liabilities: | ||
Swaps | 0 | 0 |
Obligation to return securities obtained as collateral | 0 | 0 |
Total liabilities carried at fair value | 0 | 0 |
Recurring basis | Level 3 | Agency MBS | ||
Assets: | ||
MBS and CRT securities | 0 | 0 |
Recurring basis | Level 3 | Non-Agency MBS | ||
Assets: | ||
MBS and CRT securities | 0 | 0 |
Recurring basis | Level 3 | CRT securities | ||
Assets: | ||
MBS and CRT securities | 0 | 0 |
Recurring basis | Level 3 | Residential whole loans | ||
Assets: | ||
Residential whole loans, at fair value | $ 814,682,000 | $ 623,276,000 |
Fair Value of Financial Instruments - Level 3 (Details) - Residential whole loans - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
|
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
Balance at beginning of period | $ 623,276 | $ 143,472 |
Purchases and capitalized advances | 316,407 | 534,574 |
Changes in fair value recorded in Net gain on residential whole loans held at fair value | 31,254 | 6,539 |
Collection of principal, net of liquidation gains/losses | (66,694) | (34,767) |
Repurchases | (2,909) | 0 |
Transfer to REO | (86,652) | (26,542) |
Balance at end of period | $ 814,682 | $ 623,276 |
Fair Value of Financial Instruments - Fair Value Methodology for Level 3 (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
|
Unobservable Input | ||
Residential whole loans, at fair value | $ 769,301 | $ 505,723 |
Loans which management considers the purchase price continues to reflect the fair value | 45,400 | 117,600 |
Discounted cash flow | ||
Unobservable Input | ||
Residential whole loans, at fair value | 253,287 | 113,166 |
Liquidation model | ||
Unobservable Input | ||
Residential whole loans, at fair value | 516,014 | 392,557 |
Residential loans, simple average, amount | $ 320 | $ 305 |
Residential whole loans | Level 3 | Discounted cash flow | Minimum | ||
Unobservable Input | ||
Discount rate | 5.00% | 6.00% |
Prepayment rate | 0.00% | 0.30% |
Default rate | 0.00% | 0.00% |
Loss severity | 0.00% | 10.00% |
Residential whole loans | Level 3 | Discounted cash flow | Maximum | ||
Unobservable Input | ||
Discount rate | 7.70% | 8.70% |
Prepayment rate | 12.00% | 11.10% |
Default rate | 9.70% | 9.10% |
Loss severity | 77.50% | 79.40% |
Residential whole loans | Level 3 | Discounted cash flow | Weighted Average | ||
Unobservable Input | ||
Discount rate | 6.60% | 7.00% |
Prepayment rate | 7.60% | 6.60% |
Default rate | 2.90% | 3.10% |
Loss severity | 13.00% | 17.03% |
Residential whole loans | Level 3 | Liquidation model | Minimum | ||
Unobservable Input | ||
Discount rate | 6.80% | 6.80% |
Annual change in home prices | (9.20%) | (5.50%) |
Liquidation timeline | 1 month 6 days | 8 months 12 days |
Current value of underlying properties | $ 5 | $ 14 |
Residential whole loans | Level 3 | Liquidation model | Maximum | ||
Unobservable Input | ||
Discount rate | 26.90% | 10.00% |
Annual change in home prices | 7.70% | 6.10% |
Liquidation timeline | 4 years 4 months 24 days | 4 years 4 months 24 days |
Current value of underlying properties | $ 4,900 | $ 3,500 |
Residential whole loans | Level 3 | Liquidation model | Weighted Average | ||
Unobservable Input | ||
Discount rate | 7.70% | 6.90% |
Annual change in home prices | 1.70% | 1.30% |
Liquidation timeline | 1 year 7 months 6 days | 1 year 7 months 6 days |
Current value of underlying properties | $ 634 | $ 626 |
Fair Value of Financial Instruments - Difference Between Fair Value and Unpaid Principal Balance (Details) - USD ($) $ in Thousands |
Dec. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Total loans, Fair Value | $ 814,682 | $ 623,300 |
Total loans, Unpaid Principal Balance | 966,276 | 786,330 |
Residential whole loans | ||
Fair Value, Option, Quantitative Disclosures [Line Items] | ||
Total loans, Fair Value | 814,682 | 623,276 |
Total loans, Unpaid Principal Balance | 966,174 | 786,330 |
Total loans, Difference | (151,492) | (163,054) |
Loans 90 days or more past due, Fair Value | 570,025 | 493,640 |
Loans 90 days or more past due, Unpaid Principal Balance | 695,282 | 637,459 |
Loans 90 days or more past due, Difference | $ (125,257) | $ (143,819) |
Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value (Details) - USD ($) $ in Thousands |
Dec. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Financial Assets: | ||
MBS and CRT securities | $ 9,969,163 | $ 11,356,643 |
Securities obtained and pledged as collateral, at fair value | 510,767 | 507,443 |
Residential whole loans, at carrying value | 590,540 | 271,845 |
Residential whole loans, at fair value | 814,682 | 623,300 |
Restricted cash | 58,463 | 71,538 |
Swaps | 233 | 1,127 |
Financial Liabilities: | ||
Obligation to return securities obtained as collateral | 510,767 | 507,443 |
Senior Notes | 96,733 | 96,697 |
Carrying value | ||
Financial Assets: | ||
Securities obtained and pledged as collateral, at fair value | 510,767 | 507,443 |
Cash and cash equivalents | 260,112 | 165,007 |
Restricted cash | 58,463 | 71,538 |
Swaps | 233 | 1,127 |
Financial Liabilities: | ||
Repurchase agreements | 8,472,268 | 7,887,622 |
FHLB advances | 215,000 | 1,500,000 |
Securitized debt | 0 | 21,868 |
Obligation to return securities obtained as collateral | 510,767 | 507,443 |
Senior Notes | 96,733 | 96,697 |
Swaps | 46,954 | 70,526 |
Estimated fair value | ||
Financial Assets: | ||
Securities obtained and pledged as collateral, at fair value | 510,767 | 507,443 |
Cash and cash equivalents | 260,112 | 165,007 |
Restricted cash | 58,463 | 71,538 |
Swaps | 233 | 1,127 |
Financial Liabilities: | ||
Repurchase agreements | 8,472,078 | 7,828,115 |
FHLB advances | 215,000 | 1,500,000 |
Securitized debt | 0 | 22,057 |
Obligation to return securities obtained as collateral | 510,767 | 507,443 |
Senior Notes | 101,111 | 101,391 |
Swaps | 46,954 | 70,526 |
Agency MBS | ||
Financial Assets: | ||
MBS and CRT securities | 3,738,497 | 4,752,244 |
Agency MBS | Carrying value | ||
Financial Assets: | ||
MBS and CRT securities | 3,738,497 | 4,752,244 |
Agency MBS | Estimated fair value | ||
Financial Assets: | ||
MBS and CRT securities | 3,738,497 | 4,752,244 |
Non-Agency MBS | ||
Financial Assets: | ||
MBS and CRT securities | 5,825,816 | 6,420,817 |
Non-Agency MBS | Carrying value | ||
Financial Assets: | ||
MBS and CRT securities | 5,825,816 | 6,420,817 |
Non-Agency MBS | Estimated fair value | ||
Financial Assets: | ||
MBS and CRT securities | 5,825,816 | 6,420,817 |
CRT securities | ||
Financial Assets: | ||
MBS and CRT securities | 404,850 | 183,582 |
CRT securities | Carrying value | ||
Financial Assets: | ||
MBS and CRT securities | 404,850 | 183,582 |
CRT securities | Estimated fair value | ||
Financial Assets: | ||
MBS and CRT securities | 404,850 | 183,582 |
Residential whole loans | Carrying value | ||
Financial Assets: | ||
Residential whole loans, at carrying value | 590,540 | 271,845 |
Residential whole loans, at fair value | 814,682 | 623,276 |
Residential whole loans | Estimated fair value | ||
Financial Assets: | ||
Residential whole loans, at carrying value | 621,548 | 289,696 |
Residential whole loans, at fair value | $ 814,682 | $ 623,276 |
Fair Value of Financial Instruments (Narrative) (Details) - USD ($) $ in Millions |
Dec. 31, 2016 |
Dec. 31, 2015 |
---|---|---|
Fair Value Disclosures [Abstract] | ||
Other real estate | $ 80.5 | $ 28.0 |
Other real estate, fair value | $ 91.1 |
Use of Special Purpose Entities and Variable Interest Entities (Details) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Sep. 30, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Special purpose entities and variable interest entities | ||||||||||||
MBS and CRT securities | $ 9,969,163,000 | $ 11,356,643,000 | $ 9,969,163,000 | $ 11,356,643,000 | ||||||||
Residential Whole Loans | 1,400,000,000 | 895,100,000 | 1,400,000,000 | 895,100,000 | ||||||||
Residential whole loans, at carrying value | 590,540,000 | 271,845,000 | 590,540,000 | 271,845,000 | ||||||||
Residential whole loans, at fair value | $ 814,682,000 | 623,300,000 | $ 814,682,000 | 623,300,000 | ||||||||
Equity interest in certificates | 100.00% | 100.00% | ||||||||||
Interest income residential whole loans | $ 16,000,000 | $ 23,916,000 | 16,036,000 | $ 4,083,000 | ||||||||
Net gain on residential whole loans held at fair value | $ 14,632,000 | $ 18,701,000 | $ 14,470,000 | $ 11,881,000 | 6,899,000 | $ 5,565,000 | $ 3,224,000 | $ 2,034,000 | 59,684,000 | 17,722,000 | $ 116,000 | |
Non-Agency MBS | ||||||||||||
Special purpose entities and variable interest entities | ||||||||||||
MBS and CRT securities | 5,825,816,000 | 6,420,817,000 | 5,825,816,000 | 6,420,817,000 | ||||||||
Non-Agency MBS Transfered to Consolidated VIEs | ||||||||||||
Special purpose entities and variable interest entities | ||||||||||||
Taxable income currently estimated | $ 70,900,000 | |||||||||||
Taxable income currently estimated per share (in USD per share) | $ 0.19 | |||||||||||
Non-Agency MBS Transfered to Consolidated VIEs | Non-Agency MBS | ||||||||||||
Special purpose entities and variable interest entities | ||||||||||||
MBS and CRT securities | 174,400,000 | 598,300,000 | $ 174,400,000 | 598,300,000 | ||||||||
WFMLT Series 2012-RR1 | ||||||||||||
Special purpose entities and variable interest entities | ||||||||||||
Securitized debt | $ 0 | $ 22,100,000 | $ 0 | $ 22,100,000 | ||||||||
Trust, Ownership in Residential Whole Loans | ||||||||||||
Special purpose entities and variable interest entities | ||||||||||||
Equity interest in certificates | 100.00% | 100.00% |
Summary of Quarterly Results of Operations (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2016 |
Sep. 30, 2016 |
Jun. 30, 2016 |
Mar. 31, 2016 |
Dec. 31, 2015 |
Sep. 30, 2015 |
Jun. 30, 2015 |
Mar. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2014 |
|
Quarterly Financial Information Disclosure [Abstract] | |||||||||||
Interest income | $ 112,528 | $ 112,716 | $ 114,507 | $ 117,418 | $ 118,499 | $ 119,706 | $ 123,995 | $ 129,943 | $ 457,169 | $ 492,143 | $ 463,817 |
Interest expense | (49,868) | (48,167) | (47,720) | (47,600) | (46,456) | (43,703) | (42,849) | (43,940) | (193,355) | (176,948) | (159,808) |
Net Interest Income | 62,660 | 64,549 | 66,787 | 69,818 | 72,043 | 76,003 | 81,146 | 86,003 | 263,814 | 315,195 | 304,009 |
Net Impairment Losses Recognized in Earnings | 0 | (485) | 0 | 0 | 0 | 0 | (298) | (407) | (485) | (705) | 0 |
Net gain on residential whole loans held at fair value | 14,632 | 18,701 | 14,470 | 11,881 | 6,899 | 5,565 | 3,224 | 2,034 | 59,684 | 17,722 | 116 |
Gain on sales of MBS | 9,768 | 7,083 | 9,241 | 9,745 | 9,652 | 11,196 | 7,617 | 6,435 | 35,837 | 34,900 | 37,497 |
Other income | 1,281 | 8,117 | 3,319 | 1,085 | (831) | (259) | (678) | 311 | |||
Operating and other expense | (15,704) | (14,954) | (14,867) | (14,459) | (14,292) | (12,995) | (12,940) | (12,202) | (59,984) | (52,429) | (45,290) |
Net Income | 72,637 | 83,011 | 78,950 | 78,070 | 73,471 | 79,510 | 78,071 | 82,174 | 312,668 | 313,226 | 313,504 |
Preferred stock dividends | (3,750) | (3,750) | (3,750) | (3,750) | (3,750) | (3,750) | (3,750) | (3,750) | (15,000) | (15,000) | (15,000) |
Net Income Available to Common Stock and Participating Securities | $ 68,887 | $ 79,261 | $ 75,200 | $ 74,320 | $ 69,721 | $ 75,760 | $ 74,321 | $ 78,424 | $ 297,668 | $ 298,226 | $ 298,504 |
Earnings per Common Share - Basic and Diluted (in dollars per share) | $ 0.18 | $ 0.21 | $ 0.20 | $ 0.20 | $ 0.19 | $ 0.20 | $ 0.20 | $ 0.21 | $ 0.80 | $ 0.80 | $ 0.81 |
Schedule IV - Mortgage Loans on Real Estate (Details) $ in Thousands |
12 Months Ended | |
---|---|---|
Dec. 31, 2016
USD ($)
loan
|
Dec. 31, 2015
USD ($)
loan
|
|
Movement in Mortgage Loans on Real Estate [Roll Forward] | ||
Residential whole loans, at carrying value, beginning balance | $ 271,845 | |
Residential whole loans, at fair value, beginning balance | 623,300 | |
Residential whole loans, at carrying value, ending balance | 590,540 | $ 271,845 |
Residential whole loans, at fair value, ending balance | $ 814,682 | 623,300 |
Residential whole loans | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 7,038 | |
Balance Sheet Reported Amount | $ 1,405,222 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 771,424 | |
Residential whole loans | Carrying value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 3,226 | |
Balance Sheet Reported Amount | $ 590,540 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | 76,142 | |
Movement in Mortgage Loans on Real Estate [Roll Forward] | ||
Residential whole loans, at carrying value, beginning balance | 271,845 | |
Purchases and capitalized advances | 363,089 | |
Yield accreted | 23,916 | |
Collection of principal | (44,692) | |
Collection of interest | (21,428) | |
Provision for loan loss | 175 | |
Repurchases | 0 | |
Transfer to REO | (2,365) | |
Residential whole loans, at carrying value, ending balance | $ 590,540 | $ 271,845 |
Residential whole loans | Fair value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 3,812 | 3,143 |
Balance Sheet Reported Amount | $ 814,682 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | 695,282 | |
Movement in Mortgage Loans on Real Estate [Roll Forward] | ||
Residential whole loans, at fair value, beginning balance | 623,276 | |
Purchases and capitalized advances | 316,407 | |
Collection of principal | (66,694) | |
Changes in fair value recorded in gain/(loss) on loans recorded at fair value | 31,254 | |
Repurchases | (2,909) | |
Transfer to REO | (86,652) | |
Residential whole loans, at fair value, ending balance | $ 814,682 | $ 623,276 |
Original loan balance $0 - $149,999 | Residential whole loans | Carrying value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 1,189 | |
Balance Sheet Reported Amount | $ 82,718 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 16,826 | |
Original loan balance $0 - $149,999 | Residential whole loans | Carrying value | Minimum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 0.00% | |
Original loan balance $0 - $149,999 | Residential whole loans | Carrying value | Maximum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 13.08% | |
Original loan balance $0 - $149,999 | Residential whole loans | Fair value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 1,268 | |
Balance Sheet Reported Amount | $ 101,448 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 71,868 | |
Original loan balance $0 - $149,999 | Residential whole loans | Fair value | Minimum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 1.00% | |
Original loan balance $0 - $149,999 | Residential whole loans | Fair value | Maximum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 14.99% | |
Original loan balance $150,000 - $299,999 | Residential whole loans | Carrying value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 1,107 | |
Balance Sheet Reported Amount | $ 168,636 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 19,800 | |
Original loan balance $150,000 - $299,999 | Residential whole loans | Carrying value | Minimum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 1.00% | |
Original loan balance $150,000 - $299,999 | Residential whole loans | Carrying value | Maximum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 11.00% | |
Original loan balance $150,000 - $299,999 | Residential whole loans | Fair value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 1,324 | |
Balance Sheet Reported Amount | $ 217,555 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 176,177 | |
Original loan balance $150,000 - $299,999 | Residential whole loans | Fair value | Minimum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 1.80% | |
Original loan balance $150,000 - $299,999 | Residential whole loans | Fair value | Maximum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 12.38% | |
Original loan balance $300,000 - $449,999 | Residential whole loans | Carrying value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 469 | |
Balance Sheet Reported Amount | $ 126,681 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 15,258 | |
Original loan balance $300,000 - $449,999 | Residential whole loans | Carrying value | Minimum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 1.31% | |
Original loan balance $300,000 - $449,999 | Residential whole loans | Carrying value | Maximum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 9.75% | |
Original loan balance $300,000 - $449,999 | Residential whole loans | Fair value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 621 | |
Balance Sheet Reported Amount | $ 176,389 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 155,087 | |
Original loan balance $300,000 - $449,999 | Residential whole loans | Fair value | Minimum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 1.87% | |
Original loan balance $300,000 - $449,999 | Residential whole loans | Fair value | Maximum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 11.00% | |
Original loan balance greater than $449,999 | Residential whole loans | Carrying value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 461 | |
Balance Sheet Reported Amount | $ 212,505 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 24,258 | |
Original loan balance greater than $449,999 | Residential whole loans | Carrying value | Minimum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 1.25% | |
Original loan balance greater than $449,999 | Residential whole loans | Carrying value | Maximum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 8.50% | |
Original loan balance greater than $449,999 | Residential whole loans | Fair value | ||
Mortgage Loans on Real Estate [Line Items] | ||
Number (loans) | loan | 599 | |
Balance Sheet Reported Amount | $ 319,290 | |
Principal Amount of Loans Subject to Delinquent Principal or Interest | $ 292,150 | |
Original loan balance greater than $449,999 | Residential whole loans | Fair value | Minimum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 0.00% | |
Original loan balance greater than $449,999 | Residential whole loans | Fair value | Maximum | ||
Mortgage Loans on Real Estate [Line Items] | ||
Interest Rate | 10.88% |
'KRRL"FV+^TKY14H\?R;5LW
M"?#D[/&UE;OV)1-^WM+5PA*X$HB$*^V;$]-?31S>D_DSW[^LMM7H6UG7Y:9]
M)>&Y+.LB\$\^A57W6N1/QX-U\5PW7WWXOC^\GW(XJ,M=]^[-]/@"T.W_4$L#
M!!0 ( -9@4$I VQ_G/ ( -\& 8 >&PO=V]R:W-H965T YCT9HY<)6 &UL?551CYP@$/XKQO>> @+>QC6YM6G:I$TNUUS[S.ZRJSD5"^QZ
M_?<%]#Q/V;X(#-]\\\T(0]8+^:)*SG7PVM2MVH:EUMTFBM2AY U3=Z+CK=DY
M"=DP;9;R'*E.?4G!MU(<^7]PO@U/-A4F$9[\I3#9)D@W"=)(
MD'Y8XE9,^D\2MNJI!M/$:;*DQ*&+D[SR+@-[Q^.;_ F?IOVK,(WL+#FC\R\;
M^U\C.O!2=E=^A%K_P19#0>W"\<:?S31FD^&PGW\06[YQ\1M02P,$% @
MUF!02F&VTB&T 0 T@, !D !X;"]W;W)K
:::2%;
MFJ?1=S)YBKU3LH63(;;76IC7(R@<,KJE[XY'63-*BMXZU!.+EZ+%R[C+-N[#>'.]FV#K #X!^ RXB7G8
MF"@JOQ=.Y*G!@9BQ]YT(3[P]<-^;(CAC*^*=%V^]]Y+S?9*R2R":8HYC#%_$
M;.<(YMGG%'PMQ9'_ ^?K\-VJPEV$[_ZC\ ^"9)4@B03)AR6NQ>S_2L(6/=5@
MZCA-EA38MW&2%]YY8&]Y?)/?X>.T/PA3R]:2,SK_LK'_%:(#+V5SY4>H\1]L
M-A14+AP_^;,9QVPT'';3#V+S-\[? %!+ P04 " #68%!*J43"S[4! #2
M P &0 'AL+W=O
)4E8RIX:^I6;L)2J6X-@#R5K*'RB7>LU2L7+AJJ]%!<@>P$HV=K:FH HR@%
M#:W:L,CMW$$4.;^INFK9003RUC14_-JRFO>;, [?)YZK:ZG,!"CRCE[9-Z:^
M=P>A1V"*@-9C:3MC^?6W#(@*3;9J'^';F
M^,P,8SMKA7Q1!6/:>ZUXK=9^H76S"@*U+UA%U:-H6&U6CD)65)NA/ 6JD8P>
MG%'%@R@,DZ"B9>WGF9O;RCP39\W+FFVEI\Y51>6?)\9%N_:1_S;Q7)X*;2>"
M/&OHB7UG^D>SE684#"R'LF*U*D7M279<^Q_0:H.(-7"(GR5KU:CO65=V0KS8
MP9?#V@^M(L;97EL*:IH+VS#.+9/1\;LG]8<]K>&X_\;^R3EOG-E1Q3:"_RH/
MNEC["]\[L",]<_TLVL^L=XCX7N_]5W9AW,"M$K/'7G#E_KW]66E1]2Q&2D5?
MN[:L7=MV*VG